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ABSTRACT 
The overall aim of this thesis was to investigate the distribution and regulation of membrane 
progesterone receptors (mPRs) that may be involved in regulating ciliary activity in the fallopian 
tube.  
The fallopian tube serves to transport the egg and spermatozoa to achieve fertilization. Later, the 
formation of the pre-embryo is thought to result from the movement of cilia in the epithelium and 
the muscular activity in the wall of the fallopian tube. The environment in which the gametes exist 
and develop is greatly influenced by the action of ovarian hormones. Progesterone is essential for 
many aspects of female reproduction and is also an important regulator of gamete transport and 
ciliary activity in the fallopian tube. The effects of P4 in the body are mediated predominantly 
through the activation of nuclear progesterone receptor (PGR) isoforms. Rapid effects of P4 in 
cells and tissues lacking the nuclear receptors indicate that there are other also functional receptors 
for P4 in addition to the classical nuclear receptors. In the last four to five years, evidence has been 
obtained that supports the involvement of mPRs in P4 signaling in mammalian reproductive tissues 
and the brain. The mPRs comprise three subtypes (α, β and γ) and belong to the seven-
transmembrane domain progesterone adiponectin Q receptor (PAQR) family. 
Using antibodies designed to detect specific mPR sequences, we showed that mPRs are present in 
reproductive and non-reproductive tissues in mice of both sexes. Using mice as well as tissue from 
healthy fertile women, we have shown that mPRβ and γ are expressed in ciliary cells in the 
fallopian tube epithelium. While mPRβ was specifically localized on the cilia, mPRγ was found at 
the base of the cilia of the same cells. Immunohistochemistry (IHC), confocal microscopy, 
Western blot, reverse transcriptase PCR and real time PCR were used to detect and confirm the 
expression and specific cellular localization of the mPRs in the fallopian tube. Treatment with P4 
in a gonadotropin-primed mouse model reduced the expression of the mPRβ and γ genes in the 
fallopian tube, whereas treatment with estradiol rapidly down-regulated both the gene and protein 
expression of mPRβ in immature animals. In humans, the variation in receptor expression over the 
menstrual cycle showed similarities to the regulation observed in mice before, around and after 
ovulation. A method based on light reflectometry was designed to study possible rapid effects of 
P4 on the tubal ciliary beat frequency (CBF) of mice ex vivo. We found a significant and rapid 
reduction of CBF in P4-treated cells compared to controls.   
In conclusion, this study demonstrates that mPRs are present in the ciliary cells of mouse and 
human fallopian tubes and that P4 can regulate ciliary activity within the fallopian tube. 
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POPULÄRVETENSKAPLIG SAMMANFATTNING 
Äggledarna hos en kvinna sträcker sig som två armar från livmodern till äggstockarna. Med hjälp 
av den flikiga ända som påminner om en hand fångar äggledarna upp ägget som äggstockarna 
avger vid ägglossning en gång per månad. Äggledarna transporterar sedan ägget och spermierna 
mot varandra för att en eventuell befruktning skall äga rum. Befruktningen innebär att en spermie 
smälter samman med äggcellen och blir till en ny cell. Befruktningen sker normalt genom samlag 
och om kvinnan har ägglossning, men kan också ske på konstgjort väg. I det ögonblick då 
spermien befruktar äggcellen bildas en ny cell som får en unik genetisk egenskap. Denna 
befruktade äggcellen transporteras vidare mot livmodern, en resa som normalt tar 3-4 dagar. Under 
resans gång delar cellen sig, växer och mognar för att så småningom bli ett embryo (foster i tidigt 
utveckligsstadium) och sedan ett foster. När resan genom äggledarna tar slut har embryot kommit 
till livmodern där det fäster i dess näringsrika vägg för att under graviditetens långa period växa 
och utvecklas. 
Alltså är en välfungerande äggledare grundläggande för att en kvinna skall bli gravid på ett 
naturligt sätt. Ofrivilig barnlöshet, eller oförmågan att uppnå graviditet, kan bero på många 
orsaker, dels hos mannen, dels hos kvinnan eller båda. I de fall där felet ligger hos kvinnan kan 
rubbningar i äggledarnas funktion vara orsaken till infertilitet. Äggledarna har en tub-liknande 
form som upprätthålls med hjälp av dels den vätska som rinner genom äggledarna, och dels av den 
muskel vägg som klär utsidan av äggledarna. Insidan av äggledaren består av ett skikt celler som 
huvudsakligen är av två typer: cilierade och sekretoriska celler. Ciliecellerna har utväxta 
hårliknande strukturer på sig, medan de sekretoriska cellerna saknar dessa. När ”håret” på 
cillieceller rör sig och viftar, skapas samordnade vågor som förflyttar dels ägg, spermier och 
embryot, men även avlägsnar bakterier eller virus som kan orsaka lokala infektioner. Exempel på 
en bakterieorsakad infektion är klamydia som kan leda till sammanväxningar i äggledarna. De 
signaler som gör att cilierna rör sig kommer från insidan av cellen och kan initieras till exempel av 
ämnen som rinner genom äggledarna eller av signalmolekyler i blodet (hormoner). Dessa 
signalpartiklar tas sig in i ciliecellen genom kanaler som finns i cellens hinna eller genom att 
hormonerna binder till mottagarstrukturer som sitter i cellen och ciliens hinna. De viktiga 
könshormonerna som finns i äggledaren är östrogen och progesteron. Koncentrationen av 
progesteron ökar efter ägglossning, och finns därmed i äggledaren i högre mängd efter ägglossning 
dvs. vid den tidpunkt då befruktningen kan ske. Progesteron är nödvändigt inte bara för 
äggledaren, utan för att ägglossning skall ske och för att förbereda livmodern att ta emot ett 
eventuellt befruktat ägg.  
Det övergripande syftet med mina studier i den här avhandlingen, har varit att undersöka hur 
progesteron påverkar ciliernas rörelse. Progesteron är ett steroidhormon som är fettlöslig och kan 
ta sig genom cellens hinna; inne i cellen binder progesteron till sin mottagarstruktur (också känt 
som ” den klassiska receptorn”) som sedan aktiverar gener i cellkärnan så att nya proteiner bildas. 
Denna process som går via cellkärna är långsam, dvs. tar tid och kallas ”klassiskt”. För några år 
sedan upptäcktes en ny grupp av mottagarstrukturer som sitter i cellens hinna och som förmedlar 
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effekter av progesteron på bara några minuter och skiljer sig från den klassiska processen. Under 
några år har internationell forskning lagt fram bevis för att en liten grupp av proteiner fungerar 
som mottagarstrukturer och förmedlar effekter av progesteron inom framförallt fortplantnings 
processer. I arbete I och delar av arbete II i avhandlingen har vi undersökt om 
mottagarstrukturerna för progesteron förekommer hos människor och möss. Då vävnadsmaterial 
från människor är mycket begränsad har vi använt i vissa undersökningar en djurmodell där unga, 
sexuell omogna möss studerats. Vi har sedan isolerat olika vävnader inklusive äggledarna och 
studerat dessa med hjälp av olika molekylär biologiska tekniker. Vi har visat att två 
mottagarstrukturer, kallade beta-formen respektive gamma-formen, finns i fortplantnings organ 
hos både honor och hanar. Med en mer specifik teknik har vi visat att beta och gamma formen 
finns på distinkta platser i cilicellen, vilket kan tydda på att de uppfyller olika funktioner. En 
intressant observation var också att dessa mottagarstrukturer förekommer olika mycket i vissa 
organ. Gamma-formen finns till exempel mycket i lungan, där det också finns cilieceller, medan 
beta-formen finns mycket i äggstockar hos honor och testiklar hos hanar. 
För att studera hur dessa strukturer regleras, så har vi behandlat mössen med de kvinnliga 
könshormonerna östrogen och progesteron. För att skilja mellan direkt och indirekt effekt av 
hormoner har vi behandlat både den omogna musmodellen och den sexuell mogna musmodellen 
med könshormoner. Vi har i arbete II sett att progesteron på ett snabbt sätt påverkar både beta som 
gamma-formen i den hormonell mogna musmodellen, medan östrogen påverkade receptorerna i 
den omogna modellen. Studier av humant material visade likheter med de resultaten från musen 
avseende hur receptorerna förekomst varierar kring ägglossningen.  
I arbete III försökte vi beskriva effekten av progesteron på ciliecellen genom att mäta frekvensen 
med vilken cilierna slår med eller utan behandling med progesteron. Vi använde den omogna 
musmodellen från vilken vi isolerade cilieceller från äggledare. Med hjälp av en fysikalisk metod 
som baseras på ändringar i ljusets brytning (som också kallas ljus reflektometri) kunde vi fastsälla 
en slagfrekvens för cilieceller från mus. Relativt snabbt efter behandling med progesteron såg vi en 
minskning i slagaktivitet hos cilierna som tyder på en snabb och direkt påverkan av progesteron.  
Sammanfattningsvis har vi visat att snabbt verkande mottagarmolekyler för progesteron finns i 
äggledaren hos möss och människor, samt att dessa finns på distinkta platser i ciliecellen. 
Progesteron och östrogen tycks reglera dessa mottagarmolekyler på ett snabbt sätt. Transporten av 
ägg och spermier är beroende av fungerande aktivitet hos cilierna. Denna rörelse påverkas av 
progesteron. Våra studier tyder på att icke-klassiska receptorerna kan vara inblandade i denna 
signaleringskedja. Resultaten bidrar således till en ökad förståelse kring de mekanismer som 
reglerar ägg och spermietransport. 
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INTRODUCTION 
THE FALLOPIAN TUBE  
 “Trumpets of the uterus” was the first exact description of fallopian 
tubes given by Gabriele Falloppio (1523 - 1562) (Fig. 1), one of the 
most important anatomists of the sixteenth century. The anatomical 
description of the tubes was published in his first collected work in 
1584, in Venice. He saw connecting ducts between the uterus and 
the ovaries and also considered these tubes to be semen-conveying 
vessels. Today several names, including oviducts, uterine tubes or 
salpinges, are used to describe the fallopian tubes. 
Role in reproduction 
Besides serving as the normal site of fertilization, the fallopian tubes act as ducts for the transport 
of oocytes and spermatozoa. Tubal transit has been proven to depend on several physiological 
events, such as muscle contractility [1], ciliary activity [2] the composition of the follicular fluid 
[3]. There is still debate on which is the most important contributing mechanism in tubal transport, 
but it has been shown that ciliary activity plays a central role [4, 5]. 
Fallopian tubes are also essential for other purposes besides serving as a conduit between the 
gonads and the uterus; for instance, they enable the peritoneal fluid to come in contact with the 
uterine fluid. Keeping in mind the influence of P4 on endometrial proliferation, one principal role 
of fallopian tubes might be to delay passage of the embryos until the uterus is suitably prepared 
[6]. In surgical studies with several animal models, the caudal part of the isthmus was observed to 
act as a sequestrating reservoir of viable spermatozoa in the pre-ovulatory period. The further 
progression of the spermatozoa to the site of fertilization might depend on factors present or 
introduced by ovulation in the fallopian tube [7]. 
Anatomy 
The fallopian tubes are paired tubular organs whose anatomical shape differs somewhat between 
mice and humans (Fig. 2). The human fallopian tubes stretch from the uterus to the ovaries, 
measure about 7-14 cm in length and are not directly attached to the ovaries, but rather open into 
the peritoneal cavity [8]. Besides the curly anatomical form of fallopian tubes in mice, another 
difference is that mice have a bursa surrounding both the ovary and the fallopian tube. During 
ovulation, ova released into the bursal cavity travel through the bursal fluid and enter the oviduct 
without entering the peritoneal cavity [9]. In humans, the ends of the fallopian tubes lying next to 
the ovary feather into fringe-like structures called Fimbriae (Latin for “fringe”). The Fimbriae 
sweep over the ovaries with their millions of tiny hair-like cilia and draw the newly released 
oocyte into the tube.  
 
 
 
FIGURE 1: Gabriele Falloppio 
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FIGURE 2: Anatomical illustration of the human (A) and mouse (B and C) female reproductive tracts.  
 
Considering the fallopian tube in all its length, there are four anatomical segments that differ from 
each other in structure and function [8] (Fig. 3): 
1. The infundibulum is a funnel shaped segment that contains the fimbriae. The majority of cells 
in this region are ciliated. 
2. The ampulla comprises more than half the length of the tube and has an outer diameter of 1-2 
cm in humans [10]. The meeting between the oocyte and the sperm takes place in this part of 
the fallopian tube. The mucosal folds here are large and almost fill the ampullary lumen. 
3. The isthmus is a narrow part near the uterus and is about 3 cm long in humans. It has two well-
developed muscular layers [10]. Secretory cells are predominant in this region, with smaller 
mucosal folds than in the ampulla.  
4. The intramural part is located in the uterine wall and has three muscular layers. Its luminal 
diameter is only about 1 mm, and its length is about 1 cm. The mucosal folds are fewer and the 
ciliary cells are less abundant compared to the distal parts of the tube. 
All anatomical segments are found in both humans and mice. 
Histology  
Moving from the center of the fallopian tube to the periphery, a cross-section shows: the internal 
mucosa (endosalpinx), the muscular layer (myosalpinx) and the serosa. The size of the lumen, the 
shape of the mucosa and the thickness of the muscular layer all vary along the length of the tube 
(Fig. 3).  
 
 
 
 
FIGURE 3: Schematic 
illustration of the human 
fallopian tube showing the 
folds in the A) infundibulum, 
B) ampulla and C) isthmus. 
The immunohistochemistry 
images are taken from a 
mouse fallopian tube in the 
same regions.  
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The mucosa is more complex in the ampulla, which features extensive folding. The lamina propria 
is a component of the mucosa that lies beneath the epithelium. The lamina propria contains a 
network of fibers, stroma cells, mast cells, capillaries and lymph vessels. The mucosal lining the 
mammalian fallopian tube is a simple columnar epithelium consisting of two cell types, ciliated 
cells and secretory cells, both of which bear cilia (Fig. 4). In mammals, cilia are membrane-bound 
hair-like processes that extend from the basal body. The ciliated cells of the fallopian tube have 
motile cilia, whereas the secretory cells have smaller, non-motile cilia (see below) [11].  
Motile cilia are present in the female reproductive tract, in sperm tails and in the respiratory tract 
[11, 12]. The epithelial cells may possess several hundred 9 + 2 motile cilia that extend from the 
basal body (Fig. 4A and B). The cilia proper, including the basal body and its associated proteins, 
constitute the ciliary apparatus. The formation of the ciliary apparatus, called ciliogenesis, has 
been studied in many species, including humans [13], mice [14] and rabbits [15], and it is similar 
among different animals. Moreover, ciliogenesis in the reproductive and the respiratory tract is 
fundamentally the same [16]. Ciliary movement is generated by a connection between the outer 
and inner dynein arm and the doublet of the microtubule [17, 18]. The first true ciliary disease 
leading to male infertility has been shown to result from the lack of dynein arms [19]. Ciliogenic 
cells are frequently present in the tubal epithelium in the mid-follicular phase, whereas they lose 
most of their cilia in the luteal phase of the menstrual cycle [20]. In mammals, motile cilia are 
about 5-6 µm long and 0.25 µm in diameter. They comprise an axoneme composed of 
microtubules and microtubule-associated structures. The axoneme appears in two configurations: 
the 9 + 2 motile configuration and the non-motile 9 + 0 configuration [11] (Fig. 4C and D). The 
ciliary membrane is continuous with the cell membrane but is selectively different in its 
composition. The function of the motile cilia depends on specific receptors, and ion channes 
proteins, calcium ions (Ca
2+
) channels and receptors involved in growth control pathways. Using 
cilia fractionation and proteomics, more than 1400 peptides, 200 axonemal proteins and peptide 
matches to over 200 expressed sequence tags have been identified in human cilia [21]. However, 
the distribution of certain receptors in primary versus motile cilia or in the ciliary versus apical 
membrane is not always the same [22]. 
The non-motile cilia, also named primary cilia, extend from the apical surface of secretory cells 
and are usually solitary (Fig. 4A and C). Whether the apical surface of the secretory cells is 
covered by domes, microvilli [23] or a single cilium [11] is still under debate. What is agreed 
upon, however, is that this type of cilium lacks a pair of singlet microtubules (9 + 0 configuration) 
and dyneic arms and is thus considered non-motile [24]. The physiological function of primary 
cilia has probably been underestimated for many years, but it has been shown that they may play 
sensory roles in many cellular systems [11]. The ciliary membrane of primary cilia is equipped 
with protein complexes and ion channels (e.g., Ca
2+
) that potentially function as 
mechanoreceptors. Under the influence of fluid flow and when cilia bend, Ca
2+
 channels are 
activated, resulting in an increase in Ca
2+
 influx and the consequent activation of various 
subcellular events [25]. Primary cilia have a widespread distribution among the cells of the body, 
as much in epithelial cells in the fallopian tube [11, 26] as in non-epithelial cells like fibroblast and 
smooth muscle cells [12].  
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FIGURE 4: Illustration of the fallopian tube epithelium (A) containing ciliary cells (1) and a secretory cell (2). 
Microscopy image of a ciliary cell from a mouse fallopian tube (B) (100x). Electron microscopy images showing the 
structure of motile (D) and non-motile cilia (C).  
 
Beside these two types of epithelial cells, the mucosa of the fallopian tube contains intercalary 
cells with a yet unknown function and basal cells attached to the basal membrane. The basal cells 
have been suggested to have dual functions: they may act as T-lymphocytes as a part of the 
immune system and also serve a regenerative function like stem cells [27, 28]. 
The muscular layer consists of an inner circular and outer longitudinal layer to which a third layer 
is added in the interstitial (intramural) region close to the uterus.  
The serosa is the outer surface of the fallopian tube facing the peritoneal cavity [29].  
Tubal innervation, vasculature and lymphatics 
Both parasympathetic and sympathetic nerve fibers are found in fallopian tubes. The preganglionic 
fibers of the parasympathetic system come from spinal segments S2 and S4; they traverse the 
pelvic branches and end in ganglia close to the isthmus region. The other region of the fallopian 
tube, the ampulla, receives parasympathetic nerve fibers from terminal branches of the vagus 
nerve. The preganglionic sympathetic fibers in the fallopian tube originate from spinal segments 
Th11 and Th12 and contain both long and short adrenergic neurons [1]. 
Blood supply to the fallopian tube comes from the uterine and the ovarian arteries. The uterine 
artery comes from the internal iliac artery, which is formed by a bifurcation of the aorta. The 
ovarian artery originates directly from the aorta. The arterial system is in contact with the venous 
drainage system, which allows for a counter-counter mechanism for the exchange of substances 
such as P4 and prostaglandins [30, 31]. 
The lymphatic plexus in the fallopian tube is drained by the uterine and ovarian lymphatic vessels. 
The lymph or interstitial fluid surrounding the cells enters the vessels by filtration. It has been 
Magdalena Nutu 
shown that particles introduced into the peritoneal cavity are transported via the peritoneal 
lymphatic flow, which is eventually transferred into the venous circulation system [8]. 
 
PHYSIOLOGY 
Targets for progesterone  
The steroid hormone P4 is involved in a variety of physiological events in mammals, with target 
tissues throughout the body, from the brain, to the mammary glands, ovaries, uterus and even bone 
[32]. Broadly speaking, the best-known physiological roles of P4 involve its effects on the uterus 
and ovaries for the release of the mature oocyte, facilitation of implantation and maintenance of 
pregnancy. 
Patterns of gamete transport  
The transport of the egg and spermatozoa towards the fertilization site and the further transport of 
the embryo to its implantation site in the uterus have been recognized as fundamental steps in the 
process of human procreation. One striking fact is that objects (egg, embryo or sperm) being 
transported in both directions (for fertilization or implantation) through the fallopian tube are 
subjected to a physically and chemically changing environment, reflecting regional differences and 
the complexity of the fallopian tube. 
Sperm migration  
In order to reach the site of fertilization after coitus, spermatozoa must pass through different 
anatomical regions of the female reproductive tract, such as the cervix, uterus and uterotubal 
junction. Within minutes, human sperm deposited in the vagina start their journey towards the 
cervical canal [33]; in mice, however, they are swept all the way through the cervix into the uterus 
[34]. Although sperm are exposed to several environmental impediments, such as the acidic pH of 
vaginal fluid [35], the defense mechanisms of the female immune system [36] and partly 
impenetrable mucus [37], this passage is regulated to maximize the chance of normal and vigorous 
sperm successfully completing the journey. 
Compared to the vagina, cervix or uterus, the fallopian tube provides a haven-like environment for 
sperm. Immediately after entrance into the isthmus, the sperm appear to be trapped in a reservoir, 
which might contribute to prolonged sperm fertility properties [38] while reducing the risks of 
polyspermic fertilization [39]. However, a defined sperm reservoir has never been defined in 
humans. Instead, the sperm bind to carbohydrates moieties in the epithelium of the fallopian tube, 
a phenomenon that has been observed in vivo and vitro in both human and non-human species [40-
42]. When sperm are incubated with epithelium, capacitation is delayed due to stabilization of the 
sperm membrane and reduced membrane fluidity, which prevents increases in cytoplasmatic Ca
2+
 
[43]. Viability may also be preserved by mucus in the lumen and the complexity or regional 
density of mucosal folds, which must slow down the sperm‟s migration. Although the structure 
and composition of the flagella and motile cilia are identical, the beating patterns differ between 
Membrane progesterone receptors in the fallopian tube 
17 
these organelles. The motion of flagella (e.g., in the tail of sperm) follows a propeller-like pattern. 
Thus, flagella serve in the propulsion of a single cell, such as in swimming in spermatozoa.  
 Oocyte and embryo transport along the fallopian tube 
Transport of the egg through the fallopian tube starts with the rupture of the follicle at ovulation 
and ends when the egg or embryo passes into the uterus. The time taken by the oocyte to travel 
through the fallopian tube is somewhat constant within each species, but there is some variation 
among species. Time is needed for the egg to become fertilized during its journey and for the 
endometrium to prepare for implantation and allow post-fertilization development. It is obviously 
more difficult to study ovum transport in women because of ethical concerns. However, detailed 
observations made in other species such as mice and rabbits have been useful [44].  
In humans, the fimbriae come in close contact with the ovary at ovulation and sweep the cumulus 
mass from the ruptured follicle into the fallopian tube with back-and-forth movements. 
Additionally, muscle contractions contribute to bringing the fimbria and ovary even closer together 
[45, 46]. If the egg falls into the peritoneal cavity, it is still possible for the fimbria to catch it, as 
was observed from human experiments in which microspheres were injected into the peritoneal 
cavity [9]. In humans, unlike in many other species, the egg spends most of its time in the 
ampullary segment. When the developing zygote gets to the ampullary isthmic junction (AIJ), 
passage through the isthmus takes hours or days and is induced by rapid back-and-forth 
movements suggested to occur due to muscular contractility and ciliary activity. However, 
isoproterenol treatment did not affect the CBF in rats, but abolished the undulatory movement 
caused by the muscle layer. When smooth muscle activity was blocked by isoproterenol, the 
transport rates remained unchanged. Furthermore, the ciliary beat frequency was not affected by 
isoproterenol, suggesting that ciliary movement can transport the egg in the absence of muscular 
activity [4]. 
In rodents, egg transport is stable and slow in the very beginning; however, it then starts to change, 
with more rapid forward and backward movements associated with muscular contractions. These 
rapid movements might ensure that gamete and tubal secretions are mixed [47]. In rabbits, the 
transport pattern has been worked out in detail and described to occur in several steps: the first step 
is a rapid contact between the fimbriated ends and the cumulus cell mass; the second step is a brief 
retention time near or at the AIJ, so that fertilization and the dislocation of cumulus cells can 
occur; the third step is the passage of the egg through the isthmus; and the fourth step is retention 
at the isthmic uterine junction, which accounts for over 40% of time spent by the egg in the 
fallopian tube in mice [48]. A noteworthy observation is that in mice, several eggs are transported 
and they tend to travel relatively close together.   
Transportation time  
The approximate length of the interval from ovulation to implantation varies from five days in 
rodents to 10 days in primates or 15 days in bats, but some intra-species differences were also 
observed when animals were studied under different physiological conditions [9, 44].  In mice and 
humans, the duration of tubal transport is similar, from 72 h in mice to 80 h in humans, despite the 
very different lengths of the fallopian tubes [9]. In pigs and rabbits, the transportation time is 48 
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hours and 55 hours respectively [49]. The egg travels at different speeds through the various 
portion of the fallopian tube, and there are marked differences among species in this process. In 
women, eggs appear to spend almost 60 h in the ampullary-isthmic junction after ovulation [44] . 
The passage through the isthmus takes less than 10 hours, meaning that the human egg spends 
90% of the total duration of tubal transport in the ampulla. This prolonged time in the ampulla 
seems to be typical of primates and has pathophysiological implications as well. In humans, 
aberrations or dysfunction in tubal transport may result in implantation of the embryo in the 
fallopian tube (i.e., ectopic pregnancy). In mice and rabbits, there is a similar time passage pattern, 
but the egg is kept in the ampullary-isthmic junction for only 25% of the total duration of tubal 
transport, spending much more time instead at the isthmic-uterine junction. [47, 48].  
Mechanisms of tubal transport 
It is widely accepted that the physiological phenomenon of egg passage through the fallopian tube 
is the result of mechanical energy provided by the smooth muscle, ciliated and secretory epithelial 
cells [1]. The significance of muscular and ciliary activity or flow of mucus secretions is still 
arguable, but it is generally accepted that there are regional differences along the fallopian tube in 
terms of the contribution of each factor. There are also differences among species in the anatomy 
and distribution of cellular components of the fallopian tube that complicate the entire picture of 
gamete transport.  
Ciliary movement  
There is considerable evidence for the contribution of cilia to oocyte and embryo movement in the 
fallopian tube. First, the ciliated motile cilia are found predominantly in the ampullary region 
rather than in the isthmic region of the fallopian tube in many species [9]. Second, the pattern of 
ciliary movement changes at the time of ovulation. Despite the fact that cilia often beat out of 
phase with one another, at the time of ovulation this slatternly movement changes to a 
synchronized movement oriented toward the uterus, both in humans [50] and in rabbits [51]. When 
clusters of cilia become activated, they stimulate neighboring cilia and initiate a metachronal wave 
movement across the epithelium [52]. The mechanics of ciliary movement depend on the outer and 
inner dynein arms (ODA and IDA), which are force-producing molecular motors causing the slide 
of microtubules. Generally, the ODAs and IDAs function together, but the ODAs principally 
regulate beat frequency while the IDAs control beat form [53].  In both cilia and flagella, there is a 
motility process occurring between the ciliary/flagellar membrane and the axoneme. This process 
is called intraflagellar transport (IFT), and the proper function of cilia/flagella depends on the 
assembly of precursor molecules that are bound to IFT particles in order to be transported between 
the tip of the cilia and the cell body [54]. Clinical features of primary ciliary dyskinesia (PCD), 
which include, among other pathological conditions, rhinitis, sinusitis and male infertility, point to 
physiological processes in which ciliary motility is essential [55]. Mice defective in hydin, a 
component of the central pair of microtubules, develop hydrocephalus and die shortly after birth 
[56]. In humans, fluid flow produced by the motile cilia is disturbed because people diagnosed 
with PCD have situs inversus totalis [57]. Third, if muscular activity is inhibited by isoproterenol, 
a synthetic beta-adrenoreceptor antagonist, cilia alone are capable of transporting ova to the site of 
fertilization within a normal time frame [4, 5]. In contrast, women suffering from immotile cilia 
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syndrome are not always infertile [58, 59]. A number of studies have reported a significant 
increase in CBF after ovulation [2, 60], while others have found no such cyclical variations [61]. It 
is important to interpret the results with caution due to limitations of the techniques used and, most 
importantly, due to the in vitro nature of these experiments.  
Contractile activity 
Tubal smooth muscle exhibits brief contractions (episodic) and sustained contractions (tonic) that 
have been reported to occur in the proliferative and periovulatory periods and in vitro [62, 63]. The 
electrical properties of the tubal smooth muscle layer have been studied in humans [64] and 
intensively in rabbits [1]. Compared to the ampulla, the muscular coat of the isthmus is thick and 
tonic contractions appear to take place at the AIJ and the UTJ [65]. The spread of electrical and 
mechanical activity has been shown to take diverse directions on the tubalsegment and the 
muscular layer. In humans, the electrical activity spreads toward the uterus subsequent to 
menstruation, whereas prior to ovulation the activity in the AIJ is oriented from both ends of the 
oviduct, probably to facilitate the migration of the sperm and oocyte towards each other. After 
ovulation, the activity in the AIJ is more coordinated and oriented towards the uterus to facilitate 
further movement in the correct direction [64, 66]. These changes in contractile activity are 
thought to be controlled by systemic hormones, neurotransmitters and cytokines [67].  
A counter-current transport system between blood vessels with flow in opposite directions is found 
in the testes and the kidney, and there is ample evidence that this mechanism is also present in the 
blood circulation between the fallopian tube, uterus and ovary. The ovary and uterus veins 
anastomose to form a network of blood vessels around the ovarian artery to facilitate the 
concentration of substances and communication within the female reproductive tract [68].  Many 
substances such as prostaglandins, oxytocin and steroids are transferred to tubal/ovarian blood; 
however, the concentration of free hormones is higher because protein-bound hormones do not 
pass across the vessel walls due to their much larger molecular size. In humans, it is not exactly 
known how the concentration of steroid hormones in tubal/ovarian blood compares to that in the 
peripheral blood, but in pigs, the concentrations of both P4 and E2 were higher in tubal blood 
compared to peripheral blood [69]. 
The secretory activity of the epithelial cells is pronounced in the isthmus, considering the 
decreased proportion of ciliated cells from 50% in the ampulla to approximately 27-35% in the 
isthmus [23].  After ovulation, due to decreased secretions, the cilia become visible and erect, but 
in the periovulatory period, the isthmic mucus is abundant and might play an important role in 
gamete transport. The migration of both the sperm and the ovum towards each other is prevented 
because the cilia are covered by the mucus; at the same time, E2 stimulates isthmic contraction and 
the mucus locks the ovum to prolong its stay in the ampulla [70]. Relaxation of the muscular layer 
and the disappearance of the mucus begin with increases in P4 in the postovulatory period [71]. 
Clinical interest  
With the success of In Vitro Fertilization (IVF) in 1978, when the first “test tube baby” was born, 
and with the continuous improvements in IVF techniques, the incentives to study the fallopian 
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tubes probably decreased. However, in vivo fertilization, the fallopian tube plays an indispensable 
role in gamete transport, fertilization and early embryo development. It is evident that the 
mechanism of tubal transport is a complex process and those disorders or dysfunctions in these 
events can have far-reaching consequences for the fertility of a woman. Female infertility is often 
not due to one single factor. Many pathological conditions such as infertility and ectopic 
pregnancy are associated with ciliary damage, reductions in ciliary motion or both [72]. Some 
pathogens such as Gonococci destroy ciliated cells and reduce ciliary activity, whereas Chlamydia, 
for example, damages the entire mucosa [73].  
 
REGULATION OF TRANSPORT  
Progesterone synthesis, secretion and regulation 
Progesterone (pregn-4-ene-3,20-dione), often abbreviated “P4,” belongs to a class of hormones 
called progestogens that have a basic 21-carbon skeleton (C-21). Progesterone is the major 
naturally occurring progestogen in mammals. Like other steroid hormones, it is synthesized from 
cholesterol by step-wise enzymatic conversions: 1) the conversion of cholesterol to pregnenolone 
by the enzyme P45011a1 (“cholesterol side-chain cleavage enzyme” or “cholesterol desmolase”) 
and 2) the conversion of pregnenolone to P4 by the enzyme 3β-hydroxysteroid dehydrogenase 
(Fig. 5). The major source of cholesterol for ovarian P4 production is circulating lipoproteins. 
Humans, pigs and primates utilize low-density lipoproteins (LDL), whereas mice, rats and 
ruminants primarily utilize high-density lipoproteins (HDL) [74].  
      
FIGURE 5: Chemical reactions in P4 synthesis. P450 – cholesterol desmolase; 3β-HSD – 3-β-hydroxysteroid 
dehydrogenase; NAPDH – nicotinamide adenine dinucleotide phosphate; NADH – nicotinamide adenine dinucleotide 
 
The main site of P4 production in the non-pregnant female is the adrenal glands before ovulation 
and the corpus luteum after ovulation. Before ovulation, granulosa and theca cells help each other 
to produce estrogen under the influence of FSH and LH, according to the well-accepted two-cell, 
two-gonadotropin theory [75]. If pregnancy occurs, the production of P4 is shifted to the placenta 
[76]. Progesterone is a central hormonal regulator of female reproductive processes. Its main 
functions are: 1) in the ovary and uterus: ovulation, facilitation of implantation, maintenance of 
pregnancy by facilitation of uterine growth and suppression of myometrial contractility; 2) in the 
mammary glands: lobular-alveolar development and inhibition of milk production during 
pregnancy; 3) in the brain: as a neuroactive steroid mediating signals for sexual response behavior 
Membrane progesterone receptors in the fallopian tube 
21 
[32]. The effects of P4 in the fallopian tube are still under investigation, but it has been shown to 
influence gamete transport [1, 71]. 
It is well established that the ovarian hormones E2 and P4 provide feedback to the hypothalamus 
and pituitary to trigger FSH-dependent follicular growth and LH-dependent follicle maturation and 
ovulation [77]. In vivo studies in humans indicate that P4 stimulates its own production, a 
phenomenon known as “self-priming” [78]. During the preovulatory period, the serum level of P4 
is at a basal level, but these levels increase ten-fold in humans after LH-induced ovulation. This 
high level of P4 is maintained during the first gestational period [79]. In mice, increased serum 
levels of P4 were observed after hCG administration [80], comparable to the levels of P4 in 
naturally cycling mice [81].  
Hormonal changes in the fallopian tube  
The fluid produced and secreted by the fallopian tube provides the environment in which 
important reproductive events take place. In many species, including humans, the rate of tubal 
fluid production ranges from 0.06 to 1.5 ml/day [82, 83]. Because of their anatomical position, the 
fallopian tubes are directly exposed to the steroids that ovaries produce around them. Therefore, in 
humans, follicular, peritoneal, seminal and uterine fluids might also contribute to the composition 
of tubal fluid [3]. Differently from the rest of the body, due to the counter-current exchange 
mechanism and other factors, the circulating levels of E2 and P4 throughout the fallopian tube are 
probably higher than the plasma levels. After ovulation, the concentration of E2 and P4 in 
peritoneal fluid increases markedly, and the levels of free circulating steroids are higher due to low 
levels of steroid-binding proteins in both the peritoneal and tubal fluids [84-86]. Studies in 
monkeys showed that tubal fluid concentrations of E2 and P4 were higher after ovulation [87], and 
studies from rodents have demonstrated differences in composition between ampullary and isthmic 
fluid [88]. Additional contributors to the steroid content of tubal fluid are the travelling oocyte-
cumulus complex and the extruded granulosa cells in the lumen of post-ovulation fallopian tubes 
[89-91]. Tubal fluid also contains ions to maintain osmolarity and pH, as well as nutrients such as 
glucose, lactate, pyruvate and amino acids that are the source of energy for the early embryo [92].  
The effects of steroid hormones on fallopian tubes 
Endosalpinx 
During the menstrual cycle, the fallopian tube undergoes morphological changes that are 
quantitatively different in the various parts of the tube. These cyclical morphological changes 
occur in the existing cells, since mitosis is rare in the fallopian tube [1]. Estradiol-dependent 
ciliogenesis occurs during the proliferative phase of the menstrual and estrous cycles [20, 93]. In 
both untreated and ovariectomized animals, E2 administration induced ciliogenesis in the oviduct 
epithelium [94, 95].  Interestingly, ciliogenesis occurs during gestation in the human fetal oviduct, 
whereas in mice the ciliated cells differentiate in the first week after birth [14, 96]. Ciliogenesis in 
the human fetal oviduct must be regulated by mechanisms different from those in adults. The 
thickness of the epithelium increases in the follicular phase, reaching its maximum value (30 µm) 
in the late follicular phase before gradually decreasing in the luteal phase to a lowest point of 10-
Magdalena Nutu 
15 µm. During menstruation, the epithelium thickness is uniformly low.  Before ovulation, the 
heights of ciliated and non-ciliated cells are equal, whereas the cilia become more prominent after 
ovulation due to the decreased height of non-ciliated cells [97]. Progesterone has antiestrogenic 
activity and induces deciliation in the secretory phase of the menstrual cycle [98]. Secretory 
activity is more pronounced in the isthmus, and the secretion occurs in the late proliferative phase. 
The secretory cells atrophy after ovulation and some secretory granules have been observed in 
early ciliogenic cells, indicating that they might have differentiated from atrophied secretory cells 
[70, 99].  
Ciliary beat frequency  
The well-recognized changes that the fallopian tube undergoes during the menstrual cycle are not 
only restricted to morphological changes. The cyclical variation of ovarian steroid hormones 
affects the CBF of epithelial cells, with consequences for tubal transport. Inhibition of muscle 
activity by isoproterenol did not affect ovum transport [5]. The assessment of a baseline CBF is an 
important factor in the validation of ciliary activity. In vitro studies using human samples suggest a 
mean baseline CBF between 5 and 20 Hz [2, 61, 100, 101], whereas one in vivo study reported a 
baseline CBF of 5.5 Hz [102].  Several in vitro studies reported an increase in CBF after ovulation 
[2, 51, 60, 103]. This increased activity over the cycle was observed in the ampulla and the 
isthmus [2] and correlates to the number of ciliated cells present [102]. However, some studies did 
not support significant cyclical changes in CBF [61, 104] and others failed to register significant 
CBF variations between different tubal segments [51]. The effects of exogenous P4 and E2 on CBF 
have been studied by many, both in vivo and in vitro. Progesterone, when present at a high 
concentration (10 µM) with respect to the serum levels of P4 in the luteal phase, causes a nearly 
40% reduction in CBF [100]. This effect persists for 24 hours [100]. At the same time, E2 alone 
did not affect CBF, but in combination with P4, it did prevent the P4-induced reduction in CBF as 
effectively as mifepristone, an antagonist of PGR [100]. This is difficult to explain because E2 
alone did not have any effect on CBF in any part of the tube or at any stage of the menstrual cycle 
[100]. Nevertheless, in vivo treatment with E2 has been shown to affect ovum transport in a dose-
dependent manner [105, 106]. Wessel et al. showed a rapid (15 min) decrease in CBF after 
treatment with P4 at a concentration (20µM) relevant to those found in the placenta (> 20 µmol/l) 
[107, 108]. In both studies examining CBF reduction by P4 [100, 107], treatment with RU486 
pointed at a receptor-related effect rather than a toxic effect.  
Contractile activity 
The contractile activity of the tubal muscle displays cyclic variations, whereas morphological 
changes are not observed in the myosalpinx of the fallopian tube. During the periovulatory period, 
contractile activity increases and the orientation of activity depends on the day of menstrual cycle 
and location in the tube [67]. Ovarian hormones influence the way in which the fallopian tube 
myosalpinx responds to neurotransmitters, influencing adrenergic receptors and thus potentiating 
contraction or relaxation of smooth muscle cells [67]. Progesterone controls prostaglandin 
production, which increases in the luteal phase of the menstrual cycle [67]. The effects of 
prostaglandins E and F series on tubal motility appear to differ depending on the muscle type 
(longitudinal or circular) and different segments in the fallopian tube [67, 109, 110]. 
Membrane progesterone receptors in the fallopian tube 
23 
Nuclear Progesterone Receptors  
The classical nuclear progesterone receptor (PGR), a member of the superfamily of ligand-
activated transcription factors, was first cloned and characterized in the early 1970s [111]. Since 
then, PGR expression has been described in tissues known to be P4-responsive, including 
reproductive tissues. However, PGR expression has been reported outside of the reproductive tract 
as well [32]. All members of the superfamily of nuclear receptors, to which PGR belongs, are 
organized into specific functional domains: 1) an amino terminal domain that is more variable and 
contains a transactivation domain (AF1); 2) a highly conserved DNA-binding domain (DBD) that 
gives the receptor its specificity depending on DNA sequences recognized by the DBD; and 3) a 
C-terminal ligand-binding domain (LBD) containing a second activation function domain (AF2). 
Between the DBD and LBD domains, there is a hinge region that is poorly conserved among 
members of this family and usually contains nuclear localization signals [112, 113]. The PGR is 
expressed as two major isoforms, PGR-A and PGR-B, encoded from the Pgr gene. In humans, the 
PGR-A and B proteins are 94 kDa and 114 kDa [114]. What makes PGR-B unique compared to 
PGR-A is an additional 164 amino acids at the N-terminal end [115], which contains a third 
activation function domain (AF3). As a result, the PGR isoforms recruit specific co-regulators in a 
cell- and promoter-specific manner and regulate different subsets of genes [116, 117]. Whereas 
PGR-B is a stronger activator of target genes, PGR-A can act as a dominant suppressor of PGR-B 
activity and other hormone receptors [118, 119]. The relative expression of PGR-A and -B in 
target tissues differs, and it is the ratio of PGR-A /-B that determines the cellular response to P4 
[32]. 
PGR is bound to heat shock proteins and is found in a free and inactive form in the cytoplasm and 
nucleus. Upon hormone binding, the receptor dissociates from the heat shock protein complex and 
translocate to the nucleus. Active PGR dimers bind to hormone-responsive elements (HREs) to 
facilitate transcription by coming into contact with components of the general transcription 
machinery (co-activators or co-repressors) or by promoting local chromatin remodeling. The 
consensus sequence of the HRE, common to PGR and other hormone receptors consists of a semi-
palindromic half-site sequence, 5´-TGTTCT-3´, usually separated by three base pairs [120]. The 
recruitment of differential co-regulators affecting the ultimate receptor-specific response could be 
attributed to the low degree of sequence homology of the AF1 site in different nuclear receptors 
[112]. 
In addition, PGR contains a short proline-rich sequence in the N-terminal region that, upon P4 
binding, mediates direct interaction between cytoplasmic PGR, the Scr-homology 3 (SH3) domain 
of Scr (Rous sarcoma oncogene) and tyrosine kinases at the plasma membrane. This interaction 
leads to activation of the Ras/Raf-1/MAPK signaling pathway [121]. This kind of interaction with 
the Scr domains is specific to PGR. It is still debatable whether the PGR mediation of Scr 
activation requires co-regulators, but it appears that cyclin D1 is an important downstream target 
of the MAPK signaling pathway in breast cancer cell lines at least [122-124]. 
PGR expression has been described in P4-responsive tissues, and studies in knockout mice have 
confirmed their indispensable role in reproductive physiology. The selective ablation of PGR-A or 
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-B helped to demonstrate that PGR-A is necessary and sufficient to mediate ovulatory response, 
whereas PGR-B is required for a normal proliferative P4 response in the mammary gland [125]. 
Progesterone has a central role in reproduction, as it is involved in ovulation, implantation and 
pregnancy. In the female reproductive tract, PGR is present in the uterus, ovaries, cervix, vagina, 
fallopian tubes and breasts [32]. In the ovaries, PGR is expressed in theca cells, luteinizing 
granulosa cells, the corpus luteum and stroma and epithelial cells [32, 126]. The expression of 
PGR is under the control of E2, which increases, and progesterone, which decreases PGR 
expression in most target tissues [127, 128]. However, in humans and primates, PGR expression 
persists in the corpus luteum [129], but its expression begins at earlier stages of follicular 
development [130]. More recent work by Clemens et al. has shown that E2 induction of Pgr in 
granulosa cells appears to be indirect and that E2 alone does not induce expression of Pgr in 
preovulatory rat granulosa cells [131]. In rats and mice, the expression of PGR has been shown to 
be transient [78, 132, 133]. Specific progestin binding has been described in other non-
reproductive tissue, where the action of P4 is less defined. For a review of the physiological role of 
P4 in target tissues, see Graham & Clarke (1997). 
Nuclear progesterone receptor in the fallopian tube 
The lining epithelium of the fallopian tube and the uterus undergoes cyclical changes under the 
influence of P4 and E2. The important role of steroid receptors for fallopian tube structure and 
function was recognized in the late 1980s [134]. Specific monoclonal antibodies were developed 
and used to detect PGR in the fallopian tube [135]. Immunohistochemistry (IHC) methods and 
later Western blot and mRNA transcript detection by reverse transcriptase polymerase chain 
reaction (RT-PCR) have become standard methods for the detection of PGR in the fallopian tube 
[135-137]. The expression of PGR was demonstrated in the fallopian tube and uterus in the 
oviducts of humans [138, 139], rats [137, 140], and mice [80, 130, 139]. Because they are two 
functional distinct transcription factors, the investigation of a distinct cellular distribution and 
hormonal regulation of the two isoforms is relevant. The localization of PGR was observed in the 
nucleus of stroma, muscle and epithelial cells [80, 137], as well as in the lower part of cilia [139]. 
As commonly concluded by several studies, the expression of PGR increases during the follicular 
phase of the estrous/menstrual cycle and declines towards the luteal phase [80, 137-139]. Selective 
PGR investigation revealed PGR-A to be the predominant isoform throughout the cycle [130, 
137]. Comparisons between cyclical PGR expressions in the fallopian tube with endometrial 
changes showed that levels of PGR are generally high in both tubal epithelia and endometrial 
glands during the follicular phase. In the luteal phase, however, PGR expression differs between 
these two organs [138]. The increased expression of PGR in the fallopian tubes and uterus appears 
to be important for the control of uterine and tubular responsiveness to E2 in mediating early 
events such as cell proliferation for tissue development [80, 139, 140]. Furthermore, exogenous P4 
treatment led to a time-dependent decrease in PGR expression [80] in vivo, and upon ligand 
binding, the expression of PGR was rapidly down-regulated in vitro [141]. The implication of 
PGR in P4-mediated reproductive processes in the fallopian tube has been demonstrated using both 
the PGR antagonist RU486 and E2-induced receptor regulation [80, 100, 140]. 
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Non-genomic action of progesterone  
The fundamental characteristic of nuclear receptors is their ability to interact with DNA in 
response to hormone binding or other signal molecules and thus control gene expression. In 
addition to these genomic actions, steroid hormones exert rapid effects that happen too fast to be 
explained by the classical genomic mechanism. Typically these effects are: 1) rapid, taking place 
in seconds or minutes; 2) insensitive to translation/transcription inhibitors; 3) mimicked by 
steroids coupled to membrane-impermeable molecules; 4) insensitive to classical antagonists of 
genomic steroid action; 5) provable in isolated cell membrane fractions; and 6) demonstrable in 
cells or tissues lacking the nuclear steroid receptor, knockout models or in systems that are not 
producing or using the steroid hormone. Depending on the steroid hormone and the tissue/cell 
type-specific mediated response, four types of receptors have been proposed: a) transmembrane 
receptors that are unrelated to the corresponding nuclear receptor; b) modified nuclear receptors 
that localize to the plasma membrane; c) a subpopulation of the nuclear receptor that associates 
with various signaling complexes in the cytosol or at the plasma membrane; and d) transmembrane 
receptors for neurotransmitters or neuropeptides that are modulated by steroid hormones [142-
145]. 
Progesterone receptor membrane component 1 (PGRMC1) 
In an attempt to identify steroid-binding moieties that mediate effects in a rapid fashion, partial 
purification of liver microsomal membranes yielded two proteins with apparent molecular weights 
of 28 and 56 kDa, possessing P4 binding affinity [146]. Further amino acid sequencing revealed 
that they are monomers and dimers of the same protein, now named Progesterone receptor 
membrane component 1 (PGRMC1). Before the molecular structure of PGRMC1 was established, 
several homologue proteins were reported based on cellular context and function and were 
described in several reviews [147-150].  Furthermore, PGRMC1 has homologues in organisms that 
do not synthesize or bind P4 [151], giving rise to the question of whether PGRMC1 is a functional 
P4 receptor or not. The majority of studies report an intracellular localization of PGRMC1 to the 
ER, cytosol or nucleus [152-154],  but a localization to the plasma membrane has also been 
reported [155, 156].  
Progesterone has been proposed to be the ligand of PGRMC1, as the initially purified liver 
microsomal membrane fractions were shown to bind P4 with both high (Kd 11 nM) and relatively 
low affinity (286 nM). The kinetics of association and dissociation of P4 binding to the solubilized 
membrane fractions were rapid, with a t½ value of 3-8 minutes. In the original report, P4 displayed 
its highest affinity in a single point competition assay, but other effective competitors such as 
testosterone, cortisol and corticosterone bound to PGRMC1 with affinities in the same order of 
magnitude as P4 did [146]. Furthermore, additional ligands including heme [157] and cholesterol 
[158] have been shown to bind to PGRMC1. Together, all these findings point to a limited 
hormonal specificity for PGRMC1. Correspondingly, a wide range of physiological roles has been 
proposed for PGRMC1, especially in functions mediated in association with other proteins. The 
protein-partner complexes that interact with PGRMC1 appear to be dependent on the cell type. 
The diversity of binding partners include: PAIRBP1 (formerly known as RDA288) in granulosa 
cells [159], SCAP and Insig-1, two proteins involved in sterol synthesis in COS-7 cells [160], 
Magdalena Nutu 
P450 proteins such as DAP1 [161] and an uncharacterized hormone/drug-binding protein [149].  
The regulatory elements that control PGRMC1 expression are still unknown, but the promoter 
region of the human PGRMC1 gene has been shown to contain different response elements that 
target  P4 (via GRE), 2,3,7,8-tetrachlorodibenzodioxin (TCDD) or ligands such as omeprazol or 
cytochrome P450 enzymes (via AhR/Arnt) [161-163]. 
The multiple biological functions of PGRMC1 have been proposed based on protein associates, 
cell type, and level of expression. The proposed involvement of PGRMC1 in the regulation of 
cholesterol and steroid synthesis find support in that PGRMC1 has its highest expression in liver 
and cells or tissues like adrenal or granulosa and luteal cells that are highly steroidogenic. As 
PGRMC1 is expressed in many cell types involved in mammalian reproduction, it has been 
proposed that PGRMC1 may play a role in maintaining fertility. In the ovary, however, PGRMC1 
is suggested to prevent the apoptosis of granulosa cell by mechanisms involving the regulation of 
Ca
2+
 levels and activation of kinase G-protein [164, 165]. At the same time, PGRMC1 may play a 
role in cancers associated with reproductive organs. Indeed, PGRMC1 is over-expressed in cancer 
cell lines from various tissues [166], and its increased expression is correlated with the stage of 
tumors in the ovary [167].  
γ-aminobutyric acid type A (GABAA) receptors  
Steroid hormones like P4 easily cross the blood–brain and the blood–nerve barriers, with the 
exception of their conjugated forms such as steroid sulfates. Many well-defined aspects of female 
sexual behavior in the brain are mediated by PGR in the hypothalamus and preoptic areas [168]. 
For example, in ovariectomized rats, treatment with P4 induced lordosis, whereas in PGRKO mice 
P4 has no such effect [169, 170].  
The non-classic mechanisms of P4 action in the brain also involve direct interactions of P4 
metabolites with the γ-aminobutyric (GABAA) receptor. The native GABAA receptor is a 
transmembrane ion channel for which 16 different receptor subunit genes have been identified in 
mammals [171]. 
Its natural ligand is γ-aminobutyric acid, but the response can be modulated by different factors, 
including the reduced P4 metabolite Allopregnanolone (3a-hydroxy-5a-pregnan-20-one). 
Circulating P4, originating from the gonads and the adrenal cortex, is the major source of 
substrates for allopregnanolone synthesis in the brain [172].  Allopregnanolone acts as an agonist 
on the (GABAA) receptor, modulating stress, mood and behavior [173]. The positive allosteric 
modulators of the GABAA receptor, including allopregnanolone, act by increasing the opening 
frequency of the ion channel. At concentrations higher than 100 nM, and thus physiologically 
relevant levels during pregnancy, positive neurosteroids can directly gate the GABAA receptor 
without the aid of γ-aminobutyric acid  [174]. Negative allosteric modulators, such as 
pregnanolone, act as non-competitive antagonists at site(s) distinct from those that bind the 
positive neurosteroid modulators [171]. However, the focus is on finding the specific steroid-
binding site on the GABAA receptor, and so far accumulated data show that steroid recognition 
sites reside on the receptor and not in the bilayer surrounding it [175]. 
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Membrane Progesterone Receptors  
The first strong evidence for a specific protein unrelated to PGR acting as a P4 receptor via non-
genomic mechanisms was published in 2003 [176]. The sequence of the mPR from spotted 
seatrout was then used to identify homologues in several species, including humans [177].  Using 
cDNA libraries from spotted seatrout ovaries and monoclonal antibodies, a membrane protein that 
bound P4 was identified and named mPR. The putative mPRs were classified into three distinct 
subtypes named mPRα, β and γ [176] and they were subsequently found in a variety of animal 
models [147]. The mPR subfamily belongs to the seven-transmembrane progesterone and 
adiponectin Q receptor family (PAQR) [144]. 
In the human genome, there are 11 genes that encode proteins belonging to PAQR [178, 179]. The 
newly characterized family of proteins includes the yeast osmotin receptor (Izh2p), human 
adiponectin receptors (AdipoQ) and PAQR 5, PAQR7 and PAQR 8, also named mPRγ, mPRα and 
mPRβ respectively. Phylogenetic analysis showed that these proteins are highly conserved among 
vertebrates, and a subsequent classification into three distinct classes was established. Class I 
includes human PAQR 1-4 (where PAQR 1 and 2 are the corresponding hAdipoR1 and 2) and the 
yeast PAQR homologues (Izh1p and Izh2p). Class II was divided into two subgroups: one that 
contains mPRγ (PAQR 5) and two additional human genes named PAQR 6 and PAQR 9, so far 
unidentified in other species, and a second subgroup containing mPRα (PAQR 7) and mPRβ 
(PAQR 8). Class III contains the bacterial proteins earlier characterized as hemolysins and the 
human PAQR 10 and PAQR 11 [144].  From an evolutionary point of view, the PAQR genes are 
represented widely in eukaryotes and show a high degree of homology, particularly between 
humans and mice [178]. Phylogenetic analysis devided the common ancestor of the PAQR and 
GPCR families into two major subgroups: the hemolysin (HYL3) related proteins originating from 
Eubacteria to whom some PAQR belong, and the bacterierhodopsin originated from 
Archaebacteria which evolved to the GPCR classes. It appears like PAQR family in eukaryotes to 
share similarities to the prokaryotic HYL3 family, whereas proteins belonging to the HYL3 family 
have not been found in Archaebacteria. Thus, this suggests that PAQR and HYL3 families have 
same bacterial origin, in contrast to GPCR superfamily [180]. 
Several pieces of information suggest that proteins belonging to Class II of PAQRs function as G -
proteins [180], but some studies failed to corroborate these findings [181, 182]. Interspecies 
sequence alignments and phylogenetic investigation of diverse PAQRs and GPCRs discovered a 
common core of seven transmembrane (TM) domains containing three unique and conserved 
motifs. Topological and hydropathy analysis predict an intracellular N-terminus and an 
extracellular C-terminus for proteins in Class I and II of the PAQR family. Furthermore, a 
structure with an additional eight transmembrane domains and an intracellular C-terminus has 
been proposed. The initially proposed mPR topology typical of GPCRs was recently reconfirmed 
by Thomas and co-workers, together with the involvement of the C-terminus and third intracellular 
loop domain in the activation of G-proteins [180]. There is now less controversy about human 
mPRs being bona fide steroid membrane receptors, but it is still debated whether they signal via G-
proteins or not. 
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G-protein-coupled receptors are the largest group of membrane receptors that mediate the effects 
of many different hormones. The heptahelical GPCR receptor is composed of three subunits: α, β 
and γ. When a ligand interacts with GPCR at the cell membrane, the ligand either stabilizes or 
induces a conformational modification that activates the receptor. Upon activation, GDP is 
released, GTP binds to Gα, and the Gα-GTP complex dissociates from Gβγ and from the receptor. 
Both Gα-GTP and Gβγ are then free to activate downstream effects. The duration of the signal is 
determined by the rate of GTP hydrolysis and re-association of Gα-GDP with Gβγ. There are over 
20 Gα subunits divided into four major families: Gαq/11, which activates phospholipase C(PLC); 
Gαs, which activates adenylyl cyclase (AC); Gαi/o, which inhibits adenylyl cyclase; and Gα12/13, 
which activates small GTPase [183, 184]. Furthermore, Gβγ can also mediate specific signals by 
interacting with several effectors such as: PLCβ3, β3, AC, phosphoinositide 3-kinase (PI3 kinase) 
or components of the MAPK cascade. It is also known that Gβγ activates K+ and Ca2+ channels. At 
present, five different Gβ-subunits and 12 different Gγ-subunits have been identified and have 
been shown to be able to dimerize differently in vivo and in vitro depending on cell type or tissue 
specificity [185]. 
The three mPRs (α,β and γ) proteins vary in length from 330 to 354 amino acids, with an estimated 
molecular weight of around 40 kDa. The seatrout mPR (mPRα) fulfills all seven criteria listed by 
Zhu et. al. that, together, would argue for a role of the seatrout mPR as a true receptor [176]. These 
criteria/characteristics of the receptor are: 1) a seven-transmembrane domain, GPCR-like structure, 
2) a dominant abundance of mPR mRNA in reproductive and endocrine tissues; 3) a localization at 
the plasma membrane of both oocyte and sperm; 4) high affinity (Kd 30 nM), low capacity (Bmax = 
0.49 nM), rapid and displaceable binding for P4 with rates of association and dissociation of t½ 7- 2 
min when expressed in bacterial (E. coli) systems; 5) activation of pertussis–sensitive inhibitory 
G-protein with subsequent decrease in cAMP and adenylyl cyclase activity upon progestin binding 
to the mPR; 6) in vivo and in vitro progestin and gonadotropin up-regulation of both the seatrout 
mPR gene and protein; and 7) implication of mPRα in the oocyte maturation process, as confirmed 
both by changes in receptor levels during oocyte development and by inhibition of oocyte 
maturation upon microinjection of antisense nucleotides [176]. Initially, the proteins were 
expressed in an E. coli system that does not contain any known P4 receptors. Later, culture of 
human breast cancer cells (MDA-MB-231 cells) was used instead, resulting in the expression of 
proteins in the plasma membrane and binding of both synthetic progestins and P4 [176, 180]. 
Recombinant plasma membrane proteins from MDA-MB-231 cells transfected with the seatrout 
cDNA reconfirmed the characteristics of the seatrout mPR and its high affinity (Kd 4-8 nM), 
limited capacity (Bmax = 0.03-0.3 nM) and rapid association and dissociation rate of progestin 
binding, with t½ 2-5 min) [180]. Characterization of the mPRβ and γ proteins is still under 
investigation, but information available at present suggests that they present features similar to 
their protein family sibling mPRα. Saturation analysis of P4 binding to the recombinant mouse 
mPRβ and human mPRγ in an E. coli expression system presented a single high affinity (Kd = 28-
39 nM) and saturable P4 binding (Bmax = 03-0.5 nM). Competition binding of steroids to hmPRγ 
demonstrated that P4 is the specific ligand, whereas other steroids such as E2, androgen and 
corticosteroid had low or no affinity for hmPRγ [177]. Characterization of the Xenopus mPRβ in 
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CHO cells presented a high-affinity binding site with Kd = 200 nM, which is near the half-
maximal effective concentration for induction of oocyte maturation by P4 [186]. 
Sequence comparisons of the seatrout mPRα and β showed that these mPRs share a high degree of 
homology (49-60%) across species. The mPRγ form cloned from a kidney library, however, is 
more divergent and has less sequence homology (30%) with mPRα and mPRβ [177, 187]. 
Molecular characterization of the mPRs in channel catfish (Ictalurus punctatus) and other fish and 
mammalian forms showed a high degree of homology [187]. Characterization of the rat mPRs 
showed gene homology ranging from 27% to 49% between the mPRs [188]. Transmembrane and 
lipophilicity analysis identified seven potential transmembrane domains in many species except for 
zebrafish mPRβ, for which the analysis predicted five transmembrane domains [188]. The putative 
transcriptional regulatory elements located in the 5´-flanking region of the channel catfish mPR 
revealed the presence of several candidate regulatory elements for transcription factors, including 
CRE, SF-1, various steroid hormone regulatory elements (ERE and GRE/PRE/ARE) and elements 
involved in the control of cell growth and differentiation (Egfr, AhR/Arnt) [187]. 
Although some studies have failed to confirm the cellular localization of the mPRs at the plasma 
membrane as well as a function as a membrane P4 receptor [189], a recent study by Smith et al. 
strongly supported the ability of the human PAQR (mPRs) to sense and respond to P4. This study, 
however, did not provide evidence that the mPRs signal via G-proteins. The authors used the so-
called yeast PAQR system that is equipped with two powerful tools: 1) a system that is devoid of 
the known P4 binding/sensing proteins; and 2) a system with an intact signaling apparatus for 
monitoring signal transduction upon P4 stimulation [144]. However, there are data supporting the 
notion that the mPRs are located at the plasma membrane and function by activating G-proteins 
[180], but that G-protein activation by other PAQR family members such as adiponectin receptors 
does not occur [179].  In contrast to PAQRs, both hmPRα and smPRα were demonstrated to 
possess an extracellular N-terminal domain and an intracellular C-domain that is involved together 
with the third intracellular loop in the activation of G-proteins [180]. Phylogenetic analysis 
showed a convergent ancestral origin for PAQR from HYL3 proteins found in Eubacteria and 
GPCR families from Bacteriorhodopsin found in Archaebacteria. Thus, this might explain the 
structural and functional GPCR-like characteristics stipulated for members of the PAQR family 
[180]. Since the initial report by Zhu et al. in 2003, the characteristics and possible functions of the 
mPRs have been investigated in several species, tissues and cell systems. These reports 
demonstrate gene expression in both reproductive and non-reproductive tissues (Table 1). The 
expression and cellular localization to the plasma membrane of the mPR proteins has been broadly 
demonstrated in many species and cell systems using different techniques and approaches, 
suggesting that they might be involved in diverse physiological functions in vertebrates (Table 2). 
The expression of the mPRs, however, varies among species and tissues and in relation to the 
reproductive cycle.  
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Table 1: Summary of published data characterizing mPRs mRNA level expression 
SPECIES mPRα mPRβ mPRγ 
Spotted 
Seatrout 
RT-PCR Sperm [190] ND ND 
Northern 
blot 
Ovaries, testes, brain, 
pituitary [176] 
Brain, neuronal tissues 
[176] 
 
Zebrafish RT-PCR testes, ovaries [191] 
Brain, pituitary, ovaries, 
testes [187, 191], liver, 
kidneys [192] 
ND 
Channel 
catfish 
RT-PCR 
Brain, pituitary, muscle, 
testes, aorta, gills, 
intestine, heart, spleen, 
liver, kidneys, ovaries 
[187] 
Hypothalamus, ovary, 
pituitary, testes [187] 
Intestine, gills, aorta, 
kidneys, ovaries, 
hypothalamus, 
testes [187] 
Goldfish RT-PCR ovaries [193]  ND ND 
Xenopus 
laevis 
RT-PCR ND Oocyte [186] ND 
Rat RT-PCR 
Corpus luteum, ovaries, 
adrenal, brain, kidneys, 
lungs [188] 
Brain, ovaries, kidneys, 
lungs, heart, CL [188] 
Kidneys, brain, CL [188] 
Mouse RT-PCR 
Brain, testes, uterus [194] 
 
POAH, pituitary, uterus, 
kidneys, Imm. neuronal 
cells [195] fallopian tubes, 
ovaries [196] 
Kidneys [197], fallopian 
tubes, ovaries [196]  
Sheep RT-PCR 
Hypothalamus, uterus, 
pituitary, CL [198] 
ND ND 
Human 
RT-PCR 
Sperm, testes [199], 
myometrium [181, 200, 
201]; 
lymphocytes [202];  
breast tissues, placenta, 
amnion [181, 203] 
T-lymphocytes, Jurkat 
cells, brain [186, 202]; 
myometrium, myometrial 
cells [181]; 
ovarian tumors [204] 
Endometrium [181],  
ovarian tumors [204], 
fallopian tubes [205], 
HeLa cells [202] 
Northern 
blot 
Ovaries, testes, brain, 
placenta, uterus, kidneys, 
adrenal [177] 
ND ND 
ND, not determined; RT-PCR, real-time polymerase chain reaction; POAH, preoptic anterior hypothalamus; CL, 
corpus luteum 
The expression and cellular localization of the mPRα protein has been broadly demonstrated in 
many species and cell systems, using different techniques and approaches. The expression and 
cellular localization has been demonstrated for mPRβ in several species and cell systems as well; 
however, less information is available for mPRγ. The table below summarizes the existing data 
regarding the expression and cellular localization of mPR proteins detected by different methods 
and in different species (Table 2).  
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Table 2: Summary of published data characterizing the expression and localization of mPR 
proteins  
SPECIES mPRα mPRβ mPRγ 
Spotted 
Seatrout 
WB 
Sperm
a
 (40+80 kDa) [190]; 
oocyte
a
 (40 kDa) ovaries
a
 [176] 
ND ND 
IHC 
Sperm (PM-Flagella, head) [190]; 
oocyte (PM) [176] 
ND ND 
Zebrafish 
WB Ovaries
a
 (40 kDa) [206]  
Ovaries, oocyte
a
 (40 kDa) 
[206] 
ND 
IF; SB  Oocyte (PM) [206] ND ND 
Atlantic 
Croaker 
WB 
Sperm 
a
 ((80 kDa) [192]; sperm, 
testes
a
 (40+80 kDa) [207] 
ND ND 
IHC 
Sperm (PM mid piece flagella) 
[207, 208] 
ND ND 
Goldfish WB Ovaries
a
 (40 kDa) [193] ND ND 
Xenopus 
laevis 
WB ND 
Oocyte
a
 (60 kDa; ortholog) 
[186] 
ND 
Red drum; 
Southern 
Flounder           
WB Sperm (80 kDa) [192] ND ND 
Rat WB ND 
Corpus luteum 
(microsomal fraction, 40 
kDa) [188]  
ND 
Mouse 
WB 
Testes
a
 (40+80 kDa) [199]; 
Brain, testes, uterus
a
 (40 kDa) 
[194] 
Brain, testes, uterus
a
 (40 
kDa) [194] 
Imm. neuronal cells
a
 (40 + 
80 kDa) [195]; fallopian 
tubes
a
 (40 kDa) [196] 
Lungs, liver, 
ovaries, testes 
fallopian tubes
a 
 
(40 kDa) [205] 
IF ND Gonadotrophs PM; [195] ND 
IHC ND 
PM-fallopian tube cilia 
[196] 
Apical PM 
(ciliated cells; 
[205] 
Human 
WB 
Sperm
a
 (40+80 kDa) [199]; 
lymphocytes
a
 [202] 
Lymphocytes 
a
 (80 kDa) 
[202]; myometrial cells
a
 
(40+80 kDa) [201]; 
fallopian tubes
a
 (40 kDa) 
[196] 
Fallopian tubes
a
 
(40 kDa) [205] 
IF 
Myometrium (PM muscle cell; 
[201] 
Myometrial cell (PM; [201] ND 
IHC 
Sperm (Midpiece head and 
flagella) [199] 
Fallopian tubes (PM cilia); 
[196], ovarian tumors 
(cytoplasmatic/nuclear) 
[204] 
Fallopian tubes 
(PM ciliated cell) 
[205] 
Transfected 
Cell system 
 
 
WB 
MDA-MB-231
a
 (40 + 80 kDa) 
[180];  
MDA-MB-231
a
 (45 kDa tag) [206] 
E. coli 
a 
(45 kDa+tag) [193] 
MDA-MB-231
a
 (40 + 80 
kDa) [201]; HEK 293 
a
 (30 
kDa) [182] 
HEK 293
a
 (30 
kDa) [182] 
FC/ 
IHC/IF 
MDA-MB-231 (N-term extracell./ 
C-term intracell) [180, 206] 
COS-1 (N-C-term. Intracell) [182] 
COS-1 cells (ER) [182] 
COS-1 cells 
(ER) [182] 
ELISA 
MDA-MB-231 (N-term intracell.) 
[182] 
  
ND, not determined; 
a
, plasma protein preparation; ER, endoplasmatic reticulum; PM, plasma membrane; WB, 
western blot; SB, surface biotinylation; IHC, immunohistochemistry; IF, immunofluorescence; FC, flow cytometry; 
ELISA, enzyme-linked immunosorbent assay 
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Physiological functions of mPRα 
Induction of oocyte maturation 
The localization of mPRα at the plasma membrane of the oocyte is consistent among all 
investigated species [147]. Functional studies demonstrate that the receptor is involved in 
mediating oocyte maturation [190].  In fish and amphibian oocytes, a maturation-inducing steroid 
(MIS) is secreted from follicles upon gonadotropin stimulation; it acts on its own plasma 
membrane-located MIS-receptor and induces the resumption of meiosis followed by oocyte 
maturation. Two MISs have been identified in fish species: 17,20β,21-trihydroxy-4-pregnen-3-one 
(20β-S) and 17, 20b-dihydroxy-4-pregnen-3-one (17,20βDHP) [193, 209]. In spotted seatrout, the 
binding affinity of 20β-S to the MIS-receptor is higher than that of P4 [210], whereas in other fish 
species, 17,20βDHP is the stronger MIS [211]. The abundance of the receptor protein is related to 
the hormone levels within the reproductive cycle. The concentration of mPRα in Xenopus oocytes 
was increased by hCG [212], and an in vitro study showed that there is a correlation between 
oocyte receptor abundance and steroid binding capacity [210]. The levels of MIS increased in 
female fish in response to the periovulatory LH-surge [213]. Furthermore, the increased in vivo 
ovarian receptor concentration correlates with high plasma levels of LH in spotted seatrout 
collected in the spawning season [214] and mPRα is up-regulated upon gonadotropin treatment in 
vitro [210, 215, 216]. Several lines of evidence support the notion that induced oocyte maturation 
by MIS is mediated via a rapid, non-genomic mechanism and specifically by the mPRα receptor 
[180] (Fig. 6). A particularly important finding was that microinjection of antisense nucleotides to 
the mPRα mRNA blocks the MIS-induced maturation of zebrafish oocytes [176]. The signal 
transduction pathway involves the activation of G-coupled proteins and is summarized in Fig. 6.  
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FIGURE 6: Summary of alternative signal transduction pathways activated in response to mPRα or mPRβ activation 
by P4/progestins in different species. Pathways 1-7 are mediated through activation of the inhibitory Gi-protein. 
Pathway 1): decrease of cAMP levels (PTX-sensitive) in spotted seatrout oocytes during maturation [209], in MDA-
MB-231 cells transfected with mPRα [176, 180], in human myocytes with mPRα and mPRβ [201], in Jurkat cells 
[202] and in GT1-7 cells [195]. Pathway 2): down-regulation of SRC-2 co-activator expression through mPRα in 
human myocytes [201]. Pathway 3): Activation of PGRB through mPRα and mPRβ in human myocytes [201]. 
Pathway 4): Increased intracellular Ca
2+
 levels through activation of ovine mPRα in ER [198]. Pathway 5): increased 
MAPK phosphorylation upon Mos activation in Atlantic croaker follicles [209], in MDA-MB-231 cells transfected 
with mPRα [176] and in zebrafish mPRα and mPRβ [206]; proposed signaling mechanism via mPRβ that controls 
resumption of meiosis in Xenopus oocyte maturation [186]. Pathway 6): activation of p38 resulting in phosphorylation 
of myosin light chain in human myocytes [201]. Pathway 7): activation of Akt via up-regulation of phosphodiesterase 
activity in Atlantic croaker oocytes during final maturation [209]. PM, plasma membrane; NE, nuclear envelope; ER, 
endoplasmic reticulum. 
 
Stimulation of sperm motility 
There is a plethora of studies demonstrating rapid, non-genomic effects of P4 on the activation of 
spermatozoa of many species have been reported. Progesterone has been shown to induce the 
acrosomal reaction in human and stallion sperm [217, 218], a phenomenon that does not occur in 
fish, as they lack an acrosome [219]. Progesterone  also stimulates hypermotility in mammalian 
sperm [220] as well as fish sperm [221, 222]. Furthermore, P4 present in the egg 
microenvironment by the time of ovulation is a chemoattractant for mammalian spermatozoa 
[223]. Human spermatozoa chemotactically responded to a P4 concentration gradient ranging from 
1 to 100 pM [224]. Thus, the possibility of existing specific P4 receptors and/or different receptors 
that independently mediate the effects of P4 on the acrosomal reaction and sperm hypermotility 
exists. Indeed, a variety of receptors have been proposed as potential mediators of these effects 
[217, 225, 226]. The expression and localization of mPRα protein to the plasma membrane of 
sperm has been demonstrated in several species (see Table 2). Furthermore, the abundance of the 
mPRα protein was related to the extent of sperm motility in both fish and humans [208]. The fish 
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progestin (20β-S) possesses binding characteristics in spotted seatrout and croaker mPRα that are 
similar to those of recombined seatrout mPRα. These characteristics include a high affinity (Kd 20 
nM) and low capacity (Bmax 0.08 nM) [180, 207].   
Several studies report the mPR activation of multiple classes of G-proteins, but only one study to 
date has demonstrated an activation of the Golf through mPRα in fish sperm (Fig. 7). The increased 
cAMP levels resulting from the activation of membrane adenylyl cyclase (AC) was completely 
blocked by specific inhibitors of AC and the mPRα co-immunoprecipitated with the Golf antibody 
[208]. The nuclear progestin receptor antagonist R5020 did not affect hypermotility in croaker 
sperm and did not activate the Golf receptor, meaning that the genomic mechanisms are not 
involved in this process. Various members of the mACs and Golf  protein families are present in the 
germ cells of humans, rats and mice, and disruption of mAC resulted in reduced sperm motility 
and function in mice [227-230]. Furthermore, the associated Golf and mAC signal transduction has 
been proposed to mediate sperm chemotaxis in response to odorants in mammals [231]. Under 
physiological conditions, calcium may activate phospholipases and modulate enzymes that interact 
with AC to increase cAMP; it is thus an important ion in the regulation of sperm motility [232].  
However, the molecular mechanism of calcium-activated sperm motility is still not fully 
elucidated. Because the activation of the Golf protein through mPRα has been reported only in fish 
sperm, further studies are necessary to elucidate whether this is a process occurring in other tissues 
or species. Interestingly, Gαi2 is expressed in the human endometrium and the ciliated cells of 
fallopian tubes [233, 234].  
 
 
FIGURE 7: Summary of the signal transduction pathway in fish and human sperm upon progestin/P4 stimulation of 
mPRα. Pathway 1): Increased cAMP levels in Atlantic croaker sperm by activation of a PTX-insensitive stimulatory 
G-protein (olfactory-G protein) and increased intracellular PKA [208]; Soluble adenylyl cyclase (sAC) in the axoneme 
can be activated to increase sperm motility [235]. Pathway 2): Increased Ca
2+
 levels interact with different ACs to 
increase motility; increased PKA can also diffuse to axonemal sAC and activate increased cAMP concentrations [223, 
235]. 
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Effects in human myometrium and T-lymphocytes 
During pregnancy, the levels of P4 produced by the placenta gradually increase in order to relax 
the myometrium; at labor, uniquely in humans and other primates, the levels of P4 drop 
dramatically [236]. These effects of P4 are thought to be mediated by PGR [237]. In 2006, 
however, Karteris and co-workers proposed a model for P4-mediated actions in the human 
myometrium also involving the action of the mPRs [201] (Fig. 6). This report supported the 
possibility of P4 initiation of myometrial contraction mediated via mPR through three mechanisms: 
1) decreased PGRB transactivational activity by changes in the PGRB/PGRA ratio and SRC2 
down-regulation; 2) G-protein-mediated inhibition of AC; and 3) G-protein activation of p38 and 
activation of MLC phosphorylation. This possible cross-talk mechanism between mPRs and the 
PGRs has been elegantly demonstrated in human pregnant myometria, in myometrial cell culture 
and in myocytes transfected with siRNA for mPRs. Expression of both the mPRα and mPRβ genes 
and proteins has been demonstrated, and the receptors exclusively coupled with the inhibitory G-
protein demonstrated by pertussis toxin treatment to activate AC and decrease cAMP, which, 
together with activated p38 MAPK, increase the phosphorylation of MLC. In addition, the 
elevated levels of mPRs at term, upon P4 stimulation, activate Gi-protein, which in turn initiates 
PGRB transactivation via a specific steroid receptor coactivator (SRC2). This dual action of P4, 
however, is shared with the effect of P4 on the PGRB/PGRA ratio because P4 easily passed the 
plasma membrane and pertussis toxin only partially blocked the response to P4. There is a shift in 
the PGRB and PGRA ratio during pregnancy and at term; during pregnancy, PGRA cannot act as a 
repressor of PGRB transactivation because its levels are decreased, whereas it does so at term 
when its expression increases. Thus, the transactivation of PGRB by mPR during pregnancy 
causes relaxation in the myometrium, whereas at term mPR cannot activate PGRB due to a 
changed PGR balance, and the contractile state begins as a result. 
The immunomodulatory role of P4 during pregnancy and during different phases of the menstrual 
cycle has been suggested before. The cellular immune response in the luteal phase of the menstrual 
cycle and pregnancy increases due to an increased risk of infections. The T-cell lymphocytes play 
an important and integral role in the body's defenses and CD
8
 (cluster and differentiation 8) is a 
co-receptor for the T-cell receptor. The CD
8
 antigen fulfills a cytotoxic effect, as it is capable of 
killing cells that are infected, damaged of dysfunctional. A protective role of CD
8
 T lymphocytes 
in preventing abortion has been reported in mice [238]. Investigation of potential P4 receptor 
mediators failed to detect the involvement of PGR [239]. Alternative investigations clearly 
demonstrated by several techniques the presence of both mPRα and mPRβ in the plasma 
membranes of human T-lymphocytes and Jurkat cells [202]. The characteristics of P4 binding to 
mPR in Jurkat cells were similar to those of the recombined mPRα in breast cancer cells (Kd of 4.6 
nM) [180]. Progesterone activation of G-protein was concentration-dependent, and additional 
immunoprecipitation experiments demonstrated the involvement of the Gαi subunit (Fig. 6). 
Treatment with R5020 and dexamethasone did not activate the G-protein signal transduction, thus 
demonstrating that PGR is not involved. However, this finding is not surprising because PGR was 
not detected in these cells. Importantly, because P4 activation of mPR does occur in T 
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lymphocytes, future studies must elucidate the functional implication of this activation for the 
human immune system.  
Effects of progesterone on GnRH release  
Progesterone feeds back on the hypothalamic-pituitary axis to control GnRH and gonadotropin 
release. This has been considered to be mediated by binding of P4 to its cognate receptor PGR in 
the hypothalamus and pituitary [240-243]. However, studies of PGRKO clearly demonstrated that 
P4 inhibits the release of GnRH by a mechanism independent of PGR. The presence of mPRs at 
both gene and protein levels has been demonstrated in mice gonadotrophs, and the saturation 
binding analyses showed high affinity binding (Kd 5.85 nM) and a limited capacity (Bmax 62.2 nM) 
binding for P4. The signal transduction mechanism mediated by the P4 activation of mPRα 
involved coupling to the inhibitory Gi-protein and decreased cAMP accumulation [195] (Fig. 6). In 
addition, the mPRα mRNA and protein were present in fish brains [147, 176], and a rapid negative 
feedback effect of 20β-S on GnRH secretion at the beginning of the reproductive cycle has been 
detected in the preoptic anterior hypothalamus (POAH) in Atlantic croakers [221]. However, 
several studies must be conducted to elucidate the mPR-mediated physiological actions of P4 in the 
brain.  
 Physiological functions of mPRβ  
Induction of oocyte maturation  
A classic example of rapid non-genomic effects of steroids is the induction of oocyte maturation. 
Transcripts for mPRβ have been found in the membrane of the small Xenopus oocyte fraction that 
is unable to undergo germinal vesicle breakdown (GVBD) in response to P4. The mPRα, which 
otherwise is involved in oocyte maturation in other species, was not present in Xenopus oocytes. 
Attempts to clone the Xenopus mPRα had failed, suggesting that in this species this physiological 
process is attributed exclusively to mPRβ [186] (Fig. 6). The expression of this receptor protein is 
increased by gonadotropins [212],  although at this developmental stage (stage IV), the quantity of 
receptors is lower than in other oocytes upon P4 treatment. Changes in receptor abundance are, 
however, consistent with the role for the receptor in P4-induced oocyte maturation [186]. 
Interestingly, in other species, although hCG induced oocyte maturation, mPRβ was not affected 
by hCG and varied only slightly during the reproductive cycle [191]. Supporting evidence for the 
role of mPRβ in induced oocyte maturation has been demonstrated by studies in zebrafish and pigs 
[206, 244].  
Functional effects of progesterone in the human myometrium and T-lymphocytes  
In human myometrial cells, mPRα and mPRβ are expressed and differentially regulated by ovarian 
hormones. The expression of the mPRα gene was up-regulated by both E2 and P4, with a greater 
regulation by P4 after 4 h. The PRβ gene was solely up-regulated by E2 after 8 h of treatment. 
However, this differential regulation by P4 suggests different functions for mPRα and β in the 
myometrium [201]. During pregnancy, the levels of P4 gradually increase, causing relaxation of 
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the muscle layer, whereas at term, the levels of P4 drop dramatically to initiate contractile activity. 
In rats, the expression of the mPRβ gene remained constant during gestation [188], whereas the 
onset of parturition at term coincided with a drop in mPRβ expression in humans [181]. Thus, a 
central role in the regulation of luteal functions has been attributed to mPRα. However, it has been 
shown that mPRβ is associated with Gαi-protein and dissociates upon P4 treatment. The signaling 
cascades activated by the Gαi protein appear to occur due to differential contributions of the mPRs 
present in myometrial tissue (Fig. 6). However, the exact role of mPRβ in mediating the effects of 
P4 during pregnancy and at labor remains to be elucidated. Several studies must be conducted in 
order to explore this question in more depth.  
An immunomodulatory role of P4 has been previously demonstrated, but the mechanisms of action 
are still unclear. The presence of PGRs or alternative receptors to PGR has been suggested to be 
responsible for mediating such effects, but this has been a matter of dispute, since PGR is absent in 
lymphocytes [245].  However, mPRβ is present in T-lymphocytes at both the gene and the protein 
level. The high binding affinity (Kd 4.25 nM) of P4 to the plasma membrane in Jurkat cells has 
been demonstrated and the activation of Gαi-protein was not affected by RU486 or glucocorticoid 
receptor antagonist (Fig. 6). Of note, RU486 acted both as a strong antagonist to PGR and as a 
weak antagonist to GR. The receptor protein in the plasma membrane of Jurkat cells binds P4 with 
high affinity [202]. The presence of mPRβ and mPRα in T-lymphocytes has been demonstrated, 
and the immunomodulatory role of P4 has been mainly attributed to mPRα, due to its changes in 
expression during pregnancy and the menstrual cycle. However, the function of mPRβ in 
mediating the immunomodulatory functions of P4 is still under investigation.  
Effects of progesterone on GnRH release  
Ovarian hormones are important regulators of gonadotropin release, acting on both the 
hypothalamic and pituitary axes. Considering the P4-induced regulatory effects on LH secretion 
observed in experiments with PGRKO mice, in vitro and in vivo studies have demonstrated that 
mPRs are present in POAH in several species [195, 221].  Localization of mPRβ, along with that 
of mPRα, on the plasma membrane has been confirmed by Western blot and IHC. Furthermore, 
treatment with P4, but not allopregnanolone (a P4 metabolite acting on GABAA receptors) 
suppressed LH secretion in vivo independently of PGRs. The suppression of LH secretion was 
affected by the decreased GnRH secretion and not by reduced pituitary responsiveness to GnRH. 
The rapid inhibition of cAMP accumulation by the activation of Gi protein coupled to mPRs was 
specifically mediated by mPRα (Fig. 6). From experiments with mPRβ siRNA, it was suggested 
that mPRβ contributes to the total binding of P4 in GT1-7 cells, but it does not mediate rapid 
effects on cAMP accumulation [195]. However, another signaling pathway might be considered. 
Physiological functions of mPRγ 
There are limited studies on the possible functions of mPRγ. Similar to the other two mPRs, 
specific P4 binding characteristics of the human mPRγ have been demonstrated [176, 177]. Due to 
its high levels of expression in male and female kidneys, it was speculated that mPRγ might have 
effects on renal function. However, other studies showed the transcript for mPRγ also to be 
expressed in several reproductive tissues [181, 188, 201]. Saturation analysis of P4 binding to the 
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recombinant human mPRγ in an E. coli expression system presented a single high affinity (Kd = 35 
nM) and saturable P4 binding (Bmax = 0.5 nM). Furthermore, no homologies to the ligand binding 
domain of PGR were found in any region of the mPRs. Competition binding of steroids to hmPRγ 
demonstrated no or low affinity for binding other steroids such as E2, androgens and 
corticosteroids, whereas P4 was the specific ligand for hmPRγ [177]. The work of this thesis has 
led to new proposed roles for mPRγ and (mPRβ) (see results and discussion section). 
Potential role of progesterone and mPRs in tubal transport  
Both early and late effects of P4 in regulating the CBF of ciliated cells from the fallopian tube have 
been reported in vitro/ex vivo [107, 234].  Rapid effects of P4 had only been reported previously in 
one study (cow), and the rapid effect of P4 could not be blocked by the nuclear receptor antagonist 
RU486, suggesting an involvement of mechanisms independent of PGR [107]. The recently 
discovered mPRs are present in spermatozoa and are implicated in regulating flagellar movement 
[207, 221]. In general, there is a well-known association between increased CBF of cilia in 
response to increased cAMP and Ca
2+
. Such an example is the Ca
2+
-stimulated CBF in airway cilia 
[246] and the progestin-mediated stimulation of sperm hypermotility [147]. The major classical 
sources of cAMP are the regulated isoforms of G-protein-sensitive transmembrane adenylyl 
cyclases (ACs). Indeed, increased AC activity has been reported upon G-protein activation of 
progestins [147]. However, a soluble distinct AC (sAC) reported many years ago in rat testes 
[247] was found in the axoneme itself and has been suggested to contribute to CBF regulation 
[248]. In cells transfected to overexpress mPR, intracellular Ca
2+
 increased upon stimulation of 
ER-localized mPR [198]. From the literature, the general effects of P4 on the plasma membrane 
mPRs appear to involve activation of the Gi protein. Moreover, the Gαi protein-mediating 
immunoregulatory role of P4 [202] was strengthened by studies in Gαi knockout mice [249]. Gαi 
was found in the motile cilia of rat, human and mouse fallopian tubes [233, 250]. Indeed, silencing 
the function of Gαi protein in the CNS of rats resulted in ciliostasis [233, 234]. In contrast to 
phospholipase A (PKA), which gives rise to increased CBF when phosphorylated, an effect 
consistent in all mammalian cilia, protein kinase C (PKC) has been implicated in slowing ciliary 
activity [235]. A ciliary membrane PKC phosphorylation target, p37, was found to be associated 
with the ciliary membrane in ovine cilia [251]. Even if the regulation of CBF has been studied in 
many systems, the greatest amount of information has come from studies on airway cilia. The 
structure and function of mammalian respiratory and fallopian tube cilia is similar. Whether 
equivalent signaling mechanisms are involved in the fallopian tube ciliary cells as in the lungs 
remains to be elucidated. Although the exact mechanism of P4 signaling in tubal cells is not 
established yet, existing information may be sufficient to propose putative pathways that might 
control ciliary beat frequency.  
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AIMS OF THE THESIS 
An overall aim of the thesis was to identify the distribution and regulation of mPRβ and mPRγ in 
different tissues, with a focus on the fallopian tube. Another main focus was to assess whether P4 
rapidly affects CBF in the mouse fallopian tube, thus implicating an involvement in the regulation 
of gamete transport. 
 
Specific aims of papers I-III 
 
1. To investigate the tissue and cellular distribution of mPRβ and γ in female and male mice 
(Papers I and II) 
2. To characterize the hormonal regulation of mPRβ and γ in fallopian tubes of mice and 
humans (Paper II) 
3. To examine whether progesterone rapidly regulates ciliary beat frequency in mouse 
fallopian tubes (Paper III) 
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METHODOLOGICAL CONSIDERATIONS 
Detailed descriptions of the methods that have been used in this thesis are given in each paper and 
references therein. In this section, additional considerations of some methods are discussed.   
 
MODELS 
Mouse model  
The animal experiments included in this thesis were performed in C57BL/6 mice (Mus musculus). 
Mice have most genes and gene products in common with humans, making them a very useful 
model for studying fundamental physiological functions as well as aspects of human disease. 
Among the general advantages of using mouse models is their small size, which makes them easy 
to house, the abundance of data in the literature and the availability of genetically modified strains. 
With regards to the reproductive system, similarities as well as differences exist between mice and 
humans. Despite the anatomical differences (Fig. 2) the hormonal regulation of transport and the 
duration of tubal egg transport are similar in mice and humans compared to other species [9]. 
The periovulatory interval in rodents is shorter compared to that in humans [252],  but considering 
the non-pregnant mouse model, the estrous cycle in mice and the menstrual cycle in humans are 
comparable regarding the hormonal profile [253]. Mice are versatile models that allow precise 
hormonal manipulation. However, there are examples in which in vivo responses to hormonal 
stimuli appears to be shorter and in some cases even opposite in mice compared to humans [253]. 
Immature mouse model (Papers I, II, and III) 
In Papers I, II and III, our choice of model for studying the fallopian tube was the immature mouse 
model (26 days old; 13-15 g). As endogenous steroid levels are low in these mice [80, 254], it is 
comparatively easy to interpret effects of added steroids. In studies of the effects of steroid 
hormones on steroid-responsive tissues, immature mice have, in some cases, been shown to be 
more sensitive than ovariectomized adult animals [253]. The immature model also allows study of 
the reproductive tissues without involvement of endogenous gonadotropins. By using immature 
rather than cycling mice, it is also easier to obtain animals that are at a similar developmental 
stage.  
Gonadotropin-induced mouse model (Papers I and II)  
To induce folliculogenesis, immature mice were injected with equine chorionic gonadotropins 
(eCG, 5 IU, i.p.), also known as Pregnant Mare Serum Gonadotropin or PMSG (Fig. 3). This horse 
protein, which corresponds to human chorionic gonadotropin, is a glycoprotein with both FSH and 
LH-like activity and has a long half-life in vivo [255, 256]. Treatment of immature mice with eCG 
results in follicular growth and preovulatory maturation within 48 h. 
To induce synchronized ovulation and luteinization in mice, additional hormonal treatment with 
hCG (5 IU hCG, i.p.) is necessary (Fig. 3). The action of hCG in vivo is more extended compare to 
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that of LH, partially due to a higher affinity for LHR [257]. In our animal model, ovulation occurs 
approximately 12-14 h after hCG treatment [258]. A characterization of the eCG and/or hCG 
mouse models has been performed in our laboratory [80]. The ovarian weight of immature female 
mice increased upon eCG treatment over 48 hours, mimicking the preovulatory phase of a 
reproductive cycle. Subsequent treatment with hCG (6 to 48 hours) mimicked the period preceding 
ovulation. The serum levels of E2 and P4 in immature mice treated with gonadotropins is similar to 
that in adult cycling mice [81]. 
 
 
FIGURE 8: Schematic representation showing the animal model systems used throughout the thesis. eCG, equine 
chorionic gonadotropin; i.p., intraperitoneal injection; hCG, human chorionic gonadotropin 
Human model (Papers I and II) 
In Papers I and II, we used fallopian tube tissues from fertile women aged 28-42 years undergoing 
tubal ligation at Sahlgrenska University Hospital. Tubal ligation is used as a contraceptive method 
worldwide, and it is done with the intention of permanent female sterilization. Still, through 
microsurgery, the fallopian tubes can be repaired afterwards if required, and fertility is restored in 
98% of women. Before the surgical procedure to collect samples for this study, all patients 
received a clinical examination and had a regular menstrual cycle. Accordingly, the tissue samples 
were classified in three groups based on the menstrual cycle: follicular, periovulatory and luteal 
phase. The patients had not used any hormonal drugs within three months before the surgery.  
 
ISOLATION OF TUBAL CELLS (PAPER III) 
In paper III, we aimed to study ciliary activity in vitro. The in vitro study of tubal activity has 
advantages as well as disadvantages. One advantage that the in vitro experiments have over the in 
vivo study is that they allow a very controlled exposure to hormones or other substances in the 
cells of interest without interference from other organs or systemic factors. In vitro studies also 
have disadvantages. For example, the tissue may not behave in the same way in vitro as it does in 
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vivo because of the stress exerted by taking out the tissue and because it is difficult if not 
impossible to perfectly mimic in vivo conditions.  
In order to study ciliary activity in the fallopian tube epithelium in vitro, we first attempted to 
apply the method used by Wessel et al. (2004) on cow fallopian tubes [107]. The dissection 
principle adopted by Wessel was rather simple: the fallopian tube was opened longitudinally, and 
the pieces were attached in a gel-like material with the cell surface upward for further activity 
measurements. Even though the procedure appeared simple, it was one of the most challenging 
components in this thesis. One of the obstacles in sample preparation was the tiny size and the 
curled shape of the mouse fallopian tube. Although the connective tissues that keep the fallopian 
tube coiled were carefully removed, there is an inherent tendency of the tissue to return to its 
original shape. We tried to fasten the tissue, but it broke because of its fragility. Furthermore, the 
need to keep the tissue in a proper medium to prevent dehydration and to mimic the in vivo 
environment made the handling of the tissue sample even more difficult. In order to overcome the 
difficulties we came across during tissue preparation, we tested several methods. 
We tried to straighten and fasten the tissue by inserting tubing with a small diameter into the 
fallopian tube. Next, we tried to cut open the tube-like shape with a scope to unfold it into a 
rectangular structure. As a result, the end of the pipe got trapped in the tube‟s curvatures and 
perforated its wall as the tube returned to its initial form. Since the straightened fallopian tube was 
difficult to handle in its full length, we cut the fallopian tube into smaller pieces and tried to apply 
the previous strategy to each individual segment. The insertion of tubing was, however, too 
difficult due to the small size of the tubal parts. We also pre-coated petri dishes with different 
substances (poly-L-lysine, collagen) to help pieces of tissue or cell clusters attach during 
incubation, but this did not help either. Next, we scratched out cells or small cell clusters from 
inside the tube; we observed, however, that this mechanical procedure damaged the cells. The 
approach finally selected was to chop the tissue to obtain clusters of ciliated cells. During 
dissection, the tissues were maintained and handled in a 37°C pre-warmed medium specially 
developed for the management and manipulation of oocytes and embryos in vitro. Lastly, keeping 
a clean medium that would not perturb the ciliary activity measurements proved to be a difficult 
task due to the loosening of tissue debris during cutting and handling. We tried to avoid incubation 
in dirty medium by transferring the tissue to new and clean medium after chopping. 
 
IN VIVO AND IN VITRO TREATMENT  
Hormonal treatment in vivo (Paper II) 
To determine the specific effects of E2 and P4 on the regulation of mPRs, in experiments included 
in Paper II, we treated the immature mice with steroid hormones by intraperitoneal injection. All 
drugs were administrated in a volume of 100 µl in sesame oil. The i.p. injection is a efficient way 
to administer the hormone, and it was given in the lower part of the peritoneal-abdominal cavity 
without perforating the intestines. Sesame oil is a widely used solvent for the administration of fat-
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soluble drugs. The treatment model of E2 and P4 was based on previous studies of the regulation of 
specific receptors in the mouse fallopian tube related to tubal function [80].  
In paper II, both the ESR antagonist (ICI 182,780) and the PGR antagonist (CDB-2914) were 
injected in sesame oil suspension. The antagonists mainly prevent the action of any E2 and P4 
present. Given in doses that range from 5 to 20 mg/kg, ICI 182,780 has been shown to ablate E2 
and ESR signaling in several mammalian species [259]. The dose of ICI 182,780 (8.3 mg/kg) that 
we injected appears to be relevant in this context. In rat, a single dose of 2 mg/animal CDB-2914 
has been shown to interrupt pregnancy and P4 reversed this effect [260]. The dose of CDB-2914 
that we injected was of 1 mg/animal. 
Treatment with ICI 182,780 (Faslodex TM) (Paper II) 
The most widely used ESR antagonist, tamoxifen, is also a partial agonist. A new nonsteroidal 
antiestrogen named Faslodex (ICI 182,780; Fig. 9) has no agonistic activity and was therefore 
used. 
 
 
FIGURE 9: Chemical structure of the nuclear estrogen receptor antagonist ICI 182,780 (Faslodex™) 
The addition of an akylamide side chain at position 7α of a normal E2 molecule makes Faslodex 
bind with high affinity to ESRs while causing a rapid degradation of the receptor. As a result, the 
activation of transcription never occurs and this is what makes Faslodex a “pure” antiestrogen. 
[261]. Faslodex binds the ESR with approximately 100 times higher affinity than tamoxifen. Also, 
it does not cross the blood-brain barrier (and thus may not cause hot flashes) [262-264]. The 
current challenge is to create tissue- or even cell type-specific selective ESR modulators due to 
differences in tissue expression of ESR alpha and beta. 
Treatment with CDB (VA)-2914 (Paper II) 
CDB-2914 (CDB: Contraceptive Development Branch), also known as RTI 3021-012 and HRP-
2000, is a synthetic steroid (produced by Southwest Foundation for Biomedical Research) with 
potent P4 antagonist activity derived from 19-norP4 (Fig. 10) 
 
FIGURE 10: Chemical structure of the nuclear progesterone receptor antagonist CDB-2914 
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We preferred CDB-2914 to the much more widely used mifepristone (RU 486) due to the much 
reduced anti-glucocorticoid activity and increased anti-progestin activity in vivo [265]. It is not 
known if the CDB-2914 binds to the PGR. However, metabolites of CDB-2914 were showed to 
bind with high affinity to the PGR [266]. Administration of P4 reversed the antagonistic activity of 
CDB-2914 on maintained pregnancy and on normal uterine development in immature rabbits 
[267]. As its metabolites have some activity, the pharmacological properties of CDB-2914 are still 
under evaluation. The half-life (½) for the elimination of mifepristone, a drug that has been used 
for many years, varies between 24 to 90 hours depending on the assay used [268].  
Hormonal treatment in vitro (Paper III) 
In Paper III, we aimed to study the effects of P4 on ciliary activity in vitro. We were trying to 
overcome some of the troubles that in vitro handling causes by keeping the cells in a proper 
medium, at a physiologic in vivo temperature and by performing the sample preparation in a gentle 
way. To study the influence of P4 on the CBF, we carried out two experimental series: one in 
which we measured the baseline CBF of the cells at regular time intervals, and one in which 
determination of the baseline CBF of each cell was followed by exposure to P4 in ethanol or 
ethanol only, and subsequent recording of the frequency. We chose the concentration of P4 (20 
µM) based on the concentration used in a previous study on cows [107].  
 
DETECTION OF THE RECEPTOR PROTEIN  
Plasma protein purification (Paper I and II) 
In Paper I and some of the experiments in Paper II, we used a procedure originally developed by 
Bordier [269]  and later modified by Brusca and Radolf [270] to separate and concentrate integral 
plasma proteins from other proteins. This technique exploits the unique properties of the non-ionic 
detergent Triton X-114. Based on their hydrophobic structure, detergents are commonly used in 
the purification of integral plasma membranes. Non-ionic detergents, including Triton X-114, have 
a non-denaturing effect on antigens and are appropriate for the solubilization of integral membrane 
proteins. There are three values that describe the properties of a detergent: the HLB value, which 
stands for hydrophilic-lypophilic balance, the molecular weight of the micelle, and the CMC, 
which stands for critical micelle concentration. The HLB value describes the non-denaturing 
properties of the detergent based on the number of hydrophilic groups attached to the hydrophobic 
head group. For the more water-soluble Triton X-100, this value is 13.5, whereas for Triton X-114 
it is 12.4. The critical micelle concentration, also called cloud point, was found to be 22°C for 
Triton X-114. At temperatures above the cloud point, non-ionic detergents form a cloudy 
suspension due to increased micellar size. The micellar aggregates can be pelleted by 
centrifugation to separate the detergent-rich phase from the detergent-poor phase. The content of 
Triton X-114 in each phase is about 12% and 0.04%, respectively. In Papers I and II, the protein 
concentrations in separated protein fractions were analyzed by the Bradford method and then 
further analyzed by Western blotting.  
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In Paper II, we used an alternative method to purify plasma membrane proteins based on 
subcellular protein fractionation by ultracentrifugation [271]. We briefly evaluated the purity of 
protein fractions and proper protein molecular weight by Western blotting and confirmed the 
results obtained using Triton X-114.  
Antibody production 
The peptides used to produce the polyclonal antibodies used in Papers I and II were synthesized 
for us by AgriSera, Vännäs, Sweden. The peptide sequences for mPRβ 
(GQQLRRLPKILEEGLPKMPC) and mPRγ (FGYRHPQSSATAC) were chosen from the non-membrane-
spanning part near the N-terminus of the rat mPRβ and mPRγ cDNA sequences (GenBank 
accession numbers XM_236990 and XM_236314.3 respectively). In addition, the sequences were 
selected to match the mouse cDNA sequences with 100% homology and to avoid sequence 
similarities between the different mPRs or any other proteins. The length of the peptide sequence 
should preferably be between 4 and 14 amino acids, with a terminal cysteine to allow peptide 
orientation on the carrier molecule. The peptides were linked to keyhole limpet hemocyanin 
(KLH) and rabbits were the host animals for antibody production. The KLH is a relatively large 
protein aggregate containing copper, which readily dissociates with moderate pH changes. An 
advantage that we considered when choosing the rabbit for immunization was that they produce 
large amounts of serum. The antibodies were further affinity purified. A concentration of 0.52 
mg/ml for mPRβ and 0.6 mg/ml for mPRγ and the specific activity of the antibodies were 
confirmed by ELISA. It should be kept in mind that antibody properties including affinity are pH-
dependent. 
Immunohistochemistry (Papers I and II) 
Immunohistochemistry is a good qualitative method to detect which kinds of cells express or do 
not express a certain protein. One disadvantage of this method is that the absolute or even relative 
concentrations of an antigen cannot be determined easily. The basic principle for detection of 
antigen uses an enzyme-linked antibody. Specific antibodies possess a unique part called an 
epitope that recognizes the target antigens in the tissue. In Papers I and II, we used our own 
generated polyclonal antibodies and antibodies produced in the laboratory of Peter Thomas to 
detect the membrane P4 proteins. Polyclonal antisera sometimes present lower specificity 
compared to monoclonal antibodies, since the antisera are composed of a mixture of heterologous 
antibodies. On the other hand, the use of monoclonal antibodies sometimes increases the risk of 
false negative results, since there is only one epitope that could be recognized. To eliminate false 
positive or negative results, we analyzed positive or negative control samples at the same time as 
the rest of the samples. In addition, we validated our primary antibodies using Western blotting in 
cell systems overexpressing the mPR or cell treated with short-hairpin RNA (shRNA) to reduce 
the mPR expression. 
Magdalena Nutu 
QUANTIFICATION OF THE RECEPTOR 
Western blot assay (Papers I and II) 
Western blot, or protein immunoblot, is an analytical method that allows detection of a protein in a 
sample. It does not give information on the localization of the protein within the cell or piece of 
tissue analyzed as immunohistochemistry does, but the molecular weight of the immunoreactive 
protein can be compared with the expected weight. Moreover, Western blot can evaluate whether 
the antibody binds more than one protein. In this way, it gives a higher certainty that the correct 
protein is being measured. Western blotting also allows a comparison between protein 
concentrations in different samples. To achieve a more quantitative assay, methods like enzume 
linked immuno sorbent assay (ELISA), radioimmuno assay (RIA) or enzyme immuno assay (EIA) 
may be used. However, in these methods, the molecular size of the immunoreactive protein in each 
sample cannot be controlled. The specificity and sensitivity of Western blotting depends largely on 
the antibodies used. The first step of the procedure is gel electrophoresis, which allows separation 
of proteins by size. The next step is the transfer of the separated proteins to a nitrocellulose 
membrane or some other type of protein-binding membrane (blotting), followed by detection 
(probing) with specific antibodies. The antibodies can sometimes be expensive or available only in 
limited amounts, although unbound antibody can often be reused between experiments.  
RNA detection 
In Paper II, total RNA was isolated from mouse fallopian tubes and ovaries using a commercial 
Micro column kit from Qiagen, Sweden. The mRNA expression was analyzed by two methods: 
reverse transcription polymerase chain reaction (RT-PCR) and quantitative polymerase chain 
reaction (Taqman).  
Reverse transcription polymerase chain reaction (Paper II) 
The PCR method was developed by Kary Mullis in 1984, who was awarded the Nobel Prize in 
Chemistry in 1994 for his work. This technique is a very sensitive method to detect expressed gene 
products though a specific amplification procedure. In Paper II, we used this method to confirm 
the expression of mPRs mRNA in mouse tissues. An advantage of the PCR method compared to, 
for example, Northern blotting is that it can detect very low levels of mRNA. The PCR reaction 
requires DNA polymerase (Taq polymerase), which enzymatically assembles the single-stranded 
DNA (cDNA) template, and DNA oligonucleotides (primers) to initiate new DNA synthesis. This 
process is repeated in a number of cycles, resulting in a doubling of the DNA amounts after each 
PCR cycle. 
Quantitative real-time polymerase chain reaction (Paper II) 
The qRT-PCR technique enables reliable detection and measurement of products generated during 
each cycle of the PCR process. This method requires a specific oligonucleotide probe or primers 
designed to hybridize within the target sequence. In our experiments in Paper II, we used specific 
primers designed to match the mPR genes. The probes/primers are fluorescently labeled with 
reporter fluorophores at their 5' ends and quencher fluorophores at their 3´ ends (Fig. 11). The 
quantitative real-time PCR technique has several advantages over the classical quantitative PCR 
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system. The use of fluorescent dye-labeled probes increases the sensitivity of the system by at least 
seven orders of magnitude and gives rise to a linear relationship between copy number and CT 
values. This method is used commonly nowadays; it can detect small differences in mRNA 
expression levels and quickly analyze several genes as well. The reporter fluorophore emits at a 
wavelength absorbed by the quencher fluorophore. The Taq polymerase starts extending primers 
moving toward the probes and, due to the 5´ nuclease activity, the probe is degraded and the 
reporter cleaved and separated from the quencher. The result is an increased emitted florescence 
that can be quantified. In our PCR, the generation of the product was determined by measuring the 
SYBR green fluorescence signal. Unbound SYBR Green exhibits little fluorescence, but during 
elongation, when SYBR Green binds to newly synthesized DNA, the emitted fluorescence signal 
increases proportionally with the amount of product formed. SYBR Green is not expensive to run, 
which makes it a good approach when wanting to test the expression of a number of genes. 
However, the design of the primers is important because SYBR Green can bind to all double-
stranded DNA. Therefore, the primers should not be designed to span over long introns. The PCR 
cycle threshold (CT) for a sample is used to define the real signal detected above the noise. 
Housekeeping genes are usually used to normalize gene expression and should not be influenced 
by the treatments. QPCR is optimized to have near 100% efficiency, facilitating the use of the 
ΔΔCT method. This value is calculated from the difference between the CT of the sample and the 
CT of an endogenous control such as glyceraldehyde 3-phosphate dehydrogenase (GAPDH). In 
paper II, we selected GAPDH, which is frequently used as a reference gene and worked best out of 
the reference genes we tested.  
 
 
 
 
FIGURE 11 : Illustration of the chemical events taking place in the qRT-PCR reaction 
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MEASUREMENT OF CILIARY BEAT FREQUENCY (PAPER III) 
Several studies have investigated changes in ciliary beat frequency in the tubal epithelium over the 
menstrual cycle. Different methods have been employed to study the in vitro ciliary motion in 
different tissues, including high speed cinematography combined with optical microscopy. In 
1962, Dalhamn and Rylander described the first photometric method that could register CBF 
[272]. This method was based on imaging at relatively high magnifications of light microscopy 
and electronic detection of transmitted light fluctuations produced by the beating cilia. Normally 
this method demands a short working distance and is applicable only in vitro. Later, laser light 
scattering techniques were introduced for measurements of beating cilia [273], and they have 
provided highly precise measurement of CBF. Further technique development led to 
measurements of cilia movement in situ inside the trachea or the ampulla [274, 275]. However, the 
medical applicability of this method did not overcome low frequency signals caused by breathing, 
heart beating or animal/patient or environmental movements. A convenient method of studying 
ciliary activity in the fallopian tube is not easy to find. 
In our study, we measured ciliary beat frequency using an inverted light microscope. The CBF 
readings (100 frames per second) were taken from an area of interest of approximately 50x50 
pixels. This area allows the camera to take pictures of ciliary movement. As the cilia beat, the light 
intensity is changed and detected by the camera and computed into a frequency (in Hertz). The 
light change from the initial average is computed into a frequency by Fourier transformation. This 
transformation describes the frequencies that are present in the original signal. The cell or tissue 
fragment of interest was held still with the help of a micromanipulator. The typical application of 
micromanipulation in humans is intracytoplasmatic sperm injection (ICSI). This device controlled 
by a joystick is provided with a needle, which is driven by 3D step-motors. The movement 
reduction is obtained hydraulically using pistons connected to an oil-containing tube for persistent 
fast-holding. The baseline CBF was determined over a 30-minute period on the same cell at the 
same temperature and in the same medium prior to addition of the hormone. Therefore, each cell 
acted as its own control.  
  
Membrane progesterone receptors in the fallopian tube 
49 
SUMMARY OF RESULTS AND DISCUSSION 
MEMBRANE PROGESTERONE RECEPTORS (mPR) β AND γ ARE PRESENT AT 
THE TRANSCRIPTIONAL AND TRANSLATIONAL LEVELS IN BOTH HUMAN AND 
MOUSE FALLOPIAN TUBES (PAPER I AND II)  
In Papers I and II, we aimed to investigate the general expression of mPRs in the mouse and 
human fallopian tubes. Analyzing mRNA expression is often easier and more straightforward than 
assessing protein expression directly. However, although the central dogma implies that a specific 
mRNA is translated into its corresponding protein, this is not always the case. Messenger RNA can 
be degraded before translation occurs. It is, however, agreed that both mRNA and protein 
expression measurements are useful to have for a better understanding of cell function. The 
expression of mPRα mRNA from spotted sea trout was initially identified by Northern blot 
analysis [176]. Most studies that have investigated the tissue-specific expression of mPR genes 
have applied RT-PCR techniques [181, 186-188, 195, 202, 206]. 
In Paper II, we used primers that target the specific cDNA sequences of the mPRβ and γ genes to 
demonstrate that the mPRs genes are expressed in the mouse fallopian tube and ovary (Fig. 3A,B 
and Fig. 4). Although several studies have demonstrated the expression of mPR mRNA in many 
tissues and species, to the best of our knowledge no other studies have investigated mPR gene 
expression in the fallopian tube. Although the expression of mPRα and β has been reported in an 
immortalized human fallopian tube cell line [234].  
In order to study receptor protein expression, we developed specific antibodies designed to match 
a unique, presumably antigenic sequence from the extracellular N-terminal end of each mouse 
mPR protein. Antibodies were affinity purified on a column to achieve maximum purity, and the 
antibody-containing media was then evaluated by ELISA. Although we generated our own 
antibody against mouse mPRβ, we chose to use an antibody for mPRβ produced by another 
laboratory (the lab. of Peter Thomas) in our experiments, because it was able to detect the receptor 
at higher dilutions (lower concentration of antibodies) and appeared to have somewhat higher 
specificity (less cross-reactivity with proteins of different molecular masses). Most importantly, 
the specificity of this mPRβ antibody had already been validated and used in several species and 
reproductive tissues [177, 194]. In our studies, the specificity and cross-reactivity of both the 
mPRβ and γ antibodies were demonstrated by showing that specific blocking peptides completely 
abolished all binding in different assays techniques, and/or by using the antibodies in cell lines 
where either the mPRs genes were knocked down by RNA interference or the mPRs proteins were 
overexpressed.  
Both the mPRβ and mPRγ antibodies detected a band of the expected size (approximately 40 kDa) 
in protein extract from mouse and human fallopian tubes (Paper I, Figs 3 and 4; Paper II, Figs. 2 
and 6). Another study reported the expression of mPRα and β in the human fallopian tube using 
immunohistochemistry. However, the main purpose of that study was to investigate the expression 
of the mPRs in ovarian tumors. These tumors arise from epithelial cells, and fallopian tube tissues 
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were used as controls due to the higher content of epithelial cells in the fallopian tube compared to 
the ovary [204]. 
 
 
 
 
MEMBRANE PROGESTERONE RECEPTORS (mPR) β AND γ ARE PRESENT IN 
BOTH REPRODUCTIVE AND NON-REPRODUCTIVE TISSUES IN MALE AND 
FEMALE MICE (PAPER I AND II) 
In Papers I and II, we aimed to investigate the overall distribution of the mPRs in tissues from 
male and female mice, as well as in the fallopian tube.  We found that both mPR β and γ are 
expressed in both male and female reproductive tissues. Both mPR β and γ were found to be 
expressed in the fallopian tube and ovary (Paper II, Fig. 3A). As reported in the literature, mPR 
mRNAs are broadly expressed in the reproductive tissues of a variety of species, including many 
fish species such as zebrafish [187, 191, 221], channel catfish [187] and goldfish [276], as well as 
in rat [188], sheep [198] and human [177, 181, 186, 199-202, 204]. In mice, mPRβ expression has 
been observed in the uterus [195], whereas mPRγ expression has been reported in P4 responsive 
tissues outside the reproductive tract. We have previously investigated the expression of mPR 
genes in rats, where we found the strong expression of mPRα and β in reproductive tissues such as 
the ovary and uterus, and the expression of mPR γ in the uterus [205]. 
Using antibodies specific to mPRβ and γ, our results demonstrated the expression of receptor 
proteins with a molecular size of 40 kDa. The distribution of the mPRβ protein appears to be 
broader and more evenly expressed between tissues than that of mPRγ. In reproductive tissues, the 
expression of mPRβ was highest in testis, even though it was present also in prostate and 
epididymis (Paper II, Fig. 1). Interestingly, it appears that the expression levels of mPRβ and γ are 
similar in female reproductive tissues, while mPRβ predominates in the testis (Fig. 12). Western 
blot analysis detected protein moieties of 40 and 80 kDa, corresponding to monomers and dimers, 
in extracts from fish and human sperm [190, 199]; mouse and fish testis [199, 201, 202, 207], as 
well as from transfected cell lines [180, 201]. Interestingly, the ortholog of mPRβ in the Xenopus 
oocyte had an apparent molecular weight of 60 kDa [186], whereas cells transfected with the 
human mPRβ (HEK 293) yielded a protein of 30 kDa [182]. Our results showed that mPRβ and γ 
expressed in mouse tissues have the expected molecular weight of 40 kDa.  
We have also evaluated the expression of mPRβ and γ in the mouse brain; our preliminary results 
suggest that the mPRs are involved in mediating the effect of P4. However, in mouse brain, our 
antibody against mPRγ detected a strong band at 28 kDa in addition to weak expression of the 40 
kDa protein (data not shown), which was only detected in protein preparations from the brain. This 
28 kDa protein could be a truncated form of mPRγ that is present specifically in the brain; 
Taken together, the results of Paper I and II showed that mPRβ and γ are expressed at 
both the transcriptional and translational level (mRNA and protein level) in mice and 
humans. 
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alternatively, it could represent an unrelated protein that is highly expressed in the brain and is 
recognized non-specifically by the mPRγ antibody.  
 
FIGURE 12: Tissue distribution of mPRβ (left; previously published in Paper II) and mPRγ (right; previously 
published in Paper I) in female and male mouse  
In addition to the expression of mPRs in reproductive tissues, we observed the high and specific 
expression of mPRβ and γ in tissues outside of the reproductive tract (Fig. 12). The mPRs 
expression in various mouse tissues is essentially identical in both sexes. However, our studies on 
mice did not corroborate original reports of high mPRβ expression in brain tissues [176, 187]. This 
discrepancy could be attributed to the immature mouse model used in our studies. Our analysis of 
mPRγ revealed that its highest expression was in the lung and its lowest expression was in the 
kidney (Paper I, Fig. 2), in contrast to the first report which indicated very high expression in the 
kidney [177]. There is evidence that P4 also affects pulmonary function and reduces muscle 
contractility in a rapid fashion [277]. We have found strong expression of mPRγ in mouse lung 
tissue and observed differential expression between female and male mice (Fig. 13). 
 
FIGURE 13: Relative intensity of endogenous mPRγ expression in immature and adult female and male mice (data 
not published) 
We also found mPRγ to be highly expressed in the mouse liver, although the physiological 
function of P4 in this tissue is less well known. Our findings in Paper I (Fig. 5) indicate a marked 
expression of the mPRγ protein in female mouse hepatocytes adjacent to the central veins. Rapid 
membrane depolarization in the liver (involving K+ channels) has been observed in response to P4 
[278]. In humans, mPRβ has been found in T-lymphocytes [202] and in ovarian tumors [204], 
implying an immuno-regulatory role and a possible involvement in tumor development. 
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MEMBRANE PROGESTERONE RECEPTORS (mPR) β AND γ ARE CO-
EXPRESSED IN THE EPITHELIAL CELLS OF MOUSE AND HUMAN FALLOPIAN 
TUBES BUT HAVE A DISTINCT CELLULAR DISTRIBUTION (PAPERS I AND II) 
Our current knowledge of the tissue/cellular distribution of mPRs has been primarily obtained via 
non-histological assays. However, one disadvantage of these methods is that they overlook the 
relationships between protein expression and histological structures, therefore limiting the 
understanding of the receptor‟s functions. A common strategy in elucidating the physiological 
function of a receptor is to investigate its cellular localization.  
We used several immunohistochemistry techniques to investigate the localization of the mPRβ and 
γ receptors in the fallopian tube. The fallopian tube epithelium is mainly equipped with ciliary and 
secretory cells. We found that mPRβ and γ (Paper I, Fig. 3 and Paper II, Fig. 2) were specifically 
expressed in the ciliated cells of the fallopian tube epithelium in both mouse and human. 
Furthermore, the expression of mPRβ in human fallopian tube epithelial cells was also confirmed 
by another study that used the same antibody [204]. 
Interestingly, even though the expression of mPRβ and γ was consistently detected within the 
same cells in mouse and human tubal epithelia, the localization within these cells was distinct and 
specific for each mPR subtype (Paper I, Figs. 3 and 4; Paper II, Figs. 2 and 6A). In the fallopian 
tube, mPRβ was found in the motile cilia of epithelial cells, whereas mPRγ was found to associate 
with the apical membrane of the ciliated cells (Fig. 14). This co-occurrence within the same cell 
raises the possibility of a cooperative role in mediating effects of P4.  
 
FIGURE 14: Distinct localization of mPRβ (left; published in Paper II, Fig. 2D) and mPRγ (right; published in Paper 
I, Fig. 3B) in ciliary cells of the immature mouse fallopian tube. 
Even though the apical cell membrane and the cilia membrane contain different sets of proteins, 
the specialized ciliary membrane is continued from the apical membrane of the cell [279]. The co-
localization of mPRβ and β-tubulin IV, which is a cellular marker for cilia, provides evidence of 
its ciliary localization (Paper I, Figs. 3 and 4; Paper II, Figs. 2 and 6A). In contrast to our findings 
regarding the localization of mPRβ, Romero-Sanchez et al. [204] reported unclear immunostaining 
of mPRs in all epithelial cells of the human fallopian tube, including secretory cells and ciliated 
cells, when using the same mPRβ antibody used in our study [204]. 
In the literature, the specific localization of mPRα and β to the plasma membrane was investigated 
using IHC assays, but was conducted with more of a focus on species differences. The IHC and/or 
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IF techniques revealed the plasma membrane localization of mPRs in human [199, 201], mouse 
[195] and fish [176, 190, 206-208]. However, mPRα and β were both found in plasma membrane 
preparations from testis [199], oocyte [206], gonadotrophes [195] and uterus [194, 201]. The 
mPRγ form is the least-studied of all mPRs subtypes. To the best of our knowledge, the subcellular 
localization of mPRγ had not been reported prior to our studies.  
Although mPR localization to the plasma membrane has been reported for many tissues from 
many species since 2003, some studies do not support these findings [189]. In most of these 
studies, the plasma membrane localization was investigated using antibodies specific to the N-
terminal portion of the mPR. However, Qui and colleagues showed that the staining method can be 
crucial, as the addition of Triton X-100 altered the observed staining pattern in porcine cumulus 
cells [244]. Triton X-100 is a non-ionic detergent which can damage the plasma membrane and 
allow the antibody to access the antigen. When we use 0.5% Triton X-100, the fluorescence 
appears as an intracellular staining of all epithelial cells (Fig. 15A) most likely because the plasma 
membrane is damaged, whereas specific staining to the plasma membrane, and only to the 
membrane of cililated cells (not secretory cells) is observed when Triton X-100 is excluded (Fig. 
15B). We have also noted that different fixation and staining techniques can influence the general 
cellular localization using the same antibody.  
 
FIGURE 15: Immunohistochemical analysis of mPRβ localization in immature mouse fallopian tube cells treated 
with Triton X-100 (A) or untreated (B). epi: epithelial cell; m: muscle layer  
On the other hand, it also appears that the mPR localization to the ER observed in mouse 
embryonic fibroblasts could not be explained by a detergent effect. The localization to the ER in 
some cells is also supported by other studies [182, 197, 204, 244]  and is predicted by the presence 
of motifs for endocytosis internalization and ER export found in the mPRβ transcript [280]. 
Furthermore, steroid hormones, including P4, easily pass through the plasma membrane and thus 
could reach the receptor inside the cell. Another matter of debate has been the orientation of the N- 
and C- termini of the mPRs in the plasma membrane, and their ability to sense and respond to P4. 
The mPRs are Class II PAQR receptors and have some features that distinguish them from other 
PAQR receptors [144]. The mPRs begin a signaling cascade by activating G-proteins [180], while 
PAQR family members such as adiponectin receptors do not [179].  In contrast to PAQRs, both 
the hmPRα and smPRα possess an extracellular N-terminal domain and an intracellular C-terminal 
domain that acts with the third intracellular loop to activate G-proteins [180]. The originally 
reported orientation (extracellular N terminus and intracellular C terminus) was recently confirmed 
Magdalena Nutu 
by the permeabilization of transfected cells expressing the mPRs [180]. The association between 
the presence of recombinant and wild-type mPRs in cells and increased progestin binding has also 
been demonstrated [147].  
Previous studies have proposed a cooperative role for mPRs in fish oocyte maturation induction 
and the transactivation of PGR in human myometrial cells [186, 201, 213, 214, 220, 221, 276]. 
Furthermore, the flagellar activity of human and fish sperm upon progestin stimulation is 
suggested to be mediated by mPRα [208]. The abundance of the receptor on the sperm membrane 
is related to sperm motility, as was demonstrated in both human and fish [199, 208] 
 
PROGESTERONE REGULATES THE EXPRESSION OF mPRβ AND γ IN THE 
MOUSE FALLOPIAN TUBE (PAPER II). 
In both paper I and paper II, the distinct localization of the mPRs to the fallopian tube epithelium 
was demonstrated. Part of paper II was designed to address whether ovarian steroid hormones 
regulate the expression of mPRs in the mouse fallopian tube. 
The results presented in Paper II showed that P4, a ligand of the mPRs, rapidly down-regulates the 
expression of both the mPRβ and γ genes in the fallopian tube of gonadotropin-primed mice 
(Paper II, Fig. 4). In line with our findings, treatment with the functional progestin 17α,20β-DHP 
causes the down-regulation of mPRβ mRNA expression in the ovary of the channel catfish [191]. 
Conversely, P4 does not affect the expression of mPRβ in human myometrial cells [201]. In the rat 
corpus luteum (CL), mPRs appear to be independently regulated. The mPRα gene appears to be 
regulated in both the development of the CL and during pregnancy. The expression of mPRβ is 
decreased in late pregnancy, when a dramatic drop in P4 level occurs, whereas the expression of 
mPRγ increases with advancing gestation. However, toward the end of the pregnancy the 
expression of mPRγ remains constant [188]. 
In the gonadotropin-stimulated mouse model, the regulation of mPRs could be directly mediated 
by P4 in the target tissue, or by feedback acting on gonadotropin release from the pituitary gland. 
Ovarian hormones can regulate LH/FSH secretion in the brain via feedback mechanisms and thus 
influence their own production in the ovary, in addition to other pathways. Although the 
expression and function of FSH receptors in the ovary are well-established, their presence in the 
fallopian tube has been reported but their physiological function is only poorly understood [281]. 
In E2-primed, castrated rats, P4 induce the release of both FSH and LH [282]. This model is in 
many aspects similar to that presented by immature mice injected with eCG, which leads to an 
In summary, Papers I and II demonstrated that mPRβ and γ are present in the ciliated 
cells of the fallopian tube of mice and humans. Both receptors are associated closely with 
the cilia, although they exhibit distinct cellular localizations. Taken together, these results 
suggest that these proteins might play a role in regulating some aspect of ciliary function 
in the fallopian tube.  
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endogenous E2 peak. We demonstrated the regulation of both mPRβ and mPRγ by P4 in mice 
primed with eCG, but not in immature mice. This lack of effect in the immature mouse is 
consistent with a model of P4-induced regulation of mPRs via gonadotropin release from the 
hypothalamus/pituitary gland, although this hypothesis needs to be tested further.   
Consistent with the expected feedback on gonadotropin release, we observed a similar trend of 
reduced mPRβ and mPRγ expression in E2-treated eCG-primed mice, but the effect was not 
statistically significant (Paper II, Fig. 4). In immature mice, however, E2 rapidly and significantly 
down-regulated the expression of mPRβ in the fallopian tube (Paper II, Figs. 3B and C), clearly 
suggesting a gonadotropin-independent regulation. The regulation of the mPRα gene has also been 
investigated in an immortalized fallopian tube cell line, where it was reported to be down-
regulated by E2 and up-regulated by P4 [234]. This result suggests that E2 and P4 may directly 
regulate at least one mPR in the fallopian tube. In both human myocytes and teleost ovaries, a 
direct regulation of mPRα and β by P4 and other progestin hormones has also been demonstrated in 
vitro [176, 201]. On the transcriptional level, P4 causes a greater up-regulation of the mPRα gene, 
whereas the mPRβ gene was regulated solely by E2. The observed regulation on the transcriptional 
level was associated with an increased abundance of mPRα and β proteins after 18 h of treatment. 
Differential regulation of mPRα and β by P4 in human myometrial cells suggests that the two 
receptors have divergent functions [201]. After ovulation, the continuously P4-producing cumulus 
cells surrounding the oocyte [90, 91, 283, 284] probably expose the epithelium of the fallopian 
tube to much higher P4 levels than are experienced by any other tissue in the body, at least for a 
brief period of time. Thus, it is possible that circulating steroids might be of less importance than 
local levels of P4 for the regulation of receptor levels. Indeed, the activation of sperm swimming is 
thought to be caused by a gradient of locally produced P4 as the spermatozoa approach the ovum 
inside the fallopian tube [285]. Notably, there is no intra-tubal steroid production in either the 
immature or the eCG mouse model. 
Direct regulation of the mPRs by E2 and P4 in the fallopian tube could conceivably be mediated 
either by stimulation of the classical nuclear receptors ESR and PGR, or by non-genomic signaling 
pathways, possibly involving the mPRs themselves. Tentative E2 and P4 response elements (EREs 
and PREs) are present upstream of both the mPRβ and mPRγ genes [187], suggesting a possible 
regulation via ESR and PGR. Indeed, PGR and ESR are both expressed in the epithelial, stromal 
and muscle cells of the fallopian tube [80, 137, 286]. The expression of these receptors positively 
correlates to plasma E2 levels, whereas a negative correlation to plasma P4 was found [287-289]. A 
few studies have proposed that the classical PGR is localized outside of the nucleus, possibly in 
the plasma membrane [212, 217, 290]. The classical PGR is reported to be expressed in the 
ciliated, stromal and muscle cells of the mouse [80, 137] and human fallopian tube [291]. 
Teilmann and colleagues (2006) showed intense staining of the classical PGR in the cilia proper 
[139], i.e., outside the nucleus, quite similar to the staining for mPRβ reported in Paper II. This 
localization could indicate a role for the PGR in non-genomic signaling (see also discussion p. 59-
63).   
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The ESRs have been reported to be expressed in the ciliated, secretory and smooth muscle cells in 
the fallopian tube of the immature rat [137, 292, 293]. In contrast, one study demonstrated a strong 
immunostaining for the ESRβ specifically along the cilia proper of mice, whereas the secretory 
cells remained unstained [286]. It remains to be determined how the PGR and the ESRβ are 
localized to the cilia, whether they act as functional receptors there and if so, what signaling 
pathways are involved. It has been suggested that up to 5% of ESRs can be associated with plasma 
membrane caveolae. For example, ESRs were found to associate with caveolae in endothelial 
[294] and human breast cancer cells [295]. It has been shown that ESR association with caveolae 
could be coupled to Gαi and stimulate endothelial nitric oxide synthase (NOS) [296], or epidermal 
growth factor (EGF) activity to ultimately activate MAPK signaling pathways [297]. In human 
endothelial cells, it has been shown that E2 activates ESR-associated non-nuclear PI(3)K, similar to 
the mechanisms of nuclear glucocorticoid (GR) and thyroid receptors activation upon treatment by 
dexamethasone and thyroid hormone [298]. Different structural models of the LBD with 
alternative ligand pockets (for genomic and non-genomic responses) have been proposed for ESRα 
and the vitamin D receptor (VDR) [299].  
 
 
 
THE MOUSE FALLOPIAN TUBE PROVIDES A GOOD MODEL SYSTEM FOR 
STUDYING CILIARY ACTIVITY (PAPER III) 
In Paper III, we aimed to establish a method for recording the CBF of epithelial cells using a 
mouse model. 
A number of studies have looked for a change in CBF in the fallopian tube mucosa during the 
menstrual/estrous cycle, though none of these studies have been conducted in mice. Several 
techniques for measuring CBF have been developed, most of which are adapted for larger pieces 
of tissue than can be obtained from mice. The wide range of the reported baseline CBF (between 
5-20 Hz) obtained from human studies also suggests that experimental conditions will often 
influence the CBF.  
As ethics concerns dictate that we must work with animal models to study the mechanisms that 
regulate gamete transport, we should consider that there may be significant differences across 
species. For example, the interval between ovulation and implantation varies markedly among 
species. Mice are the most common animal model for human physiology because they are 
In conclusion, the results of Paper II show that P4 and E2 regulate the expression of 
mPRs in the mouse fallopian tube. Steroid receptors are commonly regulated by their 
own ligands, thus our findings add support for a role of mPRβ and γ as functional 
progesterone receptors in the fallopian tube. The ciliated cells of the fallopian tubes are 
equipped with both nuclear and membrane-associated steroid receptors, which all could 
be involved in mediating the steroid-dependent regulation of the mPRs.  
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genetically relatively close to humans, they are easy to breed and their physiology is very well 
understood.  Furthermore, mice are amenable to hormonal manipulations, and genetically modified 
models are available or can be produced. Knockouts of the PGR gene (PGRKO mice) are available 
and will be useful for further evaluating the roles of different P4 receptors on fallopian tube 
function. In addition, the estrous cycle in mice and the menstrual cycle in humans are comparable. 
Despite the anatomical differences between humans and mice, the duration of tubal transport is 
similar: 80 h in human and 72h in mice [9]. Nevertheless, the human egg spends almost 90% of 
this period in the ampulla region in the fallopian tube, whereas in mouse the egg remains in the 
ampulla for only 25% of this time.   
Other laboratories have used immortalized human oviductal cell lines to study the hormonal 
regulation of the fallopian tube mucosa [233, 234].  However, one limitation of this approach is 
that the morphological characteristics of the ciliary epithelial cells may be lost over time. In our 
study, we performed measurements of CBF in ciliary cells from mouse fallopian tube immediately 
after tissue removal. Ex-vivo recordings of CBF over at least two hours demonstrated that the 
mouse model is compatible with our methodology. The establishment of a baseline CBF, the 
addition of hormone, and a subsequent recording of ciliary activity were possible. Establishing a 
baseline CBF is important and also required in order to examine factors that control the 
mechanism of ciliary activity. In Paper III, we found a mean CBF of approximately 22.5 ± 3.8 Hz 
in the mouse fallopian tube. In humans, however, the baseline CBF from in vitro studies ranges 
between 5 and 20 Hz [61, 100],  whereas in cow a mean CBF of 23.1 Hz with a standard deviation 
of 4.7 Hz was reported in vitro [107]. Furthermore, deviations in CBF might be caused by 
pathological conditions, especially in the observations in humans, and/or by the methodology used. 
In some ex vivo studies, the CBF increased after several hours/days in culture [100, 101]. Several 
factors, such as P4, E2, interleukin 6, prostaglandins and Ca
2+
 have been reported to affect CBF in 
different species [100, 107, 300-302]. 
Another important factor to consider is the temperature at which the measurements are performed. 
To overcome muscular contractility ex vivo, several studies have been performed at temperatures 
lower than 37°C. In order to make our studies consistent with those of Wessel et al., and to reduce 
the effect of muscular contractility, we performed the CBF measurements at 35°C [107]. The 
effect of temperature on female reproductive tissues may have been previously underestimated. In 
the male reproductive system, the temperature gradient between the testis and the deep body 
temperature is well-characterized and is known to be important for maintaining fully functional 
sperm production. The temperature of human, rabbit, pig and cow follicles are on average 1.3 - 
1.7°C cooler than the ovarian stroma [303]. Temperature differences are thought to occur due to a 
reaction within the Graafian follicles. This gradient might be important for gamete development in 
females. Interestingly, in mated pigs the isthmus appears to be about 0.7°C cooler than the other 
segments of the fallopian tube [303]. The arrest of spermatozoa in the caudal portion of the 
isthmus has been observed in several species including cow [304], and sperm motility is reduced 
in this segment of the fallopian tube. Furthermore, rabbit and human spermatozoa have the ability 
to sense temperature differences smaller than 0.5°C [305]. Temperature differences of at least this 
degree have been observed in pig and rabbit at ovulation, and lasts for at least 10 hours after 
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ovulation [306].  Similar observations in humans revealed that the temperature decreases from the 
isthmus to the uterus at ovulation [307]. Human spermatozoa have been reported to move toward 
warmer temperatures [305], and thermotaxis could be complementary to chemotaxis as a 
mechanism for sperm guidance in the fallopian tube. Taken together, it appears that gametes are 
exposed to decreased temperatures in the hours before sperm-egg interaction and fertilization 
occur. Temperature deviations of as little as 1°C may negatively influence cell organelles, protein 
chemistry and folding, especially in the oocyte maturation process [308]. However, further studies 
are required to establish the importance of a temperature gradient in the female reproductive tract, 
as well as to elucidate any differences between mouse and humans.  
Ciliary activity is also affected by fluctuations in the intracellular pH. The pH of tubal fluid 
changes during the menstrual cycle, ranging from 7.1-7.3 during the follicular phase to 7.5-8.0 
after ovulation. The pH is regulated by electrolytes and ions that pass through the lumen. The 
influence of pH on the CBF has been extensively studied in airway epithelia, where alkalization of 
the intracellular pH has shown to increase the CBF while acidification reduces it [309]. 
 
 
 
PROGESTERONE TREATMENT CAUSES A RAPID DECREASE IN CBF IN THE 
MOUSE FALLOPIAN TUBE (PAPER III) 
Progesterone has been proposed to regulate the CBF in the fallopian tube of several mammalian 
species [2, 4, 60, 105]. To investigate the effects of P4 on the CBF, we treated ciliary epithelial 
cells from immature mouse fallopian tubes with P4. Our results, presented in Paper III, show a 
significant drop in CBF (about 2.5 Hz, or 11%, compared to control cells) 30 minutes after the 
addition of P4. This result is very similar to the results found in the cow, where P4 reduced the 
CBF by 11% within 15 minutes after the addition of P4 [107]. The CBF of control cells was 
reduced by an average of 0.7 Hz by the end of the recording period. This apparent difference was 
not statistically significant. Our observations appear to be similar to those of Wessel and 
colleagues despite the relatively great evolutionary distance between the cow and mouse within the 
mammalian taxon. These data suggest that rapid effects of P4 on the CBF of the fallopian tube 
most likely exist in other mammalian species as well. Recently, a poster at the 6
th
 International 
meeting on “Rapid Responses to Steroid Hormones” 2009 in Spain, presented results supporting 
the rapid P4-induced effect on CBF in mouse fallopian tube epithelial cells [310]. In this study, a 
rapid increase in CBF was reported to occur in mouse ciliary oviduct cells in primary culture upon 
P4 treatment (10 µM), an effect that appears to involve the activation of the TRPV4 channel. This 
is not surprising, since activation of the TRPV channels results in increased Ca
2+
 levels, which are 
known to increase CBF.  
Our results show that the mouse is an appropriate model for the study of ciliary activity in 
the fallopian tube. Many factors affect the CBF and should be controlled for in any 
experimental setup.  
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In paper III we showed that treatment with 20µM of P4 decreased the CBF in mouse in a rapid 
fashion. The same concentration caused a similar effect in cow [107]. However, this concentration 
of P4 is considerably higher than physiological levels found in the general circulation. In a study in 
the cow [107],  the use of a µM concentration of P4 was based on the estimated P4 concentration in 
the human placenta [311]. In mice, the serum levels of P4 normally range between 25 and 50 nM 
[81], whereas in humans they are often between 1 and 25nM [312, 313]. However, ovarian steroid 
levels are often significantly higher in the arterial and venous uterine blood than in systemic 
circulation [314]. Furthermore, the concentration of P4 measured close to the corpus luteum in the 
peritoneal cavity (136 nM) was 4-fold higher than in other peritoneal measurements and 5-fold 
higher than in the general circulation [312]. Casslén and colleagues (1986) reported up to 342nM 
of P4 in the peritoneal fluid of a post-ovulatory woman [315]. These findings suggest that the high 
concentration of P4 released from the corpus luteum enters the peritoneal cavity and influences the 
function of nearby tissues, such as the fallopian tube, although the authors also reported low nM 
levels of P4 in human fallopian tube fluid. In rodents, but not humans, the ovary and the fallopian 
tube are surrounded by a common bursa. Thus, as the bursa of mice prevents the fluid surrounding 
the P4-producing ovary to spread freely into the peritoneal cavity, the mouse fallopian tube is 
probably exposed to even higher concentrations of P4. In addition, the cumulus cells surrounding 
the oocyte after ovulation continue to produce P4 in both mice and humans [90, 283] and are thus 
likely to contribute to an increased local concentration of P4 in the fallopian tube. Therefore, the P4 
concentration can be expected to be much higher in the environment immediately surrounding the 
cumulus complex. Thus, association between circulating levels of P4 and the CBF of the fallopian 
tube may be of limited value [2, 51, 60, 61, 104, 316, 317]. To date, we cannot state conclusively 
whether our use of 20µM P4 represents a physiologically relevant concentration similar to the 
levels of P4 encountered by cilia close to the cumulus complex. 
An important question is what receptor or receptors mediate the rapid effects of P4 on the CBF in 
the fallopian tube. The rapid nature of the response suggests that a non-genomic signaling pathway 
is involved.   
Immunoreactivity to the classical PGR has been demonstrated in the cilia proper (i.e., plasma-
membrane associated, outside the nucleus) of the epithelial cells in mouse and human fallopian 
tubes [139].  One possibility, therefore, is that the non-genomic action of P4 could be mediated via 
the nuclear receptor as well. Indeed, several studies have presented evidence of PGR localization 
outside of the nucleus [318-320]. There, the PGR has been shown to mediate ligand-independent 
gene transcription. It has also been shown that this interaction can occur directly through the poly-
proline motif of PGR, which acts as a ligand for the SH3 domain of the c-Src protein, or indirectly 
through the association of PGR and ESR, which further activates the SH2 domain of c-Src. Active 
c-Src will then trigger the activation of the MAPK signaling pathway [121, 321]. Another report 
proposed that cross-talk mediated via the plasma membrane-situated mPRs is important for signal 
transduction. In cultured myometrial cells that simultaneously express both mPRs and PGR, PGR 
activation was achieved through signaling mechanisms started at the plasma mPRs after P4 
treatment [201]. Interestingly, Wessel et al. (2004) found that pretreatment with the PGR 
antagonist RU486 could not block the effects of P4 on CBF in the cow. This could be interpreted 
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as an indication that the PGR is not involved in controlling CBF. However, as the mechanisms for 
non-genomic signaling mediated by PGR are not as clear as those for its role as a transcription 
factor, it is not certain that RU486 would be able to block PGR‟s ability to signal non-
genomically. 
The expression of mPRβ and mPRγ in ciliary cells and their highly specific localization to the cilia 
or base of cilia suggest that they play a role in the P4 regulation of CBF.  Ligand association and 
dissociation from mPRs is rapid (2-4 minutes) [180] and much shorter than that of the PGR (80-
100 minutes) [318], but typical for membrane receptors. Also, mPRs are known to transduce 
changes P4 into physiological changes within minutes in other tissues or cell types [180, 195, 201, 
206, 221].  The mPRα is also present in the spermatozoa of both fish [190, 207, 221] and 
mammals [199], another cell type with motile cilia in which progestin rapidly affects the CBF 
[199, 207, 221].  Furthermore, no homology to the ligand binding domain of the PGR has been 
found in any region of the mPRs. Consequently, neither RU486 nor Org31710 interact with human 
mPRs [177]. This lack of interaction is consistent with the lack of effect of RU486 on P4-mediated 
changes in CBF in the cow fallopian tube [107]. Taken together, these results suggest that the 
mPRs are the receptors that regulate the effects of P4 on the CBF.   
If secreted P4 from the cumulus cells indeed acts as a beacon to reveal the exact position of the 
ovum to the fallopian tube, cells of the fallopian tube should be able to differentiate between the 
levels of P4 found very close to the ovum and the rest of the fallopian tube. For example, the 
recombinant mouse mPRβ and human mPRγ proteins produced in an E. coli expression system 
both had high affinity (Kd = 30-40 nM) and saturable (Bmax = 0.3–0.5 nM) P4 binding sites [177]. 
The nuclear PGR in sea trout displayed a 4-fold higher binding affinity (Kd = 1.9 nM) [318] than 
did s-mPRα (Kd = 8 nM), and the affinity of P4 binding to the human PGR-B was 5-fold higher 
(Kd = 0.8 nM) [322] than human mPRα (Kd = 4.2 nM). Given the affinities of the PGR and the 
mPRs to progesterone, all would be expected to be fully activated at 20µM. It is quite possible that 
the level of P4 represents a supra-physiological concentration. Determining whether lower 
concentrations of P4 have a similar effect on the CBF is therefore an important next step. 
The intracellular signaling pathway in the fallopian tube that connects P4 concentration to changes 
in the CBF is not yet known. Information on both mPR activities in other cell systems as well as 
knowledge of various intracellular events that influence the CBF of different organs, particularly 
airway cilia, can be used to suggest possible pathways (Fig. 16). The structure and function of the 
mammalian respiratory and fallopian tube cilia are similar in many aspects.  
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FIGURE 16: Summary of proposed pathways regulating mammalian CBF in the fallopian tube. Red and blue arrows 
represent factors known to stimulate the CBF; blunt blue lines represent known inhibitory interactions. Pathway 1 - 
Activation of membrane AC with increased cAMP, demonstrated in the Atlantic croaker [208]; Pathways 2 and 3 – 
Activation of a cAMP-independent signaling pathway (IP3) has been proposed to be involved in oocyte maturation in 
Atlantic croaker [209]. The remaining signaling pathways involving cAMP activation of PKA, Ca
2+
 activation of PKG 
and the effects of pH and Ca
2+
 on CBF have been established in mammalian airway ciliary cells and spermatozoa 
[235]. The plasma membrane TRPV4 channel contributes to increase the CBF via Ca
2+
 influx [323] and/or through 
IP3R [324]; the involvement of TRPV4 in decreasing CBF is regulated by PGR [325]. Abbreviations: tmAC: 
transmembrane adenylyl cyclase; sAC: soluble adenylyl cyclase; PKA, PKC, PKG: protein kinase A,C,G; TRPV: 
transient receptor potential vanilloid; 4αPDD 4α-phorbol 12,3-didecanoate; P4 : progesterone; PM: plasma membrane. 
 
There is a well-known association between increased CBF and elevated Ca
2+
. The calcium that 
mediates increased CBF is derived from both intracellular stores and external Ca
2+
 influx [326, 
327]. Increased cAMP and PKA phosphorylation can also lead to an increased CBF [328, 329]. 
Classically, the major sources of cAMP are the G-protein-sensitive transmembrane or soluble 
adenylyl cyclases (ACs) [147, 247, 248]. It is possible that upon P4 binding, mPRs could activate 
intraciliary and/or membrane localized ACs to modulate the CBF. The physiological roles of Gαi in 
mediating responses to P4 [147] has been strengthened by studies in Gαi knockout mice [249]. 
Interestingly, Gαi is specifically localized to motile cilia in rats and humans, suggesting that these 
proteins might play a cilia-specific physiological role [233, 250]. In fact, the Gαi-protein has been 
clearly demonstrated to participate in the regulation of CBF in the central nervous system of the 
rat, and further evidence for this involvement was provided by Gαi-knockdown mice [330]. The 
injection of specific antisense oligonucleotides resulted in damage and loss of cilia, thus causing 
ciliary stasis [330]. Furthermore, 1-100 nM P4 treatment affects the release of GnRH by the 
hypothalamus in gonadotrophic mice in vivo and in GnRH-producing cells in vitro through a 
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mechanism involving the mPRs and G proteins (Gi), but not PGR [195]. In contrast to PKA, which 
is consistently activated in all mammalian cilia, protein kinase C (PKC) has been implicated in 
slowing ciliary activity [235]. A ciliary membrane PKC phosphorylation target, p37, was found to 
be associated with the ciliary membrane in ovine tracheal cilia [251]. Interestingly, acute effects on 
the phosphorylation of p38 and MLC were observed after exposure to free P4 in myometrial cells, 
which also express mPRs [201]. Recently, the involvement of the transient receptor potential 
vanilloid (TRPV) channel (TRPV4) in P4-mediated modulation of CBF in the mouse fallopian 
tube has been suggested [310, 325]. TRPV4 is a thermosensor that is activated at temperatures 
below 33°C, as well as by other stimuli including heat, acidic pH and endogenous agonists, such 
as P4. It has been proposed that TRPV channels are permeable to ions such as Ca
2+
 and can be 
controlled by P4 in the mouse fallopian tube, thus allowing the regulation of the CBF. However, an 
indirect effect of P4 mediated via PGR is to decrease the expression of TRPV4 channels, thus 
resulting in decreased Ca
2+
 influx and reduced CBF in human tracheal epithelial cells [325]. 
Indeed, PGR expression has been reported in both ciliated cells from rat and mouse [80, 137] and 
in the cilia proper of the mouse and human fallopian tube [139]. Furthermore, the PGR has been 
found in airway epithelial cells of other species [331, 332]. Together, these observations suggest 
that multiple intracellular pathways may be involved in the regulation of CBF by P4, but our 
understanding of this process is far from complete. 
 
  
In summary, the results of Paper III show that ciliary cells of the mouse fallopian tube 
beat at a frequency of approximately 22 Hz ex vivo. Treatment with P4 causes a rapid 
decrease in CBF, an effect that is likely mediated via non-genomic signaling. The mPRβ 
and γ are the primary receptor candidates proposed to mediate the effects of P4 in the 
fallopian tube, thus influencing tubal transport. Multiple intracellular pathways may be 
involved in translating the receptor binding into a modulation of the CBF. 
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CONCLUDING REMARKS 
The studies in this thesis have resulted in the following main conclusions: 
1. Membrane progesterone receptors (mPR) β and γ are present at transcriptional and 
translational level in both human and mouse fallopian tube  
 
2. The distribution of the receptor proteins is present in both the reproductive and non-
reproductive tissues in male and female mice  
 
3. The mPRβ and γ specifically and distinctly co-localize in the epithelial cells of female 
mouse and human fallopian tube  
 
4. Progesterone rapidly regulate the expression of mPRs in the mouse fallopian tube  
 
5. The mouse model provide a good model system for measurement of CBF  
 
6. Progesterone treatment caused a rapid decrease in CBF in the ciliary cells from the 
fallopian tube of mouse  
The role of progesterone and the recently discovered membrane progesterone receptors (mPR) in 
mediating physiological functions in reproduction is certainly comprehensive. In this thesis, we 
have hypothesized that the mPRs might play a role in gamete transport in the fallopian tube. 
Understanding the dynamic interaction between tubal epithelium, tubal fluid contents including the 
hormones, gametes and embryo is crucial for a successful pregnancy. The knowledge of endocrine 
regulation of tubal transport to ensure fertilization, embryo development and transport to the 
implantation place is however far from complete. 
  
Magdalena Nutu 
ACKNOWLEDGEMENTS 
Under min tid som doktorand på Fysiologen har jag haft förmånen att arbeta och lära känna 
personer som jag aldrig kommer att glömma. Jag vill därför uttrycka min tacksamhet till Er alla. 
Särkilt vill jag tacka: 
Joakim Larsson, min huvudhandledare, jag vill tacka dig för att du har trott på mig och stöttat 
mig ända ut till sluttampen. Med din oändliga entusiasm har du trots hårda vindar stått bredvid 
mig. När jag grät över vissa negativa resultat, så såg du det positiva i dem och fortsättningsvis 
möjligheterna. Det är jag tacksam för. Jag vill också tacka dig för din värdefulla kritik som har 
bidragit till att jag blivit en bättre människa och forskare. Djupt imponerad har jag blivit över din 
arbetsmoral och att du i alla läge är närvarande dag som kväll, vardag som helg. Tack för din 
konstruktiva kritik med alla manuskript och inte minst denna bok.  
Håkan Billig, min biträdande handledare som har öppnat mina ögon till forskarvärlden! Jag har 
lärt mig så mycket av dina vetenskapliga erfarenheter och filosofiska syn på det vardagliga livet. 
Du har också varit den som dämpat onödig entusiasm och försökt få mig att resonera istället. Tack 
för att du inte talade om för mig: ”så är det!”, utan sade istället ”ponera nu att”. Jag har alltid 
uppskattat din mjuka och professionella attityd och jag kommer definitivt att tänka på dina kloka 
ord. 
Peter Thomas, my mentor from across the Atlantic, who despite the distance have been very close 
to me during all these years. Your exceptional work on mPRs has helped my project to be born. 
The “spirit of Peter” has been hovering over my lab bench a long time; you have your own folder 
on my computer, your own binder on my desk and you „exist‟ even in the freezer. So, you have 
been around all the time. Thank you. I would also like to thank you for taking the time to meet 
with me on various exotic places like Hawaii and Tucson.  
Ruijin Shao, the master of the fallopian tube. Together, we have traveled an exciting journey. You 
helped me see things from different perspectives. Many times I thought you were wrong, so many 
times I did not agree. But, you opened my eyes to see and helped me understand that being wrong 
isn´t bad. Thank you!  You also encourage me to think for myself and you cheered me up when I 
needed it the most. Thanks to you also I know more. My gratitude to you is endless! You have 
kept me in good spirit ...and we also have fun, really fun, but…Who cares!  
Birgitta Weijdergård, du är en pärla. Din utomordentliga hjälp och din skicklighet på lab har 
hjälp mig såååå mycket! Din tekniska expertis och pålitlighet har inga gränser. Du har stått ut med 
mina antikroppar så länge….nu är du FRI! TACK! 
Emilia Rung, tack för förtroende och vänskapen du visat mig under dessa år. Tack för att du alltid 
har lyssnat och för alla dina goda och kloka råd.  
Louise Nilsson, du har betytt mycket för mig och vad vore man utan sina vänner? Under åren som 
gått har vi delat mycket glädje, tårar, barn-prat, fru-snack, kill-snack och inte minst svett (tänkte 
Membrane progesterone receptors in the fallopian tube 
65 
faktiskt på Midnattsloppet). Du är en person som tänker på andra och den som ofta fixar jobbet 
som många låtsas inte se. Jag är glad att jag fått lära känna dig! I din närvaro är jag mig själv!  
Anders Friberg, som har hjälpt mig med allt möjligt: dator, apparater som inte fungerar, program 
som hakar upp sig etc etc etc. Du kan det mesta…och hur många gånger under min doktorand tid, 
har inte jag hört: ”fråga Anders” eller ”gör som Anders”. Det har varit spännande och mycket 
trevligt att ha dig som sällskap på borta-kurser och konferens till Hawaii. Jag har uppskattat ditt 
humör och din förmåga att underhålla.  
Linda Samuelsson & Lina Gunnarsson, för att ni har varit så perfekta rumskompisar. I min 
fantasivärld har Vårt rum varit Min båt. Denna båt har seglat i alla väder. Ni har rott båten 
tillsammans med mig och det är också tack vare er som Min båt nu, närmar sig hamnen. Hipp hipp 
hurra till världens bästa sjömän (flickor )! Tack! 
Anna Bylander, för din praktiska hjälp och den tid du lagt på CBF mätningar. Utan dina insatser 
så hade helhetsbilden sett annorlunda ut. Tack och Lycka till med din utbildning!  
Rikard Wellander, Mattias Goksör, för att jag fick vara på Ert lab och för att jag känt mig 
välkommen. Rikard, min uppskattning till din hjälp saknar ord. Du har stått ut med mig, som inte 
förstår ditt fysikaliska språk, och mina förbaskade celler under nästan ett år! Tack!  
Lena Olofsson, vår avdelnings otroliga, fantastiska, oumbärliga kärna. Jag saknar ord för att 
uttrycka min tacksamhet till dig. Finns inga problem som du inte kan lösa!  
Arbetskamraterna på endokrin, gamla som nya, ingen nämnd och ingen glömd, för att ni skapat 
en trivsam arbetsmiljö, för roliga fikastunder, luncher och diskussioner. 
Arne Larsson, när du inte är på jobbet saknas du! Jag är så tacksam att du hjälper oss med det 
som ingen har tid att fixa.  
Kjell Olmarker, min mentor. Utan din hjälp vore jag inte här. Jag finner inte tillräckligt många 
ord att tacka dig . Du har ställt upp för mig och det är du som har varit min första kontakt med 
forskningen. Jag har satt stort värde på ditt breda vetenskapliga kunnande! 
Helena Brisby, du har inspirerat mig under mina första år som forskare. Tack för all hjälp och för 
att du alltid trott på mig. Du har lärt mig att det fixar sig! 
Personalen på EBM och Center for Cellular Imaging (CCI), för trevligt bemötande och 
samarbete. Särkillt vill jag tacka Lillebil Hagberg och Julia Fernandez-Rodriguez. 
Cristina & Dan, Camelia & Lassi, Simina & Calin, mina käraste vänner. Tack för att ni finns. 
Ni är för mig som en andra familj. På Er kan man lita. Och så kommer ni alltid på alla barnkalas. 
Camelia, tack för att du alltid tar dig tid att fråga hur vi mår. Jag har alltid uppskattat dig och dina 
långa mail, även om jag inte kunnat skriva lika mycket, speciellt på sistone. Cristina och Simina, 
tusen tack för att man alltid kan ringa när barnen är sjuka oavsett tid. Ni har alltid råd eller recept i 
fickan. Cristina, du ringer alltid….precis innan jag skulle ha gjort det! Tack för att du alltid har 
Magdalena Nutu 
brytt dig! Simina, din glada attityd och roliga historier kryddar alltid våra trevliga träffar! Jag 
skulle ha jobbat med kloning istället. Killar, ni får en kram istället ! 
Angela & Enci, tack för att ni kom tillbaka. Angela, tack för all hjälp med språkgranskningen, 
goda råd och idéer och för att du tog hand om tjejerna när jag behövde. Ni är så värdefulla vänner. 
Enci, din konstnärliga åsikt blev en omslagsbild. Tack!  
Iolanda & Cristian, tack för er vänskap sedan länge länge. Iolanda, min MSN-vän som alltid tar 
sig tid att skicka ett ”Cucu”! Tack för att du inte gett upp att fråga hur jag mår och om jag 
fortfarande lever! Cristi, du gör världen till en bättre plats. Du är såååå-unik! 
Liana och Ionel, mina ”svenska” föräldrar som alltid ställer upp. Oavsett! Tack för all hjälp som 
jag har fått med bland annat barnpassning, skjutsningar, men framför allt goda och ärliga råd. Ni är 
så omtänksamma! 
Mariana si Bebe Nutu, multumesc pentru ajutorul primit cu fetele si treburile casnice, un ajutor 
fårå de care n-ar fi functionat.  
Gabi si Cristi Stancu, fratele si ”sora” mea. Cristi, nu a fost usor så fiu sora elevului briliant, 
premiant si sef de promotie . Am fost in schimb intodeauna mindra de tine si ai fost un exemplar 
”frate mai mare” Gabi, am apreciat intotdeauna ajutorul tåu, si faptul cå esti asa intelegåtoare si 
inteleaptå.  
Mama, Tata si Boni, pentru cå sinteti mereu alåturi de mine. Nu pot så exprim in cuvinte de cit 
ajutor ati fost in toate vacantele cind Nathalie si mai tirziu Caroline au fost in Romania ca eu så pot 
lucra. Mi-aduc aminte de toate eforturile pe care le-ati fåcut ca parinti dar cel mai mult de 
vacantele minunate petrecute de-alungul si latul tårii. Vå iubesc! 
Nathalie och Caroline, mina prinsessor som lyser upp mitt liv. Vad hade jag gjort utan er? Tack 
för att ni älskar mig så mycket och för att ni gör livet så enkelt. Som jag lovat, kommer jag inte att 
skriva fler böcker, så nu kan vi pyssla och busa mera!  
Razvan, mitt ALLT! Du gör mig hel! Du är den som har stått ut med allt inklusive mina 
hormoner, speciellt på sistone! Ditt stöd har varit helt fantastiskt! När jag gick i tankarna att börja 
läsa på högskola så sade Du att jag självklart skulle. När jag funderade på att börja forskarskolan 
så sade Du att jag utan tvekan skulle börja. När detta projekt kom på tal så hade Du inga 
tveksamheter. Tar det slut någon gång!? Tack för att du trott på mig, stöttat mig och uppmuntrat 
mig. Under dessa långa år har det känts att om vi klarar detta så klarar vi vadsomhelst. Och det 
gjorde vi! Jag älskar dig sååååååååååååååååååååååå mycket! Tack! 
 
 
Yes I can, and so can you!   
Membrane progesterone receptors in the fallopian tube 
67 
REFERENCES 
1. Jansen RP. Endocrine response in the fallopian tube. Endocr Rev 1984; 5: 525-551. 
2. Critoph FN, Dennis KJ. Ciliary activity in the human oviduct. Obstet Gynecol Surv 1977; 
32: 602-603. 
3. Leese HJ, Tay JI, Reischl J, Downing SJ. Formation of Fallopian tubal fluid: role of a 
neglected epithelium. Reproduction 2001; 121: 339-346. 
4. Halbert SA, Becker DR, Szal SE. Ovum transport in the rat oviductal ampulla in the 
absence of muscle contractility. Biol Reprod 1989; 40: 1131-1136. 
5. Halbert SA, Tam PY, Blandau RJ. Egg transport in the rabbit oviduct: the roles of cilia and 
muscle. Science 1976; 191: 1052-1053. 
6. Chang MC. Development and fate of transferred rabbit ova or blastocyst in relation to the 
ovulation time of recipients. Journal of Exprerimental Zoology 1950; 114: 197-225. 
7. Hunter RH. Pre-ovulatory arrest and peri-ovulatory redistribution of competent 
spermatozoa in the isthmus of the pig oviduct. J Reprod Fertil 1984; 72: 203-211. 
8. Eddy CA, Pauerstein CJ. Anatomy and physiology of the fallopian tube. Clin Obstet 
Gynecol 1980; 23: 1177-1193. 
9. Croxatto HB. Physiology of gamete and embryo transport through the fallopian tube. 
Reprod Biomed Online 2002; 4: 160-169. 
10. Colborn GL. The anatomy of the fallopian tube. In: AM S (ed.) The Fallopian tube. Basic 
studies and clinical contributors. Mount Kisco: Futura Publishing; 1986: 3-11. 
11. Hagiwara H, Ohwada N, Aoki T, Suzuki T, Takata K. The primary cilia of secretory cells 
in the human oviduct mucosa. Med Mol Morphol 2008; 41: 193-198. 
12. Satir P, Christensen ST. Overview of structure and function of mammalian cilia. Annu Rev 
Physiol 2007; 69: 377-400. 
13. Hagiwara H, Harada S, Maeda S, Aoki T, Ohwada N, Takata K. Ultrastructural and 
immunohistochemical study of the basal apparatus of solitary cilia in the human oviduct 
epithelium. J Anat 2002; 200: 89-96. 
14. Komatsu M, Fujita H. Electron-microscopic studies on the development and aging of the 
oviduct epithelium of mice. Anat Embryol (Berl) 1978; 152: 243-259. 
15. Loots GP, Nel PP. Early stages of ciliogenesis in the respiratory epithelium of the nasal 
cavity of rabbit embryos. Cell Tissue Res 1989; 255: 589-594. 
16. Dirksen ER. Centriole and basal body formation during ciliogenesis revisited. Biol Cell 
1991; 72: 31-38. 
17. Porter ME. Axonemal dyneins: assembly, organization, and regulation. Curr Opin Cell 
Biol 1996; 8: 10-17. 
18. Witman GB. Axonemal dyneins. Curr Opin Cell Biol 1992; 4: 74-79. 
19. Afzelius BA. A human syndrome caused by immotile cilia. Science 1976; 193: 317-319. 
20. Verhage HG, Bareither ML, Jaffe RC, Akbar M. Cyclic changes in ciliation, secretion and 
cell height of the oviductal epithelium in women. Am J Anat 1979; 156: 505-521. 
21. Ostrowski LE, Blackburn K, Radde KM, Moyer MB, Schlatzer DM, Moseley A, Boucher 
RC. A proteomic analysis of human cilia: identification of novel components. Mol Cell 
Proteomics 2002; 1: 451-465. 
22. Satir P. Mechanisms of ciliary movement: contributions from electron microscopy. 
Scanning Microsc 1992; 6: 573-579. 
23. Crow J, Amso NN, Lewin J, Shaw RW. Morphology and ultrastructure of fallopian tube 
epithelium at different stages of the menstrual cycle and menopause. Hum Reprod 1994; 9: 
2224-2233. 
24. Poole CA, Jensen CG, Snyder JA, Gray CG, Hermanutz VL, Wheatley DN. Confocal 
analysis of primary cilia structure and colocalization with the Golgi apparatus in 
chondrocytes and aortic smooth muscle cells. Cell Biol Int 1997; 21: 483-494. 
25. Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, Elia AE, Lu W, Brown EM, 
Quinn SJ, Ingber DE, Zhou J. Polycystins 1 and 2 mediate mechanosensation in the 
primary cilium of kidney cells. Nat Genet 2003; 33: 129-137. 
26. Odor DL, Blandau RJ. Observations on the solitary cilium of rabbit oviductal epithelium: 
its motility and ultrastructure. Am J Anat 1985; 174: 437-453. 
27. Peters WM. Nature of "basal" and "reserve" cells in oviductal and cervical epithelium in 
man. J Clin Pathol 1986; 39: 306-312. 
Magdalena Nutu 
28. Odor DL. The question of "basal" cells in oviductal and endocervical epithelium. Fertil 
Steril 1974; 25: 1047-1062. 
29. Pauerstein CJ, Eddy CA. The morphology of the fallopian tube. In: FK B, GFB S (eds.), 
The biology of the fluids of the female genital tract. North-Holland: Elsevier; 1979: 299-
317. 
30. Bendz A. The anatomical basis for a possible counter current exchange mechanism in the 
human adnexa. Prostaglandins 1977; 13: 355-362. 
31. Bendz A, Lundgren O, Hamberger L. Countercurrent exchange of progesterone and 
antipyrine between human utero-ovarian vessels, and of antipyrine between the femoral 
vessels in the cat. Acta Physiol Scand 1982; 114: 611-616. 
32. Graham JD, Clarke CL. Physiological action of progesterone in target tissues. Endocr Rev 
1997; 18: 502-519. 
33. Sobrero AJ, Macleod J. The immediate postcoital test. Fertil Steril 1962; 13: 184-189. 
34. Bedford JM, Yanagimachi R. Initiation of sperm motility after mating in the rat and 
hamster. J Androl 1992; 13: 444-449. 
35. Boskey ER, Cone RA, Whaley KJ, Moench TR. Origins of vaginal acidity: high D/L 
lactate ratio is consistent with bacteria being the primary source. Hum Reprod 2001; 16: 
1809-1813. 
36. Amaral E, Perdigao A, Souza MH, Mauck C, Waller D, Zaneveld L, Faundes A. Postcoital 
testing after the use of a bio-adhesive acid buffering gel (ACIDFORM) and a 2% 
nonoxynol-9 product. Contraception 2004; 70: 492-497. 
37. Yudin AI, Hanson FW, Katz DF. Human cervical mucus and its interaction with sperm: a 
fine-structural view. Biol Reprod 1989; 40: 661-671. 
38. Kervancioglu ME, Djahanbakhch O, Aitken RJ. Epithelial cell coculture and the induction 
of sperm capacitation. Fertil Steril 1994; 61: 1103-1108. 
39. Hunter RH. Polyspermic fertilization in pigs after tubal deposition of excessive numbers of 
spermatozoa. J Exp Zool 1973; 183: 57-63. 
40. Baillie HS, Pacey AA, Warren MA, Scudamore IW, Barratt CL. Greater numbers of 
human spermatozoa associate with endosalpingeal cells derived from the isthmus 
compared with those from the ampulla. Hum Reprod 1997; 12: 1985-1992. 
41. Reeve L, Ledger WL, Pacey AA. Does the Arg-Gly-Asp (RGD) adhesion sequence play a 
role in mediating sperm interaction with the human endosalpinx? Hum Reprod 2003; 18: 
1461-1468. 
42. Smith TT, Yanagimachi R. Attachment and release of spermatozoa from the caudal 
isthmus of the hamster oviduct. J Reprod Fertil 1991; 91: 567-573. 
43. Murray SC, Smith TT. Sperm interaction with fallopian tube apical membrane enhances 
sperm motility and delays capacitation. Fertil Steril 1997; 68: 351-357. 
44. Croxatto HB, Ortiz ME. Egg transport in the fallopian tube. Gynecol Invest 1975; 6: 215-
225. 
45. Okamura H, Morikawa H, Oshima M, Man-i M, Nishimura T. A morphological and 
physiological study of mesotubarium ovarica in humans. Int J Fertil 1977; 22: 179-183. 
46. Morikawa H, Okamura H, Takenaka A, Morimoto K, Nishimura T. Physiological study of 
the human mesotubarium ovarica. Obstet Gynecol 1980; 55: 493-496. 
47. Humphrey KW. Observations on transport of ova in the oviduct of the mouse. J Endocrinol 
1968; 40: 267-273. 
48. Greenwald GS. A study of the transport of ova through the rabbit oviduct. Fertil Steril 
1961; 12: 80-95. 
49. Boling JL, Blandau RJ. Egg transport through the ampullae of the oviducts of rabbits under 
various experimental conditions. Biol Reprod 1971; 4: 174-184. 
50. Gaddum-Rosse P, Blandau RJ, Thiersch JB. Ciliary activity in the human and Macaca 
nemestrina oviduct. Am J Anat 1973; 138: 269-275. 
51. Borell U, Nilsson O, Westman A. Ciliary activity in the rabbit fallopian tube during oestrus 
and after copulation. Acta Obstet Gynecol Scand 1957; 36: 22-28. 
52. Sanderson MJ, Sleigh MA. Ciliary activity of cultured rabbit tracheal epithelium: beat 
pattern and metachrony. J Cell Sci 1981; 47: 331-347. 
53. Satir P, Christensen ST. Structure and function of mammalian cilia. Histochem Cell Biol 
2008; 129: 687-693. 
54. Qin H, Wang Z, Diener D, Rosenbaum J. Intraflagellar transport protein 27 is a small G 
protein involved in cell-cycle control. Curr Biol 2007; 17: 193-202. 
55. Afzelius BA. Cilia-related diseases. J Pathol 2004; 204: 470-477. 
Membrane progesterone receptors in the fallopian tube 
69 
56. Lechtreck KF, Delmotte P, Robinson ML, Sanderson MJ, Witman GB. Mutations in Hydin 
impair ciliary motility in mice. J Cell Biol 2008; 180: 633-643. 
57. Hirokawa N, Tanaka Y, Okada Y, Takeda S. Nodal flow and the generation of left-right 
asymmetry. Cell 2006; 125: 33-45. 
58. Eliyahu S, Shalev E. A fertile woman with Kartagener's syndrome and three consecutive 
pregnancies. Hum Reprod 1996; 11: 683. 
59. Lurie M, Tur-Kaspa I, Weill S, Katz I, Rabinovici J, Goldenberg S. Ciliary ultrastructure of 
respiratory and fallopian tube epithelium in a sterile woman with Kartagener's syndrome. A 
quantitative estimation. Chest 1989; 95: 578-581. 
60. Lyons RA, Djahanbakhch O, Mahmood T, Saridogan E, Sattar S, Sheaff MT, Naftalin AA, 
Chenoy R. Fallopian tube ciliary beat frequency in relation to the stage of menstrual cycle 
and anatomical site. Hum Reprod 2002; 17: 584-588. 
61. Westrom L, Mardh PA, Mecklenburg CV, Hakansson CH. Studies on ciliated epithelia of 
the human genital tract. II. The mucociliary wave pattern of fallopian tube epithelium. 
Fertil Steril 1977; 28: 955-961. 
62. Lindblom B, Hamberger L, Ljung B. Contractile patterns of isolated oviductal smooth 
muscle under different hormonal conditions. Fertil Steril 1980; 33: 283-287. 
63. Helm G, Owman C, Sjoberg NO, Walles B. Quantitative pharmacological characterization 
of beta-receptors and two types of alpha-receptors mediating sympathomimetic smooth 
muscle response in the human Fallopian tube at various cyclic stages. Acta Physiol Scand 
1982; 114: 425-432. 
64. Talo A, Pulkkinen MO. Electrical activity in the human oviduct during the menstrual cycle. 
Am J Obstet Gynecol 1982; 142: 135-147. 
65. Daniel EE, Posey VA, Paton DM. A structural analysis of the myogenic control systems of 
the human Fallopian tube. Am J Obstet Gynecol 1975; 121: 1054-1066. 
66. Battalia DE, Yanagimachi R. Enhanced and co-ordinated movement of the hamster oviduct 
during the periovulatory period. J Reprod Fertil 1979; 56: 515-520. 
67. Helm G, Owman C, Sjoberg NO, Walles B. Motor activity of the human Fallopian tube in 
vitro in relation to plasma concentration of oestradiol and progesterone, and the influence 
of noradrenaline. J Reprod Fertil 1982; 64: 233-242. 
68. Einer-Jensen N, Hunter RH. Physiological and pharmacological aspects of local transfer of 
substances in the ovarian adnexa in women. Hum Reprod Update 2000; 6: 132-138. 
69. Hunter RH, Cook B, Poyser NL. Regulation of oviduct function in pigs by local transfer of 
ovarian steroids and prostaglandins: a mechanism to influence sperm transport. Eur J 
Obstet Gynecol Reprod Biol 1983; 14: 225-232. 
70. Jansen RP. Cyclic changes in the human fallopian tube isthmus and their functional 
importance. Am J Obstet Gynecol 1980; 136: 292-308. 
71. Jansen RP. Fallopian tube isthmic mucus and ovum transport. Science 1978; 201: 349-351. 
72. Tay JI, Moore J, Walker JJ. Ectopic pregnancy. BMJ 2000; 320: 916-919. 
73. Lyons RA, Saridogan E, Djahanbakhch O. The reproductive significance of human 
Fallopian tube cilia. Hum Reprod Update 2006; 12: 363-372. 
74. Christenson LK, Devoto L. Cholesterol transport and steroidogenesis by the corpus luteum. 
Reprod Biol Endocrinol 2003; 1: 90. 
75. Dorrington JH, Moon YS, Armstrong DT. Estradiol-17beta biosynthesis in cultured 
granulosa cells from hypophysectomized immature rats; stimulation by follicle-stimulating 
hormone. Endocrinology 1975; 97: 1328-1331. 
76. Landgren BM, Campo S, Cekan SZ, Diczfalusy E. Studies on the pattern of circulating 
steroids in the normal menstrual cycle. 5. Changes around the onset of menstruation. Acta 
Endocrinol (Copenh) 1977; 86: 608-620. 
77. Hillier SG. Gonadotropic control of ovarian follicular growth and development. Mol Cell 
Endocrinol 2001; 179: 39-46. 
78. Natraj U, Richards JS. Hormonal regulation, localization, and functional activity of the 
progesterone receptor in granulosa cells of rat preovulatory follicles. Endocrinology 1993; 
133: 761-769. 
79. Barnea ER, Oelsner G, Benveniste R, Romero R, DeCherney AH. Progesterone, estradiol, 
and alpha-human chorionic gonadotropin secretion in patients with ectopic pregnancy. J 
Clin Endocrinol Metab 1986; 62: 529-531. 
80. Shao R, Weijdegard B, Ljungstrom K, Friberg A, Zhu C, Wang X, Zhu Y, Fernandez-
Rodriguez J, Egecioglu E, Rung E, Billig H. Nuclear progesterone receptor A and B 
Magdalena Nutu 
isoforms in mouse fallopian tube and uterus: implications for expression, regulation, and 
cellular function. Am J Physiol Endocrinol Metab 2006; 291: E59-72. 
81. Walmer DK, Wrona MA, Hughes CL, Nelson KG. Lactoferrin expression in the mouse 
reproductive tract during the natural estrous cycle: correlation with circulating estradiol and 
progesterone. Endocrinology 1992; 131: 1458-1466. 
82. Bishop DW. Active secretion in the rabbit oviduct. Am J Physiol 1956; 187: 347-352. 
83. David A, Garcia CR, Czernobilsky B. Human hydrosalpinx. Histologic study and chemical 
composition of fluid. Am J Obstet Gynecol 1969; 105: 400-411. 
84. Batra S, Helm G, Owman C, Sjoberg NO, Walles B. Female sex steroid concentrations in 
the ampullary and isthmic regions of the human fallopian tube and their relationship to 
plasma concentrations during the menstrual cycle. Am J Obstet Gynecol 1980; 136: 986-
991. 
85. Devoto L, Soto E, Magofke AM, Sierralta W. Unconjugated steroids in the fallopian tube 
and peripheral blood during the normal menstrual cycle. Fertil Steril 1980; 33: 613-617. 
86. Koninckx PR, Heyns W, Verhoeven G, Van Baelen H, Lissens WD, De Moor P, Brosens 
IA. Biochemical characterization of peritoneal fluid in women during the menstrual cycle. 
J Clin Endocrinol Metab 1980; 51: 1239-1244. 
87. Wu CH, Mastroianni L, Jr., Mikhail G. Steroid hormones in monkey oviductal fluid. Fertil 
Steril 1977; 28: 1250-1256. 
88. Roblero L, Biggers JD, Lechene CP. Electron probe analysis of the elemental 
microenvironment of oviducal mouse embryos. J Reprod Fertil 1976; 46: 431-434. 
89. Yamashita Y, Shimada M, Okazaki T, Maeda T, Terada T. Production of progesterone 
from de novo-synthesized cholesterol in cumulus cells and its physiological role during 
meiotic resumption of porcine oocytes. Biol Reprod 2003; 68: 1193-1198. 
90. Vanderhyden BC, Tonary AM. Differential regulation of progesterone and estradiol 
production by mouse cumulus and mural granulosa cells by A factor(s) secreted by the 
oocyte. Biol Reprod 1995; 53: 1243-1250. 
91. Chian RC, Ao A, Clarke HJ, Tulandi T, Tan SL. Production of steroids from human 
cumulus cells treated with different concentrations of gonadotropins during culture in vitro. 
Fertil Steril 1999; 71: 61-66. 
92. Tay JI, Rutherford AJ, Killick SR, Maguiness SD, Partridge RJ, Leese HJ. Human tubal 
fluid: production, nutrient composition and response to adrenergic agents. Hum Reprod 
1997; 12: 2451-2456. 
93. Abughrien BM, Dore MA. Ciliogenesis in the uterine tube of control and superovulated 
heifers. Cells Tissues Organs 2000; 166: 338-348. 
94. Abe H, Oikawa T. Effects of estradiol and progesterone on the cytodifferentiation of 
epithelial cells in the oviduct of the newborn golden hamster. Anat Rec 1993; 235: 390-
398. 
95. Anderson RG, Brenner RM. The formation of basal bodies (centrioles) in the Rhesus 
monkey oviduct. J Cell Biol 1971; 50: 10-34. 
96. Konishi I, Fujii S, Parmley TH, Mori T. Development of ciliated cells in the human fetal 
oviduct: an ultrastructural study. Anat Rec 1987; 219: 60-68. 
97. Patek E, Nilsson L, Johannisson E, Hellema M, Bout J. Scanning electron microscopic 
study of the human fallopian tube. 3. The effect of midpregnancy and of various steroids. 
Fertil Steril 1973; 24: 31-43. 
98. Donnez J, Casanas-Roux F, Caprasse J, Ferin J, Thomas K. Cyclic changes in ciliation, cell 
height, and mitotic activity in human tubal epithelium during reproductive life. Fertil Steril 
1985; 43: 554-559. 
99. Hagiwara H, Shibasaki S, Ohwada N. Ciliogenesis in the human oviduct epithelium during 
the normal menstrual cycle. J Electron Microsc (Tokyo) 1992; 41: 321-329. 
100. Mahmood T, Saridogan E, Smutna S, Habib AM, Djahanbakhch O. The effect of ovarian 
steroids on epithelial ciliary beat frequency in the human Fallopian tube. Hum Reprod 
1998; 13: 2991-2994. 
101. Morales P, Palma V, Salgado AM, Villalon M. Sperm interaction with human oviductal 
cells in vitro. Hum Reprod 1996; 11: 1504-1509. 
102. Paltieli Y, Weichselbaum A, Hoffman N, Eibschitz I, Kam Z. Laser scattering instrument 
for real time in-vivo measurement of ciliary activity in human fallopian tubes. Hum Reprod 
1995; 10: 1638-1641. 
103. Lyons RA, Saridogan E, Djahanbakhch O. The effect of ovarian follicular fluid and 
peritoneal fluid on Fallopian tube ciliary beat frequency. Hum Reprod 2006; 21: 52-56. 
Membrane progesterone receptors in the fallopian tube 
71 
104. Kugler P, Wrobel KH, Wallner HJ, Heinzmann U. [Histochemical and histological 
investigations on the human fallopian tube under different hormonal influences. I. 
Demonstration of ATPase with special reference to reactive ciliated cells (author's transl)]. 
Arch Gynakol 1976; 221: 345-366. 
105. Ortiz ME, Villalon M, Croxatto HB. Ovum transport and fertility following postovulatory 
treatment with estradiol in rats. Biol Reprod 1979; 21: 1163-1167. 
106. Rios M, Orihuela PA, Croxatto HB. Intraoviductal administration of ribonucleic acid from 
estrogen-treated rats mimics the effect of estrogen on ovum transport. Biol Reprod 1997; 
56: 279-283. 
107. Wessel T, Schuchter U, Walt H. Ciliary motility in bovine oviducts for sensing rapid non-
genomic reactions upon exposure to progesterone. Horm Metab Res 2004; 36: 136-141. 
108. Runnebaum B, Stober I, Zander J. Progesterone, 20 alpha-dihydroprogesterone and 20 
beta-dihydroprogesterone in mother and child at birth. Acta Endocrinol (Copenh) 1975; 80: 
569-576. 
109. Lindblom B, Hamberger L, Wiqvist N. Differentiated contractile effects of prostaglandins 
E and F on the isolated circular and longitudinal smooth muscle of the human oviduct. 
Fertil Steril 1978; 30: 553-559. 
110. Lindblom B, Wilhelmsson L, Wiqvist N. The action of prostacyclin (PGI2) on the 
contractility of the isolated circular and longitudinal muscle layers of the human oviduct. 
Prostaglandins 1979; 17: 99-104. 
111. Conneely OM, Sullivan WP, Toft DO, Birnbaumer M, Cook RG, Maxwell BL, Zarucki-
Schulz T, Greene GL, Schrader WT, O'Malley BW. Molecular cloning of the chicken 
progesterone receptor. Science 1986; 233: 767-770. 
112. Bain DL, Heneghan AF, Connaghan-Jones KD, Miura MT. Nuclear receptor structure: 
implications for function. Annu Rev Physiol 2007; 69: 201-220. 
113. Giangrande PH, Kimbrel EA, Edwards DP, McDonnell DP. The opposing transcriptional 
activities of the two isoforms of the human progesterone receptor are due to differential 
cofactor binding. Mol Cell Biol 2000; 20: 3102-3115. 
114. Lessey BA, Alexander PS, Horwitz KB. The subunit structure of human breast cancer 
progesterone receptors: characterization by chromatography and photoaffinity labeling. 
Endocrinology 1983; 112: 1267-1274. 
115. Kastner P, Bocquel MT, Turcotte B, Garnier JM, Horwitz KB, Chambon P, Gronemeyer 
H. Transient expression of human and chicken progesterone receptors does not support 
alternative translational initiation from a single mRNA as the mechanism generating two 
receptor isoforms. J Biol Chem 1990; 265: 12163-12167. 
116. Giangrande PH, McDonnell DP. The A and B isoforms of the human progesterone 
receptor: two functionally different transcription factors encoded by a single gene. Recent 
Prog Horm Res 1999; 54: 291-313; discussion 313-294. 
117. Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB. Differential 
gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J 
Biol Chem 2002; 277: 5209-5218. 
118. McDonnell DP, Shahbaz MM, Vegeto E, Goldman ME. The human progesterone receptor 
A-form functions as a transcriptional modulator of mineralocorticoid receptor 
transcriptional activity. J Steroid Biochem Mol Biol 1994; 48: 425-432. 
119. Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW, McDonnell DP. Human 
progesterone receptor A form is a cell- and promoter-specific repressor of human 
progesterone receptor B function. Mol Endocrinol 1993; 7: 1244-1255. 
120. Edwards DP, Wardell SE, Boonyaratanakornkit V. Progesterone receptor interacting 
coregulatory proteins and cross talk with cell signaling pathways. J Steroid Biochem Mol 
Biol 2002; 83: 173-186. 
121. Boonyaratanakornkit V, Scott MP, Ribon V, Sherman L, Anderson SM, Maller JL, Miller 
WT, Edwards DP. Progesterone receptor contains a proline-rich motif that directly interacts 
with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell 2001; 8: 269-280. 
122. Lange CA. Making sense of cross-talk between steroid hormone receptors and intracellular 
signaling pathways: who will have the last word? Mol Endocrinol 2004; 18: 269-278. 
123. Lange CA, Gioeli D, Hammes SR, Marker PC. Integration of rapid signaling events with 
steroid hormone receptor action in breast and prostate cancer. Annu Rev Physiol 2007; 69: 
171-199. 
Magdalena Nutu 
124. Faivre E, Skildum A, Pierson-Mullany L, Lange CA. Integration of progesterone receptor 
mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-
activated protein kinases and cell cycle regulators. Steroids 2005; 70: 418-426. 
125. Mulac-Jericevic B, Lydon JP, DeMayo FJ, Conneely OM. Defective mammary gland 
morphogenesis in mice lacking the progesterone receptor B isoform. Proc Natl Acad Sci U 
S A 2003; 100: 9744-9749. 
126. Chaffin CL, Stouffer RL. Local role of progesterone in the ovary during the periovulatory 
interval. Rev Endocr Metab Disord 2002; 3: 65-72. 
127. Janne O, Kontula K, Vihko R. Progestin receptors in human tissues: concentrations and 
binding kinetics. J Steroid Biochem 1976; 7: 1061-1068. 
128. Leavitt WW, Toft DO, Strott CA, O'Malley BW. A specific progesterone receptor in the 
hamster uterus: physiologic properties and regulation during the estrous cycle. 
Endocrinology 1974; 94: 1041-1053. 
129. Iwai T, Nanbu Y, Iwai M, Taii S, Fujii S, Mori T. Immunohistochemical localization of 
oestrogen receptors and progesterone receptors in the human ovary throughout the 
menstrual cycle. Virchows Arch A Pathol Anat Histopathol 1990; 417: 369-375. 
130. Gava N, Clarke CL, Byth K, Arnett-Mansfield RL, deFazio A. Expression of progesterone 
receptors A and B in the mouse ovary during the estrous cycle. Endocrinology 2004; 145: 
3487-3494. 
131. Clemens JW, Robker RL, Kraus WL, Katzenellenbogen BS, Richards JS. Hormone 
induction of progesterone receptor (PR) messenger ribonucleic acid and activation of PR 
promoter regions in ovarian granulosa cells: evidence for a role of cyclic adenosine 3',5'-
monophosphate but not estradiol. Mol Endocrinol 1998; 12: 1201-1214. 
132. Park OK, Mayo KE. Transient expression of progesterone receptor messenger RNA in 
ovarian granulosa cells after the preovulatory luteinizing hormone surge. Mol Endocrinol 
1991; 5: 967-978. 
133. Shao R, Markstrom E, Friberg PA, Johansson M, Billig H. Expression of progesterone 
receptor (PR) A and B isoforms in mouse granulosa cells: stage-dependent PR-mediated 
regulation of apoptosis and cell proliferation. Biol Reprod 2003; 68: 914-921. 
134. Hyde BA, Blaustein JD, Black DL. Differential regulation of progestin receptor 
immunoreactivity in the rabbit oviduct. Endocrinology 1989; 125: 1479-1483. 
135. Press MF, Udove JA, Greene GL. Progesterone receptor distribution in the human 
endometrium. Analysis using monoclonal antibodies to the human progesterone receptor. 
Am J Pathol 1988; 131: 112-124. 
136. Okada A, Ohta Y, Buchanan DL, Sato T, Inoue S, Hiroi H, Muramatsu M, Iguchi T. 
Changes in ontogenetic expression of estrogen receptor alpha and not of estrogen receptor 
beta in the female rat reproductive tract. J Mol Endocrinol 2002; 28: 87-97. 
137. Okada A, Ohta Y, Inoue S, Hiroi H, Muramatsu M, Iguchi T. Expression of estrogen, 
progesterone and androgen receptors in the oviduct of developing, cycling and pre-
implantation rats. J Mol Endocrinol 2003; 30: 301-315. 
138. Amso NN, Crow J, Shaw RW. Comparative immunohistochemical study of oestrogen and 
progesterone receptors in the fallopian tube and uterus at different stages of the menstrual 
cycle and the menopause. Hum Reprod 1994; 9: 1027-1037. 
139. Teilmann SC, Clement CA, Thorup J, Byskov AG, Christensen ST. Expression and 
localization of the progesterone receptor in mouse and human reproductive organs. J 
Endocrinol 2006; 191: 525-535. 
140. Fuentealba B, Nieto M, Croxatto HB. Estrogen and progesterone receptors in the oviduct 
during egg transport in cyclic and pregnant rats. Biol Reprod 1988; 39: 751-757. 
141. Lange CA, Shen T, Horwitz KB. Phosphorylation of human progesterone receptors at 
serine-294 by mitogen-activated protein kinase signals their degradation by the 26S 
proteasome. Proc Natl Acad Sci U S A 2000; 97: 1032-1037. 
142. Bramley T. Non-genomic progesterone receptors in the mammalian ovary: some 
unresolved issues. Reproduction 2003; 125: 3-15. 
143. Losel R, Wehling M. Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol 
2003; 4: 46-56. 
144. Smith JL, Kupchak BR, Garitaonandia I, Hoang LK, Maina AS, Regalla LM, Lyons TJ. 
Heterologous expression of human mPRalpha, mPRbeta and mPRgamma in yeast confirms 
their ability to function as membrane progesterone receptors. Steroids 2008; 73: 1160-
1173. 
Membrane progesterone receptors in the fallopian tube 
73 
145. Edwards DP. Regulation of signal transduction pathways by estrogen and progesterone. 
Annu Rev Physiol 2005; 67: 335-376. 
146. Meyer C, Schmid R, Scriba PC, Wehling M. Purification and partial sequencing of high-
affinity progesterone-binding site(s) from porcine liver membranes. Eur J Biochem 1996; 
239: 726-731. 
147. Thomas P. Characteristics of membrane progestin receptor alpha (mPRalpha) and 
progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating 
rapid progestin actions. Front Neuroendocrinol 2008; 29: 292-312. 
148. Cahill MA. Progesterone receptor membrane component 1: an integrative review. J Steroid 
Biochem Mol Biol 2007; 105: 16-36. 
149. Rohe HJ, Ahmed IS, Twist KE, Craven RJ. PGRMC1 (progesterone receptor membrane 
component 1): a targetable protein with multiple functions in steroid signaling, P450 
activation and drug binding. Pharmacol Ther 2009; 121: 14-19. 
150. Losel RM, Besong D, Peluso JJ, Wehling M. Progesterone receptor membrane component 
1--many tasks for a versatile protein. Steroids 2008; 73: 929-934. 
151. Min L, Strushkevich NV, Harnastai IN, Iwamoto H, Gilep AA, Takemori H, Usanov SA, 
Nonaka Y, Hori H, Vinson GP, Okamoto M. Molecular identification of adrenal inner zone 
antigen as a heme-binding protein. FEBS J 2005; 272: 5832-5843. 
152. Nolte I, Jeckel D, Wieland FT, Sohn K. Localization and topology of ratp28, a member of 
a novel family of putative steroid-binding proteins. Biochim Biophys Acta 2000; 1543: 
123-130. 
153. Falkenstein E, Schmieding K, Lange A, Meyer C, Gerdes D, Welsch U, Wehling M. 
Localization of a putative progesterone membrane binding protein in porcine hepatocytes. 
Cell Mol Biol (Noisy-le-grand) 1998; 44: 571-578. 
154. Beausoleil SA, Jedrychowski M, Schwartz D, Elias JE, Villen J, Li J, Cohn MA, Cantley 
LC, Gygi SP. Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc Natl 
Acad Sci U S A 2004; 101: 12130-12135. 
155. Peluso JJ, Pappalardo A, Losel R, Wehling M. Progesterone membrane receptor 
component 1 expression in the immature rat ovary and its role in mediating progesterone's 
antiapoptotic action. Endocrinology 2006; 147: 3133-3140. 
156. Losel R, Dorn-Beineke A, Falkenstein E, Wehling M, Feuring M. Porcine spermatozoa 
contain more than one membrane progesterone receptor. Int J Biochem Cell Biol 2004; 36: 
1532-1541. 
157. Min L, Takemori H, Nonaka Y, Katoh Y, Doi J, Horike N, Osamu H, Raza FS, Vinson GP, 
Okamoto M. Characterization of the adrenal-specific antigen IZA (inner zone antigen) and 
its role in the steroidogenesis. Mol Cell Endocrinol 2004; 215: 143-148. 
158. Menzies GS, Howland K, Rae MT, Bramley TA. Stimulation of specific binding of [3H]-
progesterone to bovine luteal cell-surface membranes: specificity of digitonin. Mol Cell 
Endocrinol 1999; 153: 57-69. 
159. Peluso JJ, Pappalardo A, Fernandez G, Wu CA. Involvement of an unnamed protein, 
RDA288, in the mechanism through which progesterone mediates its antiapoptotic action 
in spontaneously immortalized granulosa cells. Endocrinology 2004; 145: 3014-3022. 
160. Suchanek M, Radzikowska A, Thiele C. Photo-leucine and photo-methionine allow 
identification of protein-protein interactions in living cells. Nat Methods 2005; 2: 261-267. 
161. Hughes AL, Powell DW, Bard M, Eckstein J, Barbuch R, Link AJ, Espenshade PJ. 
Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes. Cell Metab 2007; 5: 143-
149. 
162. Krebs CJ, Jarvis ED, Chan J, Lydon JP, Ogawa S, Pfaff DW. A membrane-associated 
progesterone-binding protein, 25-Dx, is regulated by progesterone in brain regions 
involved in female reproductive behaviors. Proc Natl Acad Sci U S A 2000; 97: 12816-
12821. 
163. Cairns C, Gustafsson JA, Carlstedt-Duke J. Identification of protein contact sites within the 
glucocorticoid/progestin response element. Mol Endocrinol 1991; 5: 598-604. 
164. Peluso JJ, Fernandez G, Pappalardo A, White BA. Membrane-initiated events account for 
progesterone's ability to regulate intracellular free calcium levels and inhibit rat granulosa 
cell mitosis. Biol Reprod 2002; 67: 379-385. 
165. Peluso JJ, Pappalardo A. Progesterone regulates granulosa cell viability through a protein 
kinase G-dependent mechanism that may involve 14-3-3sigma. Biol Reprod 2004; 71: 
1870-1878. 
Magdalena Nutu 
166. Crudden G, Loesel R, Craven RJ. Overexpression of the cytochrome p450 activator hpr6 
(heme-1 domain protein/human progesterone receptor) in tumors. Tumour Biol 2005; 26: 
142-146. 
167. Peluso JJ, Liu X, Saunders MM, Claffey KP, Phoenix K. Regulation of ovarian cancer cell 
viability and sensitivity to cisplatin by progesterone receptor membrane component-1. J 
Clin Endocrinol Metab 2008; 93: 1592-1599. 
168. Yamada NM, Hirata S, Kato J. Distribution and postnatal changes of aromatase mRNA in 
the female rat brain. J Steroid Biochem Mol Biol 1994; 48: 529-533. 
169. Blaustein JD. Progesterone and progestin receptors in the brain: the neglected ones. 
Endocrinology 2008; 149: 2737-2738. 
170. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA, Jr., Shyamala 
G, Conneely OM, O'Malley BW. Mice lacking progesterone receptor exhibit pleiotropic 
reproductive abnormalities. Genes Dev 1995; 9: 2266-2278. 
171. Jorge JC, McIntyre KL, Henderson LP. The function and the expression of forebrain 
GABA(A) receptors change with hormonal state in the adult mouse. J Neurobiol 2002; 50: 
137-149. 
172. Wolf OT, Neumann O, Hellhammer DH, Geiben AC, Strasburger CJ, Dressendorfer RA, 
Pirke KM, Kirschbaum C. Effects of a two-week physiological dehydroepiandrosterone 
substitution on cognitive performance and well-being in healthy elderly women and men. J 
Clin Endocrinol Metab 1997; 82: 2363-2367. 
173. Schumacher M, Coirini H, McEwen BS. Regulation of high-affinity GABAa receptors in 
specific brain regions by ovarian hormones. Neuroendocrinology 1989; 50: 315-320. 
174. Belelli D, Herd MB, Mitchell EA, Peden DR, Vardy AW, Gentet L, Lambert JJ. 
Neuroactive steroids and inhibitory neurotransmission: mechanisms of action and 
physiological relevance. Neuroscience 2006; 138: 821-829. 
175. Giusti L, Belfiore MS, Martini C, Lucacchini A. 3 alpha-hydroxy-5 alpha-pregnan-20-one 
modulation of solubilized GABA/benzodiazepine receptor complex. J Steroid Biochem 
Mol Biol 1993; 45: 309-314. 
176. Zhu Y, Rice CD, Pang Y, Pace M, Thomas P. Cloning, expression, and characterization of 
a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of 
fish oocytes. Proc Natl Acad Sci U S A 2003; 100: 2231-2236. 
177. Zhu Y, Bond J, Thomas P. Identification, classification, and partial characterization of 
genes in humans and other vertebrates homologous to a fish membrane progestin receptor. 
Proc Natl Acad Sci U S A 2003; 100: 2237-2242. 
178. Tang YT, Hu T, Arterburn M, Boyle B, Bright JM, Emtage PC, Funk WD. PAQR proteins: 
a novel membrane receptor family defined by an ancient 7-transmembrane pass motif. J 
Mol Evol 2005; 61: 372-380. 
179. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi 
M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno 
NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu 
T, Nagai R, Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic 
metabolic effects. Nature 2003; 423: 762-769. 
180. Thomas P, Pang Y, Dong J, Groenen P, Kelder J, de Vlieg J, Zhu Y, Tubbs C. Steroid and 
G protein binding characteristics of the seatrout and human progestin membrane receptor 
alpha subtypes and their evolutionary origins. Endocrinology 2007; 148: 705-718. 
181. Fernandes MS, Pierron V, Michalovich D, Astle S, Thornton S, Peltoketo H, Lam EW, 
Gellersen B, Huhtaniemi I, Allen J, Brosens JJ. Regulated expression of putative 
membrane progestin receptor homologues in human endometrium and gestational tissues. J 
Endocrinol 2005; 187: 89-101. 
182. Krietsch T, Fernandes MS, Kero J, Losel R, Heyens M, Lam EW, Huhtaniemi I, Brosens 
JJ, Gellersen B. Human homologs of the putative G protein-coupled membrane progestin 
receptors (mPRalpha, beta, and gamma) localize to the endoplasmic reticulum and are not 
activated by progesterone. Mol Endocrinol 2006; 20: 3146-3164. 
183. Luttrell LM, Daaka Y, Della Rocca GJ, Lefkowitz RJ. G protein-coupled receptors mediate 
two functionally distinct pathways of tyrosine phosphorylation in rat 1a fibroblasts. Shc 
phosphorylation and receptor endocytosis correlate with activation of Erk kinases. J Biol 
Chem 1997; 272: 31648-31656. 
184. Cabrera-Vera TM, Vanhauwe J, Thomas TO, Medkova M, Preininger A, Mazzoni MR, 
Hamm HE. Insights into G protein structure, function, and regulation. Endocr Rev 2003; 
24: 765-781. 
Membrane progesterone receptors in the fallopian tube 
75 
185. Tamir H, Fawzi AB, Tamir A, Evans T, Northup JK. G-protein beta gamma forms: identity 
of beta and diversity of gamma subunits. Biochemistry 1991; 30: 3929-3936. 
186. Josefsberg Ben-Yehoshua L, Lewellyn AL, Thomas P, Maller JL. The role of Xenopus 
membrane progesterone receptor beta in mediating the effect of progesterone on oocyte 
maturation. Mol Endocrinol 2007; 21: 664-673. 
187. Kazeto Y, Goto-Kazeto R, Thomas P, Trant JM. Molecular characterization of three forms 
of putative membrane-bound progestin receptors and their tissue-distribution in channel 
catfish, Ictalurus punctatus. J Mol Endocrinol 2005; 34: 781-791. 
188. Cai Z, Stocco C. Expression and regulation of progestin membrane receptors in the rat 
corpus luteum. Endocrinology 2005; 146: 5522-5532. 
189. Fernandes MS, Brosens JJ, Gellersen B. Honey, we need to talk about the membrane 
progestin receptors. Steroids 2008; 73: 942-952. 
190. Tubbs C, Thomas P. Functional characteristics of membrane progestin receptor alpha 
(mPRalpha) subtypes: a review with new data showing mPRalpha expression in seatrout 
sperm and its association with sperm motility. Steroids 2008; 73: 935-941. 
191. Kazeto Y, Goto-Kazeto R, Trant JM. Membrane-bound progestin receptors in channel 
catfish and zebrafish ovary: changes in gene expression associated with the reproductive 
cycles and hormonal reagents. Gen Comp Endocrinol 2005; 142: 204-211. 
192. Thomas P, Dressing G, Pang Y, Berg H, Tubbs C, Benninghoff A, Doughty K. Progestin, 
estrogen and androgen G-protein coupled receptors in fish gonads. Steroids 2006; 71: 310-
316. 
193. Tokumoto T, Tokumoto M, Thomas P. Interactions of diethylstilbestrol (DES) and DES 
analogs with membrane progestin receptor-alpha and the correlation with their nongenomic 
progestin activities. Endocrinology 2007; 148: 3459-3467. 
194. Thomas P. Discoveryof a new family of membrane progesterone receptors in vertebrates 
and detection of the alpha and beta subtypes in mouse brain, testis and uterus. Med Chem 
Res 2004; 13:3/4: 202-209. 
195. Sleiter N, Pang Y, Park C, Horton TH, Dong J, Thomas P, Levine JE. Progesterone 
receptor A (PRA) and PRB-independent effects of progesterone on gonadotropin-releasing 
hormone release. Endocrinology 2009; 150: 3833-3844. 
196. Nutu M. WB, Thomas P.,Thurin-Kjellberg A., Billig H., Larsson D.G.J. Distribution and 
hormonal regulation of membrane progesterone receptors beta and gamma in ciliated 
epithelial cells of mouse and human fallopian tubes. Reprod Biol Endocrinol 2009; in 
press. 
197. Lemale J, Bloch-Faure M, Grimont A, El Abida B, Imbert-Teboul M, Crambert G. 
Membrane progestin receptors alpha and gamma in renal epithelium. Biochim Biophys 
Acta 2008; 1783: 2234-2240. 
198. Ashley RL, Clay CM, Farmerie TA, Niswender GD, Nett TM. Cloning and 
characterization of an ovine intracellular seven transmembrane receptor for progesterone 
that mediates calcium mobilization. Endocrinology 2006; 147: 4151-4159. 
199. Thomas P, Tubbs C, Garry VF. Progestin functions in vertebrate gametes mediated by 
membrane progestin receptors (mPRs): Identification of mPRalpha on human sperm and its 
association with sperm motility. Steroids 2009; 74: 614-621. 
200. Chapman NR, Kennelly MM, Harper KA, Europe-Finner GN, Robson SC. Examining the 
spatio-temporal expression of mRNA encoding the membrane-bound progesterone 
receptor-alpha isoform in human cervix and myometrium during pregnancy and labour. 
Mol Hum Reprod 2006; 12: 19-24. 
201. Karteris E, Zervou S, Pang Y, Dong J, Hillhouse EW, Randeva HS, Thomas P. 
Progesterone signaling in human myometrium through two novel membrane G protein-
coupled receptors: potential role in functional progesterone withdrawal at term. Mol 
Endocrinol 2006; 20: 1519-1534. 
202. Dosiou C, Hamilton AE, Pang Y, Overgaard MT, Tulac S, Dong J, Thomas P, Giudice LC. 
Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells 
and activation of G-proteins by progesterone. J Endocrinol 2008; 196: 67-77. 
203. Dressing GE, Thomas P. Identification of membrane progestin receptors in human breast 
cancer cell lines and biopsies and their potential involvement in breast cancer. Steroids 
2007; 72: 111-116. 
204. Romero-Sanchez M, Peiper SC, Evans B, Wang Z, Catasus L, Ribe A, Prat J, Giri JG. 
Expression profile of heptahelical putative membrane progesterone receptors in epithelial 
ovarian tumors. Hum Pathol 2008; 39: 1026-1033. 
Magdalena Nutu 
205. Nutu M, Weijdegard B, Thomas P, Bergh C, Thurin-Kjellberg A, Pang Y, Billig H, 
Larsson DG. Membrane progesterone receptor gamma: tissue distribution and expression 
in ciliated cells in the fallopian tube. Mol Reprod Dev 2007; 74: 843-850. 
206. Hanna R, Pang Y, Thomas P, Zhu Y. Cell-surface expression, progestin binding, and rapid 
nongenomic signaling of zebrafish membrane progestin receptors alpha and beta in 
transfected cells. J Endocrinol 2006; 190: 247-260. 
207. Thomas P, Tubbs C, Detweiler C, Das S, Ford L, Breckenridge-Miller D. Binding 
characteristics, hormonal regulation and identity of the sperm membrane progestin receptor 
in Atlantic croaker. Steroids 2005; 70: 427-433. 
208. Tubbs C, Thomas P. Progestin signaling through an olfactory G protein and membrane 
progestin receptor-alpha in Atlantic croaker sperm: potential role in induction of sperm 
hypermotility. Endocrinology 2009; 150: 473-484. 
209. Pace MC, Thomas P. Activation of a pertussis toxin-sensitive, inhibitory G-protein is 
necessary for steroid-mediated oocyte maturation in spotted seatrout. Dev Biol 2005; 285: 
70-79. 
210. Thomas P, Das S. Correlation between binding affinities of C21 steroids for the 
maturation-inducing steroid membrane receptor in spotted seatrout ovaries and their 
agonist and antagonist activities in an oocyte maturation bioassay. Biol Reprod 1997; 57: 
999-1007. 
211. Yoshikuni M, Matsushita H, Shibata N, Nagahama Y. Purification and characterization of 
17 alpha,20 beta-dihydroxy-4-pregnen-3-one binding protein from plasma of rainbow trout, 
Oncorhynchus mykiss. Gen Comp Endocrinol 1994; 96: 189-196. 
212. Liu Z, Patino R. High-affinity binding of progesterone to the plasma membrane of 
Xenopus oocytes: characteristics of binding and hormonal and developmental control. Biol 
Reprod 1993; 49: 980-988. 
213. Thomas P, Zhu Y, Pace M. Progestin membrane receptors involved in the meiotic 
maturation of teleost oocytes: a review with some new findings. Steroids 2002; 67: 511-
517. 
214. Thomas P, Pinter J, Das S. Upregulation of the maturation-inducing steroid membrane 
receptor in spotted seatrout ovaries by gonadotropin during oocyte maturation and its 
physiological significance. Biol Reprod 2001; 64: 21-29. 
215. Patino R, Bolamba D, Thomas P, Kumakura N. Effects of external pH on hormonally 
regulated ovarian follicle maturation and ovulation in Atlantic croaker. Gen Comp 
Endocrinol 2005; 141: 126-134. 
216. Patino R, Yoshizaki G, Thomas P, Kagawa H. Gonadotropic control of ovarian follicle 
maturation: the two-stage concept and its mechanisms. Comp Biochem Physiol B Biochem 
Mol Biol 2001; 129: 427-439. 
217. Sabeur K, Edwards DP, Meizel S. Human sperm plasma membrane progesterone 
receptor(s) and the acrosome reaction. Biol Reprod 1996; 54: 993-1001. 
218. Cheng FP, Fazeli AR, Voorhout WF, Tremoleda JL, Bevers MM, Colenbrander B. 
Progesterone in mare follicular fluid induces the acrosome reaction in stallion spermatozoa 
and enhances in vitro binding to the zona pellucida. Int J Androl 1998; 21: 57-66. 
219. Gwo JC. Ultrastructural study of osmolality effect on spermatozoa of three marine teleosts. 
Tissue Cell 1995; 27: 491-497. 
220. Tubbs C, Pace M, Thomas P. Expression and gonadotropin regulation of membrane 
progestin receptor alpha in Atlantic croaker (Micropogonias undulatus) gonads: Role in 
gamete maturation. Gen Comp Endocrinol 2009. 
221. Thomas P, Pang Y, Zhu Y, Detweiler C, Doughty K. Multiple rapid progestin actions and 
progestin membrane receptor subtypes in fish. Steroids 2004; 69: 567-573. 
222. Finet B, Jalabert B, Garg SK. Effect of defolliculation and 17 alpha-hydroxy, 20 beta-
dihydroprogesterone on cyclic AMP level in full-grown oocytes of the rainbow trout, 
Salmo gairdneri. Gamete Res 1988; 19: 241-252. 
223. Luconi M, Forti G, Baldi E. Pathophysiology of sperm motility. Front Biosci 2006; 11: 
1433-1447. 
224. Teves ME, Barbano F, Guidobaldi HA, Sanchez R, Miska W, Giojalas LC. Progesterone at 
the picomolar range is a chemoattractant for mammalian spermatozoa. Fertil Steril 2006; 
86: 745-749. 
225. Revelli A, Modotti M, Piffaretti-Yanez A, Massobrio M, Balerna M. Steroid receptors in 
human spermatozoa. Hum Reprod 1994; 9: 760-766. 
Membrane progesterone receptors in the fallopian tube 
77 
226. Uhler ML, Leung A, Chan SY, Wang C. Direct effects of progesterone and 
antiprogesterone on human sperm hyperactivated motility and acrosome reaction. Fertil 
Steril 1992; 58: 1191-1198. 
227. Spehr M, Schwane K, Riffell JA, Barbour J, Zimmer RK, Neuhaus EM, Hatt H. Particulate 
adenylate cyclase plays a key role in human sperm olfactory receptor-mediated 
chemotaxis. J Biol Chem 2004; 279: 40194-40203. 
228. Baxendale RW, Fraser LR. Evidence for multiple distinctly localized adenylyl cyclase 
isoforms in mammalian spermatozoa. Mol Reprod Dev 2003; 66: 181-189. 
229. Defer N, Marinx O, Poyard M, Lienard MO, Jegou B, Hanoune J. The olfactory adenylyl 
cyclase type 3 is expressed in male germ cells. FEBS Lett 1998; 424: 216-220. 
230. Livera G, Xie F, Garcia MA, Jaiswal B, Chen J, Law E, Storm DR, Conti M. Inactivation 
of the mouse adenylyl cyclase 3 gene disrupts male fertility and spermatozoon function. 
Mol Endocrinol 2005; 19: 1277-1290. 
231. Spehr M, Gisselmann G, Poplawski A, Riffell JA, Wetzel CH, Zimmer RK, Hatt H. 
Identification of a testicular odorant receptor mediating human sperm chemotaxis. Science 
2003; 299: 2054-2058. 
232. Luconi M, Baldi E. How do sperm swim? Molecular mechanisms underlying sperm 
motility. Cell Mol Biol (Noisy-le-grand) 2003; 49: 357-369. 
233. Monkkonen KS, Aflatoonian R, Lee KF, Yeung WS, Tsao SW, Laitinen JT, Tuckerman 
EM, Li TC, Fazeli A. Localization and variable expression of G alpha(i2) in human 
endometrium and Fallopian tubes. Hum Reprod 2007; 22: 1224-1230. 
234. Monkkonen KS, Aflatoonian R, Lee KF, Yeung WS, Tsao SW, Laitinen JT, Fazeli A. 
Hormonal regulation of Galphai2 and mPRalpha in immortalized human oviductal cell line 
OE-E6/E7. Mol Hum Reprod 2007; 13: 845-851. 
235. Salathe M. Regulation of mammalian ciliary beating. Annu Rev Physiol 2007; 69: 401-
422. 
236. Smith R, Mesiano S, McGrath S. Hormone trajectories leading to human birth. Regul Pept 
2002; 108: 159-164. 
237. Walsh SW, Stanczyk FZ, Novy MJ. Daily hormonal changes in the maternal, fetal, and 
amniotic fluid compartments before parturition in a primate species. J Clin Endocrinol 
Metab 1984; 58: 629-639. 
238. Blois SM, Joachim R, Kandil J, Margni R, Tometten M, Klapp BF, Arck PC. Depletion of 
CD8+ cells abolishes the pregnancy protective effect of progesterone substitution with 
dydrogesterone in mice by altering the Th1/Th2 cytokine profile. J Immunol 2004; 172: 
5893-5899. 
239. Bamberger CM, Else T, Bamberger AM, Beil FU, Schulte HM. Dissociative glucocorticoid 
activity of medroxyprogesterone acetate in normal human lymphocytes. J Clin Endocrinol 
Metab 1999; 84: 4055-4061. 
240. Turgeon JL, Waring DW. Progesterone regulation of the progesterone receptor in rat 
gonadotropes. Endocrinology 2000; 141: 3422-3429. 
241. Waring DW, Turgeon JL. A pathway for luteinizing hormone releasing-hormone self-
potentiation: cross-talk with the progesterone receptor. Endocrinology 1992; 130: 3275-
3282. 
242. O'Byrne KT, Thalabard JC, Grosser PM, Wilson RC, Williams CL, Chen MD, Ladendorf 
D, Hotchkiss J, Knobil E. Radiotelemetric monitoring of hypothalamic gonadotropin-
releasing hormone pulse generator activity throughout the menstrual cycle of the rhesus 
monkey. Endocrinology 1991; 129: 1207-1214. 
243. Skinner DC, Evans NP, Delaleu B, Goodman RL, Bouchard P, Caraty A. The negative 
feedback actions of progesterone on gonadotropin-releasing hormone secretion are 
transduced by the classical progesterone receptor. Proc Natl Acad Sci U S A 1998; 95: 
10978-10983. 
244. Qiu HB, Lu SS, Ji KL, Song XM, Lu YQ, Zhang M, Lu KH. Membrane progestin receptor 
beta (mPR-beta): A protein related to cumulus expansion that is involved in in vitro 
maturation of pig cumulus-oocyte complexes. Steroids 2008; 73: 1416-1423. 
245. Szekeres-Bartho J, Szekeres G, Debre P, Autran B, Chaouat G. Reactivity of lymphocytes 
to a progesterone receptor-specific monoclonal antibody. Cell Immunol 1990; 125: 273-
283. 
246. Delmotte P, Sanderson MJ. Ciliary beat frequency is maintained at a maximal rate in the 
small airways of mouse lung slices. Am J Respir Cell Mol Biol 2006; 35: 110-117. 
Magdalena Nutu 
247. Braun T, Dods RF. Development of a Mn-2+-sensitive, "soluble" adenylate cyclase in rat 
testis. Proc Natl Acad Sci U S A 1975; 72: 1097-1101. 
248. Schmid A, Sutto Z, Nlend MC, Horvath G, Schmid N, Buck J, Levin LR, Conner GE, 
Fregien N, Salathe M. Soluble adenylyl cyclase is localized to cilia and contributes to 
ciliary beat frequency regulation via production of cAMP. J Gen Physiol 2007; 130: 99-
109. 
249. Fan H, Zingarelli B, Peck OM, Teti G, Tempel GE, Halushka PV, Spicher K, Boulay G, 
Birnbaumer L, Cook JA. Lipopolysaccharide- and gram-positive bacteria-induced cellular 
inflammatory responses: role of heterotrimeric Galpha(i) proteins. Am J Physiol Cell 
Physiol 2005; 289: C293-301. 
250. Shinohara H, Asano T, Kato K, Kameshima T, Semba R. Localization of a G protein Gi2 
in the cilia of rat ependyma, oviduct and trachea. Eur J Neurosci 1998; 10: 699-707. 
251. Salathe M, Pratt MM, Wanner A. Protein kinase C-dependent phosphorylation of a ciliary 
membrane protein and inhibition of ciliary beating. J Cell Sci 1993; 106 ( Pt 4): 1211-
1220. 
252. Sirois J, Dore M. The late induction of prostaglandin G/H synthase-2 in equine 
preovulatory follicles supports its role as a determinant of the ovulatory process. 
Endocrinology 1997; 138: 4427-4434. 
253. Groothuis PG, Dassen HH, Romano A, Punyadeera C. Estrogen and the endometrium: 
lessons learned from gene expression profiling in rodents and human. Hum Reprod Update 
2007; 13: 405-417. 
254. Shao R, Ljungstrom K, Weijdegard B, Egecioglu E, Fernandez-Rodriguez J, Zhang FP, 
Thurin-Kjellberg A, Bergh C, Billig H. Estrogen-induced upregulation of AR expression 
and enhancement of AR nuclear translocation in mouse fallopian tubes in vivo. Am J 
Physiol Endocrinol Metab 2007; 292: E604-614. 
255. Christakos S, Bahl OP. Pregnant mare serum gonadotropin. Purification and 
physicochemical, biological, and immunological characterization. J Biol Chem 1979; 254: 
4253-4261. 
256. Murphy BD, Martinuk SD. Equine chorionic gonadotropin. Endocr Rev 1991; 12: 27-44. 
257. Segaloff DL, Ascoli M. The lutropin/choriogonadotropin receptor ... 4 years later. Endocr 
Rev 1993; 14: 324-347. 
258. Neal P, Baker TG. Response of mouse ovaries in vivo and in organ culture to pregnant 
mare's serum gonadotrophin and human chorionic gonadotrophin. J Reprod Fertil 1974; 37: 
399-404. 
259. Howell A, Osborne CK, Morris C, Wakeling AE. ICI 182,780 (Faslodex): development of 
a novel, "pure" antiestrogen. Cancer 2000; 89: 817-825. 
260. Gainer EE, Ulmann A. Pharmacologic properties of CDB(VA)-2914. Steroids 2003; 68: 
1005-1011. 
261. Wakeling AE, Bowler J. Steroidal pure antioestrogens. J Endocrinol 1987; 112: R7-10. 
262. Wakeling AE, Dukes M, Bowler J. A potent specific pure antiestrogen with clinical 
potential. Cancer Res 1991; 51: 3867-3873. 
263. Wade GN, Blaustein JD, Gray JM, Meredith JM. ICI 182,780: a pure antiestrogen that 
affects behaviors and energy balance in rats without acting in the brain. Am J Physiol 
1993; 265: R1392-1398. 
264. Howell A, DeFriend DJ, Robertson JF, Blamey RW, Anderson L, Anderson E, Sutcliffe 
FA, Walton P. Pharmacokinetics, pharmacological and anti-tumour effects of the specific 
anti-oestrogen ICI 182780 in women with advanced breast cancer. Br J Cancer 1996; 74: 
300-308. 
265. Reel JR, Hild-Petito S, Blye RP. Antiovulatory and postcoital antifertility activity of the 
antiprogestin CDB-2914 when administered as single, multiple, or continuous doses to rats. 
Contraception 1998; 58: 129-136. 
266. Attardi BJ, Burgenson J, Hild SA, Reel JR. In vitro antiprogestational/antiglucocorticoid 
activity and progestin and glucocorticoid receptor binding of the putative metabolites and 
synthetic derivatives of CDB-2914, CDB-4124, and mifepristone. J Steroid Biochem Mol 
Biol 2004; 88: 277-288. 
267. Hild SA, Reel JR, Hoffman LH, Blye RP. CDB-2914: anti-progestational/anti-
glucocorticoid profile and post-coital anti-fertility activity in rats and rabbits. Hum Reprod 
2000; 15: 822-829. 
268. Heikinheimo O. Clinical pharmacokinetics of mifepristone. Clin Pharmacokinet 1997; 33: 
7-17. 
Membrane progesterone receptors in the fallopian tube 
79 
269. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J Biol 
Chem 1981; 256: 1604-1607. 
270. Brusca JS, Radolf JD. Isolation of integral membrane proteins by phase partitioning with 
Triton X-114. Methods Enzymol 1994; 228: 182-193. 
271. Fujii E, Mellon SH. Regulation of uterine gamma-aminobutyric acid(A) receptor subunit 
expression throughout pregnancy. Endocrinology 2001; 142: 1770-1777. 
272. Dalhamn T, Rylander R. Frequency of ciliary beat measured with a photo-sensitive cell. 
Nature 1962; 196: 592-593. 
273. Lee WI, Verdugo P. Laser light-scattering spectroscopy: a new application in the study of 
ciliary activity. Biophys J 1976; 16: 1115-1119. 
274. Verdugo P, Golborne CE. Remote detection of ciliary movement by fiber optic laser-
Doppler spectroscopy. IEEE Trans Biomed Eng 1988; 35: 303-307. 
275. Svartengren K, Wiman LG, Thyberg P, Rigler R. Laser light scattering spectroscopy: a 
new method to measure tracheobronchial mucociliary activity. Thorax 1989; 44: 539-547. 
276. Tokumoto M, Nagahama Y, Thomas P, Tokumoto T. Cloning and identification of a 
membrane progestin receptor in goldfish ovaries and evidence it is an intermediary in 
oocyte meiotic maturation. Gen Comp Endocrinol 2006; 145: 101-108. 
277. Hagerty JA, Ortiz J, Reich D, Manzarbeitia C. Fungal infections in solid organ transplant 
patients. Surg Infect (Larchmt) 2003; 4: 263-271. 
278. Waldegger S, Beisse F, Apfel H, Breit S, Kolb HA, Haussinger D, Lang F. 
Electrophysiological effects of progesterone on hepatocytes. Biochim Biophys Acta 1995; 
1266: 186-190. 
279. Gilula NB, Satir P. The ciliary necklace. A ciliary membrane specialization. J Cell Biol 
1972; 53: 494-509. 
280. Jackson MR, Nilsson T, Peterson PA. Identification of a consensus motif for retention of 
transmembrane proteins in the endoplasmic reticulum. EMBO J 1990; 9: 3153-3162. 
281. Zheng W, Magid MS, Kramer EE, Chen YT. Follicle-stimulating hormone receptor is 
expressed in human ovarian surface epithelium and fallopian tube. Am J Pathol 1996; 148: 
47-53. 
282. Caligaris L, Astrada JJ, Taleisnik S. Biphasic effect of progesterone on the release of 
gonadotropin in rats. Endocrinology 1971; 89: 331-337. 
283. Bar-Ami S, Gitay-Goren H, Brandes JM. Different morphological and steroidogenic 
patterns in oocyte/cumulus-corona cell complexes aspirated at in vitro fertilization. Biol 
Reprod 1989; 41: 761-770. 
284. Guidobaldi HA, Teves ME, Unates DR, Anastasia A, Giojalas LC. Progesterone from the 
cumulus cells is the sperm chemoattractant secreted by the rabbit oocyte cumulus complex. 
PLoS ONE 2008; 3: e3040. 
285. Harper CV, Barratt CL, Publicover SJ. Stimulation of human spermatozoa with 
progesterone gradients to simulate approach to the oocyte. Induction of [Ca(2+)](i) 
oscillations and cyclical transitions in flagellar beating. J Biol Chem 2004; 279: 46315-
46325. 
286. Shao R, Weijdegard B, Fernandez-Rodriguez J, Egecioglu E, Zhu C, Andersson N, Thurin-
Kjellberg A, Bergh C, Billig H. Ciliated epithelial-specific and regional-specific expression 
and regulation of the estrogen receptor-beta2 in the fallopian tubes of immature rats: a 
possible mechanism for estrogen-mediated transport process in vivo. Am J Physiol 
Endocrinol Metab 2007; 293: E147-158. 
287. Levy C, Robel P, Gautray JP, De Brux J, Verma U, Descomps B, Baulieu EE. Estradiol 
and progesterone receptors in human endometrium: normal and abnormal menstrual cycles 
and early pregnancy. Am J Obstet Gynecol 1980; 136: 646-651. 
288. Pino AM, Devoto L, Soto E, Castro O, Sierralta W. Changes in cytosolic and nuclear 
estradiol receptors of normal Fallopian tube throughout the menstrual cycle. J Steroid 
Biochem 1982; 16: 193-197. 
289. Verhage HG, Akbar M, Jaffe RC. Cyclic changes in cytosol progesterone receptor of 
human fallopian tube. J Clin Endocrinol Metab 1980; 51: 776-780. 
290. Flores-Herrera H, Diaz-Cervantes P, De la Mora G, Zaga-Clavellina V, Uribe-Salas F, 
Castro I. A possible role of progesterone receptor in mouse oocyte in vitro fertilization 
regulated by norethisterone and its reduced metabolite. Contraception 2008; 78: 507-512. 
291. Amso NN, Crow J, Lewin J, Shaw RW. A comparative morphological and ultrastructural 
study of endometrial gland and fallopian tube epithelia at different stages of the menstrual 
cycle and the menopause. Hum Reprod 1994; 9: 2234-2241. 
Magdalena Nutu 
292. Pelletier G, Labrie C, Labrie F. Localization of oestrogen receptor alpha, oestrogen 
receptor beta and androgen receptors in the rat reproductive organs. J Endocrinol 2000; 
165: 359-370. 
293. Wang H, Eriksson H, Sahlin L. Estrogen receptors alpha and beta in the female 
reproductive tract of the rat during the estrous cycle. Biol Reprod 2000; 63: 1331-1340. 
294. Chambliss KL, Yuhanna IS, Anderson RG, Mendelsohn ME, Shaul PW. ERbeta has 
nongenomic action in caveolae. Mol Endocrinol 2002; 16: 938-946. 
295. Song RX, McPherson RA, Adam L, Bao Y, Shupnik M, Kumar R, Santen RJ. Linkage of 
rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway 
activation. Mol Endocrinol 2002; 16: 116-127. 
296. Wyckoff MH, Chambliss KL, Mineo C, Yuhanna IS, Mendelsohn ME, Mumby SM, Shaul 
PW. Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase 
through Galpha(i). J Biol Chem 2001; 276: 27071-27076. 
297. Razandi M, Pedram A, Park ST, Levin ER. Proximal events in signaling by plasma 
membrane estrogen receptors. J Biol Chem 2003; 278: 2701-2712. 
298. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of 
oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 
2000; 407: 538-541. 
299. Norman AW, Mizwicki MT, Norman DP. Steroid-hormone rapid actions, membrane 
receptors and a conformational ensemble model. Nat Rev Drug Discov 2004; 3: 27-41. 
300. Papathanasiou A, Djahanbakhch O, Saridogan E, Lyons RA. The effect of interleukin-6 on 
ciliary beat frequency in the human fallopian tube. Fertil Steril 2008; 90: 391-394. 
301. Spilman CH, Harper MJ. Effects of prostaglandins on oviductal motility and egg transport. 
Gynecol Invest 1975; 6: 186-205. 
302. Verdugo P. Ca2+-dependent hormonal stimulation of ciliary activity. Nature 1980; 283: 
764-765. 
303. Hunter RH, Einer-Jensen N. Pre-ovulatory temperature gradients within mammalian 
ovaries: a review. J Anim Physiol Anim Nutr (Berl) 2005; 89: 240-243. 
304. Hunter RH, Wilmut I. Sperm transport in the cow: peri-ovulatory redistribution of viable 
cells within the oviduct. Reprod Nutr Dev 1984; 24: 597-608. 
305. Bahat A, Tur-Kaspa I, Gakamsky A, Giojalas LC, Breitbart H, Eisenbach M. Thermotaxis 
of mammalian sperm cells: a potential navigation mechanism in the female genital tract. 
Nat Med 2003; 9: 149-150. 
306. Eisenbach M. Sperm chemotaxis. Rev Reprod 1999; 4: 56-66. 
307. Cicinelli E, Einer-Jensen N, Barba B, Luisi D, Alfonso R, Tartagni M. Blood to the cornual 
area of the uterus is mainly supplied from the ovarian artery in the follicular phase and 
from the uterine artery in the luteal phase. Hum Reprod 2004; 19: 1003-1008. 
308. Shi DS, Avery B, Greve T. Effects of temperature gradients on in vitro maturation of 
bovine oocytes. Theriogenology 1998; 50: 667-674. 
309. Sutto Z, Conner GE, Salathe M. Regulation of human airway ciliary beat frequency by 
intracellular pH. J Physiol 2004; 560: 519-532. 
310. Jung C, Fandos C, Lorenzo IM, Plata C, Fernandes J, Gené GG, Vazquez E, Valverde MA. 
Genomic and non genomic regulation of TRPV4 mediated effects in epithelial cells by 
progesterone. In: 6th international meeting Rapid Responses to Steroid Hormones. 
Alicante, Spain; 2009. 
311. Khan-Dawood FS, Dawood MY. Estrogen and progesterone receptor and hormone levels 
in human myometrium and placenta in term pregnancy. Am J Obstet Gynecol 1984; 150: 
501-505. 
312. Cicinelli E, Einer-Jensen N, Hunter RH, Cignarelli M, Cignarelli A, Colafiglio G, Tinelli 
R, Pinto V. Peritoneal fluid concentrations of progesterone in women are higher close to 
the corpus luteum compared with elsewhere in the abdominal cavity. Fertil Steril 2009; 92: 
306-310. 
313. Tang Y, Gong F, Lin G, Lu G. Early follicular progesterone concentrations and in vitro 
fertilization pregnancy outcomes. Fertil Steril 2007; 87: 991-994. 
314. Cicinelli E, Einer-Jensen N, Cignarelli M, Mangiacotti L, Luisi D, Schonauer S. 
Preferential transfer of endogenous ovarian steroid hormones to the uterus during both the 
follicular and luteal phases. Hum Reprod 2004; 19: 2001-2004. 
315. Casslen B. Uterine fluid volume. Cyclic variations and possible extrauterine contributions. 
J Reprod Med 1986; 31: 506-510. 
Membrane progesterone receptors in the fallopian tube 
81 
316. Kugler P, Wrobel KH, Wallner HJ, Heinzmann U. [Histochemical and histological 
investigations on the human Fallopian tube under different hormonal influences. II. 
Proliferative processes within endosalpingeal epithelium (author's transl)]. Arch Gynakol 
1977; 222: 197-211. 
317. Lyons RA, Djahanbakhch O, Saridogan E, Naftalin AA, Mahmood T, Weekes A, Chenoy 
R. Peritoneal fluid, endometriosis, and ciliary beat frequency in the human fallopian tube. 
Lancet 2002; 360: 1221-1222. 
318. Pinter J, Thomas P. Characterization of a progestogen receptor in the ovary of the spotted 
seatrout, Cynoscion nebulosus. Biol Reprod 1995; 52: 667-675. 
319. Pollow K, Inthraphuvasak J, Manz B, Grill HJ, Pollow B. A comparison of cytoplasmic 
and nuclear estradiol and progesterone receptors in human fallopian tube and endometrial 
tissue. Fertil Steril 1981; 36: 615-622. 
320. Smith DF, Toft DO. Steroid receptors and their associated proteins. Mol Endocrinol 1993; 
7: 4-11. 
321. Migliaccio A, Piccolo D, Castoria G, Di Domenico M, Bilancio A, Lombardi M, Gong W, 
Beato M, Auricchio F. Activation of the Src/p21ras/Erk pathway by progesterone receptor 
via cross-talk with estrogen receptor. EMBO J 1998; 17: 2008-2018. 
322. Dijkema R, Schoonen WG, Teuwen R, van der Struik E, de Ries RJ, van der Kar BA, 
Olijve W. Human progesterone receptor A and B isoforms in CHO cells. I. Stable 
transfection of receptor and receptor-responsive reporter genes: transcription modulation 
by (anti)progestagens. J Steroid Biochem Mol Biol 1998; 64: 147-156. 
323. Lorenzo IM, Liedtke W, Sanderson MJ, Valverde MA. TRPV4 channel participates in 
receptor-operated calcium entry and ciliary beat frequency regulation in mouse airway 
epithelial cells. Proc Natl Acad Sci U S A 2008; 105: 12611-12616. 
324. Garcia-Elias A, Lorenzo IM, Vicente R, Valverde MA. IP3 receptor binds to and sensitizes 
TRPV4 channel to osmotic stimuli via a calmodulin-binding site. J Biol Chem 2008; 283: 
31284-31288. 
325. Jung C, Fandos C, Lorenzo IM, Plata C, Fernandes J, Gene GG, Vazquez E, Valverde MA. 
The progesterone receptor regulates the expression of TRPV4 channel. Pflugers Arch 2009. 
326. Salathe M, Lipson EJ, Ivonnet PI, Bookman RJ. Muscarinic signaling in ciliated tracheal 
epithelial cells: dual effects on Ca2+ and ciliary beating. Am J Physiol 1997; 272: L301-
310. 
327. Barrera NP, Morales B, Villalon M. Plasma and intracellular membrane inositol 1,4,5-
trisphosphate receptors mediate the Ca(2+) increase associated with the ATP-induced 
increase in ciliary beat frequency. Am J Physiol Cell Physiol 2004; 287: C1114-1124. 
328. Nlend MC, Schmid A, Sutto Z, Ransford GA, Conner GE, Fregien N, Salathe M. Calcium-
mediated, purinergic stimulation and polarized localization of calcium-sensitive adenylyl 
cyclase isoforms in human airway epithelia. FEBS Lett 2007; 581: 3241-3246. 
329. Lieb T, Frei CW, Frohock JI, Bookman RJ, Salathe M. Prolonged increase in ciliary beat 
frequency after short-term purinergic stimulation in human airway epithelial cells. J 
Physiol 2002; 538: 633-646. 
330. Monkkonen KS, Hakumaki JM, Hirst RA, Miettinen RA, O'Callaghan C, Mannisto PT, 
Laitinen JT. Intracerebroventricular antisense knockdown of G alpha i2 results in ciliary 
stasis and ventricular dilatation in the rat. BMC Neurosci 2007; 8: 26. 
331. Pasanen S, Ylikomi T, Syvala H, Tuohimaa P. Distribution of progesterone receptor in 
chicken: novel target organs for progesterone and estrogen action. Mol Cell Endocrinol 
1997; 135: 79-91. 
332. Camacho-Arroyo I, Ruiz A, Gamboa-Dominguez A, Perez-Palacios G, Cerbon MA. 
Immunohistochemical localization of intracellular progesterone and glucocorticoid 
receptors in the rabbit lung. J Endocrinol 1994; 142: 311-316. 
 
 
 
 
 
 
